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 i 
Résumé 
Le nœud sinusal (NS) est le centre de l‟automatisme cardiaque. Grâce à son activité 
électrique spontanée, il dicte la fréquence cardiaque (FC) en réponse aux demandes 
physiologiques. A ce jour, le NS demeure un sujet de recherche important puisque les 
mécanismes moléculaires responsables de sa régulation sont encore méconnus. Par exemple, 
les processus menant à la bradycardie sinusale et à la maladie du sinus (MS) chez les 
personnes âgées sont mécompris et présentement l‟implantation d‟un stimulateur cardiaque 
demeure le seul traitement disponible. Ainsi, l‟objectif de cette thèse était de déterminer les 
changements moléculaires et cellulaires se produisant au niveau du NS en réponse à divers 
stimuli physiologiques et pathologiques afin d'établir leurs rôles potentiels dans la régulation 
de la FC et le développement de la MS. 
Dans les deux premiers chapitres, la grossesse est présentée comme modèle 
physiologique. En effet, la réponse adaptative aux demandes croissantes de la mère et du fœtus 
engendre des changements physiologiques considérables au niveau du myocarde, dont une 
augmentation de la FC essentielle pour la perfusion adéquate des organes. Toutefois, cette 
augmentation peut aussi favoriser le développement d‟arythmies.  
Dans le troisième chapitre, l‟inflammation, un facteur présent lors du vieillissement et 
dans plusieurs pathologies où la MS se manifeste, a fait l‟objet d‟une étude dans le but de 
déterminer son rôle dans le développement de la MS.  
Les résultats obtenus dans cette thèse démontrent que la grossesse induit une hausse de 
la FC chez la souris gestante similaire à celle retrouvée chez la femme enceinte. Cette 
accélération était due à un remodelage électrique du NS. Plus spécifiquement, la fréquence des 
potentiels d‟action ainsi que la densité et l‟expression des courants pacemaker (If) et calcique 
de type L (ICaL) étaient augmentées. De plus, une accélération des transitoires calciques 
spontanés et de la vitesse de relâche calcique du réticulum sarcoplasmique a été observée. 
La régulation de l‟automaticité par un stimulus pathologique, l‟interleukine-1β, est 
abordée par la suite. L‟interleukine-1β, une cytokine ayant un rôle majeur comme médiateur 
inflammatoire, se retrouve en concentrations élevées dans plusieurs maladies associées avec la 
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MS. Nos résultats démontrent que l‟interleukine-1β engendre une diminution de l‟automaticité 
associée à une réduction de If et ICaL dans les cardiomyocytes humains de type nodal dérivés 
de cellules souches induites pluripotentes (hiPSC-CM). En parallèle, le phénotype 
électrophysiologique et moléculaire des hiPSC-CM a été caractérisé démontrant leur 
homologie avec les cellules du NS humain adulte, les validant comme modèle in vitro de 
cellules nodales humaines.  
En conclusion, les études présentées dans cette thèse démontrent que le NS est plus 
qu‟un simple tissu régulé par l‟innervation autonome. En effet, son automaticité est 
dynamique et peut être influencée par des facteurs physiologiques ou pathologiques. Nos 
résultats contribuent ainsi à une meilleure compréhension des mécanismes sous-jacents à 
l‟automaticité. Ces avancées sont importantes non seulement pour la santé des femmes, mais 
aussi pour les individus souffrant de la MS. À terme, nous espérons que ces résultats 
contribueront au développement de stratégies thérapeutiques pour traiter des complications 
liées aux troubles d‟automaticité cardiaque. 
 
Mots-clés : Nœud sinusal, maladie du sinus, automaticité, fréquence cardiaque, 
arythmies, grossesse, inflammation, interleukine-1β, hiPSC-CM 
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Abstract 
The sinoatrial node (SAN) is the dominant cardiac pacemaker. With its spontaneous 
automaticity, it dictates rhythm and controls heart rate in response to varying physiological 
demands. Despite its modest size, the SAN is a very heterogeneous and complex structure that 
remains the topic of research efforts due, in part, to uncertainties in the mechanisms that 
regulate pacemaking in various conditions. For instance, the processes that lead to severe sinus 
bradycardia and SAN dysfunction (SND) in the elderly are unknown and to date, the 
implantation of electronic pacemaker remains the only SND treatment. Accordingly, the 
overall objective of this thesis was to explore and highlight the molecular and cellular changes 
that occur within the SAN in both physiological and pathological states, while determining 
how they contribute to regulation of heart rate and potentially SND.  
In the first two chapters, we present pregnancy as a physiological model considering it 
is a period during which substantial adaptive changes to the myocardium and increases in 
heart rate occur. Paradoxically, the rapid rate, which is essential for adequate organ perfusion 
of both mother and foetus, may also increase vulnerability to certain arrhythmias.  
In the third chapter, inflammation, a central process in pathology and common factor to 
several diseases and even ageing, was evaluated as potential underlying circumstance 
contributing to the development of sinus bradycardia and SND. Combinations of in vivo, ex 
vivo, biochemical, molecular and cellular approaches were used in order to generate an 
integrated understanding of the models we examined. 
Our data shows that in pregnant mice, an increase in heart rate similar to that of 
pregnant women occurs and was due to an electrical remodelling of the SAN. Specifically, an 
increase in action potential frequency of isolated individual SAN cells was observed. This was 
attributed to increased expression and density of pacemaker (If) and L-type Ca
2+
 currents (ICaL) 
along with a rapid spontaneous Ca
2+
 transient  rate and faster intracellular sarcoplasmic 
reticulum Ca
2+ 
release. 
We then demonstrate that the pro-inflammatory cytokine interleukin-1β which is a 
major inflammatory mediator that is upregulated in several diseases associated with SND, 
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dramatically slows automaticity by reducing If and ICaL density in nodal-like cardiomyocytes 
derived from human-induced pluripotent stem cells (hiPSC-CM). Importantly, in that study, 
hiPSC-CMs were also physiologically and molecularly characterized revealing their high 
resemblance to adult human SAN and a potential use as a novel in vitro model to study 
pacemaking in humans. 
 In conclusion, the results of this thesis demonstrate that the SAN is not a simple, 
neurally controlled tissue, but a rather dynamic pacemaker that undergoes extensive intrinsic 
remodelling during states of health and disease. The results contribute to understanding 
physiological mechanisms of pacemaking and how they are altered by disease and may be 
relevant for both women‟s health and the individuals affected by SND. Ultimately, we hope 
these findings will be helpful in the development of therapeutic strategies to treat pacemaking-
related complications. 
Keywords : Sinoatrial node, sinus node disease, pacemaking, heart rate, arrhythmias, 
pregnancy, inflammation, interleukin-1β, hiPSC-CM. 
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1 Introduction 
 
 Cardiac contraction is triggered by a finely coordinated electrical influx that 
propagates across the myocardial tissue. This electrical activity must remain synchronized and 
this is achieved thanks to various specialized structures within the heart that have evolved to 
transmit electrical impulses. Together, these tissues form what is known as the cardiac 
conduction system. The conduction system is comprised of both slow and fast conducting 
components: the sinoatrial node (SAN), a complete atrio-ventricular conduction axis which 
includes Bachmann‟s bundle as well as anterior, middle, and posterior internodal tracts that 
terminate at the atrio-ventricular (AV) node, the His bundle and branches and the Purkinje 
fibres (Figure 1).
1,2
 While both nodes possess automaticity and are slow conducting, the SAN 
is the dominant pacemaker that initiates the depolarization and the AV node may act as an 
accessory pacemaker if required. Thus, in case of SAN failure, the AV node is capable of 
stimulating the ventricles, albeit at  much slower rate.
3
 As the primary pacemaker, the SAN 
generates an impulse that is rapidly propagated across the atrial tissue before reaching the AV 
node where it gets delayed. This slowing in conduction allows the ventricles enough time to 
recover from the previous cardiac cycle before transmitting the electrical influx through the 
fast conducting His bundle and branches and the Purkinje fibre network.
4
 The atrioventricular 
node is therefore the connecting point between the atrial and ventricular conduction pathways 
 Representation of the human Figure 1.
cardiac conduction system (Wikimedia 
commons). 
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and interestingly, in cases of rapid atrial pacing or fibrillation it can also block the impulse in 
order to protect the ventricles from arrhythmias. Once the impulse is transmitted to the 
ventricles, it spreads through the fast conducting and large network of fibres that allow 
propagation of the impulse deep within both ventricles simultaneously and in an apical to 
basal fashion i.e. from the base of the ventricles, upwards. The resulting cardiac contraction is 
thereby optimized for ejecting blood towards the pulmonary arteries and aorta.
3
 Although the 
conduction system has been subject to investigation for more than a century now, much 
remains to be discovered. The work presented in this thesis will focus exclusively on the SAN, 
the specialized pacemaking cardiac tissue. After introducing the current state of knowledge, 
three articles related to SAN regulation will be presented. In brief, these studies delve into a 
relatively novel concept that portrays the SAN as an adaptive master regulator of heart rate. 
We propose that this specialized tissue is not static, but a rather dynamic pacemaker that can 
undergo extensive remodelling in response to both physiological and pathological stimuli. We 
present two models relevant healthy and pathological states, respectively, and by using a wide 
array of electrophysiological, cellular, molecular and imaging tools, we provide data showing 
how the pacemaking mechanisms were altered in each of these instances. Nonetheless, before 
presenting the data it will be important to review the SAN and place into its historical, 
anatomical and functional context. 
 
1.1 The sinoatrial node: 110 years since its discovery 
Sir Arthur Keith was a Scottish anatomist, anthropologist, evolutionary biologist and 
demonstrator at the London Hospital. Over the course of his career, he published numerous 
articles and books, held prestigious academic positions and through his work, presentations 
and honours became an internationally known scientist.
5
 In the early 1900s, Keith was 
particularly interested by the heart and its anatomy. For years he thoroughly and meticulously 
examined cardiac preparations and specimens derived from various species including human 
and rodents. Eventually, this led him to believe that he knew everything about this fascinating 
biological pump.  
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Rather confidently, he decided one day to draft a letter to The Lancet denying the 
existence of a newly described cardiac feature, the AV node and conducting bundle, which he 
constantly failed to find in his preparations.
6
 First extensively described by Sunao Tawara in 
1906, the AV node discovery was published in German in a seminal paper entitled Das 
Reizleitungssystem Des Säugetierherzens (The conduction system of the mammalian heart). 
Tawara was a Japanese anatomist working under the supervision of pathologist Ludwig 
Aschoff in Germany and in his paper he described a structure at the end of the His bundle 
shaped into a “complex knotten” that, along with Purkinje fibers, formed a conduction system 
for the cardiac impulse.
5
 Fortunately, after one additional search, Keith was finally able to find 
these structures and humbly admitted his oversights. He consequently amended the letter, 
which now corroborated Tawara‟s findings and sent it for publication.7 
By the late summer 1906, Keith was still investigating cardiac anatomy in the study of 
his cottage in Kent, England. He actually transformed the study room into a laboratory, 
equipping it with ovens, microtomes, microscopes and a large supply of human and animal 
heart tissues. Quite unusual by today‟s standards, animals were mostly captured by traps and 
they included rats, mice, moles and hedgehogs, probably caught around the neighbouring 
gardens and vast parks of the Kent area.  The idea behind this entire setup was to try and 
extend the work of Tawara, searching for irregular tissues within the heart. Keith had recruited 
a young fellow, Martin Flack, an Oxford graduate interested in pursuing a medical career.
6
 
Flack was the son of a local grocer and Keith was immediately delighted by his personality 
and ambition. One day after a hot summer bicycle ride with his wife, Keith came back to the 
cottage to find Flack staring at a peculiar structure under the microscope. It was near the sinus 
venosus region and while examining the hearts of the different species they had in their 
possession, they were always capable of tracing this structure right to the sino-atrial junction. 
In fact, it tremendously resembled the “knotten” previously described by Tawara, albeit, it was 
further upwards the AV node. The fibres of this section were somewhat striated, fusiform and 
densely packed in connective tissue. Keith and Flack also pointed out a close connection to the 
sympathetic and vagal nerves and a distinct artery irrigating the structure.
8
 This was indeed the 
first documented evidence of the SAN as we know it today and the findings of this 
breakthrough by Keith and Flack were published in 1907. With this paper, the last piece of the 
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puzzle was finally added; solving, at least anatomically, the conduction system and answering 
many questions related to the beating of the heart.  
Evidently, this was not the end, but merely the beginning of things. The SAN still 
needed functional validation and a few years later following its discovery, evidence 
elucidating the role of the SAN in the conduction system began to appear in the literature. 
Around 1909, using a setup consisting of a twin string galvanometer, Thomas Lewis was 
capable of measuring small electric currents at two locations on the heart simultaneously. By 
tracing the electrical impulse on a dog heart using this clever technique, he was able to 
pinpoint the exact location of the first electrical impulse. Sure enough, he found the SAN to be 
the precise site where the heart impulse was initiated. In 1924, when Einthoven, the inventor 
of the galvanometer for electrocardiography, was awarded the Nobel Prize, he heavily 
acknowledged Lewis and his findings which allowed the invention to serve a genuine purpose 
and actually be heard of.
5
 
 
1.2 Anatomy, molecular determinants and physiology of the SAN 
Fast forward to modern times and the SAN still fascinates many, including our group. 
There is still much to be learned and the SAN remains a source of discussion. Although 
nowadays, the debates have shifted from the old topics that questioned its importance in 
initiating the heartbeat to subjects related to the identity and contribution of various 
mechanisms within the SAN that are responsible for initiating the cardiac impulse. What are 
the molecular and electrophysiological characteristics on the SAN? How is the SAN regulated 
intrinsically and extrinsically? What role do physiological adaptations and disease play in 
regulating the SAN? These are only some of the fundamental questions being asked today; 
questions in which our laboratory has been particularly interested in and we hope, by the work 
presented herein, to provide some answers. Modern scientific tools including cellular, 
molecular and imaging techniques have allowed unprecedented insight into the SAN. With 
anatomy being one of the earliest investigated aspects of the SAN, the next section will debut 
by discussing the structure of the SAN and showing relatively recent computer-assisted data, 
resolving the 3-dimensional organization of the pacemaker tissue. 
 18 
1.2.1 Basic anatomy of the SAN 
The SAN is a small comma or crescent-shaped structure located at the junction of the 
right atrium and superior vena cava and extending down the crista terminalis. The cells within 
this structure do not resemble working myocardium myocytes but instead they are packed in 
connective and fibrous tissue, small and irregular in shape.
9,10
 Indeed, in mice and other 
rodents, we find the average cellular capacitance of SAN cells to be around ~25-30 pF 
compared to ~70 and 150 pF for atrial and ventricular myocytes, respectively. When the SAN 
is enzymatically digested and cells released, the SAN cells are distinguishable by their 
heterogeneous morphology that falls into three different categories as shown in Figure 2. 
 
 
  
 Morphology of isolated individual SAN cells. Following enzymatic Figure 2.
digestion of the SAN individual nodal cells can be obtained. Top- Isolated rabbit 
SAN cells yield three distinct nodal cell shapes: elongated spindle, spindle and 
spider-like cells that differ drastically from atrial myocytes. SAN beat spontaneously 
under normal conditions. Bottom- Similar shapes are found in isolated mouse SAN 
cells. Cells are labelled in red for pacemaker ion channel HCN4, signature ion 
channel of the SAN. Modified from Verheijck et al. 1998 and Herrmann 2012.
10,25
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While the SAN has been classically reported as a nodule within the right atria, 
evidence suggests that its structure in humans is very heterogeneous and complex, even more 
so than in small mammals. Indeed it was reported that not only does the length of the SAN 
vary, but its location and orientation too, shifting from epicardial to endocardial.
11
 
Furthermore, the cells within the entire SAN region are also highly heterogeneous in shape 
and function while also varying amongst species. The SAN can be divided into two main 
distinct regions, so called a “head” and “tail”. Closely surrounding the sinus node artery 
(Figure 3), cells have poorly structured myofilaments, low number of mitochondria and 
irregular shapes such as spindle and “spider” (Figure 2).12,13 The myocytes in the head region 
are thought to form the dominant pacemaker, although under some circumstances, such as 
vagal stimulation, the leading pacemaker can shift to other areas of the SAN including the tail, 
which is lower, and runs parallel to the crista terminalis.
14
 Nodal cells are evidently known for 
their distinct slow and spontaneous depolarization slope, depolarized potential and distinct 
action potential configuration that show sustained automaticity and of course, high expression 
 Histology of the SAN. Masson‟s trichrome stain of human SAN Figure 3.
showing cardiac muscle in red and connective tissue in blue. The SAN body 
with its central sinus artery, packed in fibrous tissue, is encircled with a red line. 
The black line runs around a recently identified paranodal area. Modified from 
Dobrzynski H. et al. 2013.
2
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of hyperpolarization-activated pacemaker channels, HCN.
15
 However, moving towards the 
periphery of the SAN, cells begin to have mixed nodal and atrial phenotype. The transition 
into peripheral myocytes occurs gradually as nodal cells begin to progressively acquire atrial 
traits such as bigger size, organized myofilaments and structure as well as expressing atrial ion 
channels and in fact, these cells have even been found to interweave with atrial myocytes at 
some levels (Figure 4).
11
 Electrophysiological studies showed that these peripheral nodal cells 
have a certain degree of atrial electrophysiological properties as well, consistent with the 
gradient model of SAN heterogeneity, stating that nodal cells progressively acquire an 
increasing number of atrial traits the further they move away from the centre of the SAN. 
Indeed, although peripheral nodal myocytes retain their spontaneity, the action potential of 
these cells acquires faster, atrial-like phase 0 depolarization associated with higher expression 
of fast Na
+
 channel
16
 in addition to an increased expression of a major resting membrane 
potential channel Kir2.1, and fast-conducting connexin 43 compared to centre node cells 
(these channels will be discussed in more detail in the next sections).
17,18
 It is important to note 
 Computer reconstruction of rabbit SAN. Left- Location of the SAN Figure 4.
within the right atria is shown from endocardium and epicardium views. Lines 
indicate cell orientation. Right- Schematic diagram of the SAN and its peripheral 
tissue in the heart. Ao indicates aorta; SVC, superior vena cava; PV, pulmonary 
vein; CS, coronary sinus; IVC, inferior vena cava; RA, right atria; RV, right 
ventricle. Modified from Dobrzynski et al. 2005.
3
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that the peripheral SAN region also contains atrial myocytes. The presence of these myocytes 
along with nodal cells supports the mosaic effect model of SAN heterogeneity where the 
atrial/nodal cell proportion, but not individual properties, progressively increases with further 
distance from centre of the SAN.
12,19
 Considering the SAN is surrounded by atrial tissue, these 
peripheral cells are thought to play a critical role in shielding the SAN from the inhibitory 
adjacent hyperpolarized potentials while preventing the centre of the node of becoming a 
source of re-entry in addition to efficiently regulating impulse exit and propagation towards 
the adjacent atria tissue.
17,20
 While overall these various structures seem to be relatively 
conserved across species, in human SAN, they appear to be even more complex. A few years 
ago, a morphologically distinct paranodal region (Figure 3) was identified and characterized in 
human SAN preparations. With its mix of atrial and nodal myocytes, the paranodal region is 
hypothesized to serve an impulse exit function, analogous to the rabbit periphery SAN 
discussed above (Figure 4), although its exact role remains unknown (Figure 5).
9,21
 The 
paranodal is peculiar in a sense that it is much larger than the actual SAN, thus, it extends far 
more than expected into surrounding atrial tissue. It has myocytes that are loosely packed in 
adipose tissue and has lower expression levels of the signature pacemaker channel HCN4.
9
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 Computer reconstruction of human SAN and paranodal area. Figure 5.
Reconstructed models of the paranodal area wrapped around the SAN are shown 
from different views. Schematic representation (right) shows the SAN and paranodal 
area in a human heart with electrical propagation into the right atria. Action potentials 
of varying morphology (SN: sinus node; PA: paranodal area; RA: right atria) are also 
shown on the activation front along with activation time (ms). They originate from 
the leading pacemaker site, shown as a white dot. Ao indicates aorta; SVC, superior 
vena cava; PA, pulmonary artery, PV, pulmonary vein; IVC, inferior vena cava; RA, 
right atria; RV, right ventricle. Modified from Chandler et al. 2011.
21
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1.2.2 Physiology and pacemaking mechanism of the SAN 
The various genetic networks regulated during development and distinct expression 
pattern of ion channels, pumps and transporters are ultimately responsible for generating 
pacemaking capabilities within the SAN. Automaticity of the SAN can be electrically 
observed by recording action potentials (APs). Using the patch-clamp technique in current-
clamp mode, individual, spontaneously beating SAN cells can be patched and recorded. We 
extensively use this technique in our laboratory; and under physiological conditions with no 
stimulation or current injection, we observe spontaneous APs that have a distinct configuration 
that is very different from typical atrial and ventricular myocytes APs. Indeed, the hallmark 
feature of the SAN AP is the presence of a diastolic depolarization slope (phase 4) which 
highly influences pacing rate.
22
 During this phase, various voltage-gated channels and Ca
2+
-
dependent mechanisms participate in bringing membrane potential close to threshold potential 
of the AP by depolarizing the cell allowing it to fire an AP.
15
 This is in clear contrast to 
working myocardium where Kir2.x channels impose a resting potential of around -80 mV, as 
the cell awaits the next stimulation. 
 These basic pacemaking mechanisms have been separated into two entities termed 
“voltage-clock” and “Ca2+-clock”. These clocks have, for years, fuelled heated debates over 
their individual importance and contribution to pacemaking.
23
 Today, there is general 
agreement that both of these mechanisms are important in their own respective way, mostly 
because blocking either one severely disturbs pacemaking. Thus, the more recent term 
“coupled-clock” was coined to reflect the substantial contribution of both mechanisms to SAN 
automaticity. These two clocks will first be reviewed individually before discussing their 
integrated function. 
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1.2.2.1 Voltage-Clock 
The voltage-clock, also known as M-clock, or membrane-clock consists of voltage-
gated membrane ion channels, and their underlying currents, that control cell membrane 
potential in the SAN. It includes the pacemaker funny channels, HCN, L and T-type Ca2+ 
channels and repolarizing K
+
 channels which are variable among species and include Kv4.3, 
Kv1.5, Kv7.1 and Kv11.1 (ERG).
9
 In mouse SAN, mERG, plays a major role in repolarization 
and driving down membrane potential.
24
  
Funny current (If): is encoded by HCN1-4, with HCN4 being the most importantly 
expressed isoform across several species, although HCN1 and 2 also contribute to human and 
mouse If, respectively.
9,17,25
 The funny current has been originally described more than 35 
years ago and tremendous amount of work has allowed it to evolve from a basic concept in 
cardiac physiology to a drug target for rate control with indications for angina and heart 
failure.
26,27
 Termed “funny” at the time because the current counter-intuitively activated with 
hyperpolarization  and was also found to be permeable to Na
+
 despite its signature K
+
 channel 
motif in the selectivity pore region. If  plays a crucial role in the early phase of the diastolic 
depolarization (DD) also known as phase 4 of the AP. Indeed, the repolarization of the AP, 
bringing membrane potentials below -50 mV, triggers the activation of the HCN channels 
which generate a strong inward current through permeation of Na
+
 and K
+
 resulting in 
increases in membrane potential and the beginning of the depolarization phase.
15
 A key feature 
of HCN channels is their regulation by cyclic nucleotides, notably cAMP which binds to a 
conserved cyclic nucleotide-binding domain (CNBD) in the C terminus.  Increases and 
decreases of intracellular cAMP levels, through sympathetic and parasympathetic tones for 
instance, will modify voltage-dependency of HCN channels leading to an increase or decrease 
in current density at diastolic potential. Consequently, the steepening or lowering of the 
depolarization slope, results in acceleration or deceleration of AP frequency, respectively.
28,29
 
Although all HCN channels share common structural and functional features, the sensitivity to 
cAMP, the voltage-dependence and the kinetics of the different isoforms varies. Indeed, 
HCN1 channels have the fastest kinetics and lowest cAMP sensitivity compared to HCN4 that 
is the slowest to activate while having the highest sensitivity to cAMP. In addition, HCN1 is 
known to activate at more hyperpolarized voltages compared to HCN4.
26,30,31
 HCN2 and 3 are 
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known to have intermediate properties that are found to be between those of HCN1 and 4. For 
instance, HCN2 has a lower cAMP sensitivity and activates faster than HCN4, although to a 
lesser extent than HCN1.
32
 Through knockout studies in the mouse, HCN2 has been shown to 
have a functional role in regulating resting heart rate while accounting for about 30% of If 
current in SAN cells. The presence of HCN2 thus, plays a role in regulating overall sensitivity 
to cAMP as well as overall kinetics.
33
 
T- and L- type Ca
2+
 currents (ICaT,  ICaL): In the SAN both T-type channel transcripts 
CaV3.1 and CaV3.2 are found although transgenic approaches seem to support a major 
functional role only for CaV3.1. Indeed, in CaV3.2
-/-
 knockout mice, no alterations in the ECG 
were noted while the CaV3.1
-/-
 mice had bradycardia suggesting altered SAN function. Further 
analysis revealed that SAN AP firing rate was significantly reduced in CaV3.1
-/-
 mice 
indicating a clear role for CaV3.1 in pacemaking.
34
  Since ICaT peaks rather negatively, at 
around -45 mV, its physiological role is thought to extend the If-induced depolarization (If 
conductance being close to nil at -40 mV), thereby bringing membrane potential further 
towards the activation threshold of L-type Ca
2+
 channels.
15
 Thus, ICaT is implicated in the mid 
DD phase and serves as an important link between If and ICaL that are essential in the early and 
late DD, respectively. In the SAN, there is a particular enrichment in CaV1.3 transcripts 
compared to the working myocardium that is abundant in CaV1.2. Functionally, it is estimated 
that ~70% of ICaL in the SAN is generated by CaV1.3.
9,35
 Since CaV1.3 activates more rapidly 
and at more negative membrane potentials compared to CaV1.2, this allows ICaL to have a more 
significant and efficient contribution to the diastolic depolarization in SAN cells. By 
beginning to activate towards -50 mV (close to peak ICaT), ICaL rapidly, drives the last end of 
the DD towards activation threshold and triggers the upstroke depolarization (phase 0) which 
also involves CaV1.2.
35
 
ERG channels (IKr):  In mouse SAN cells, the activation of the rapid component of the 
delayed rectifier K
+
 current (IKr, encoded by mERG1) is very important for the repolarization 
of the AP. Considering there is virtually no Kir2.1 (IK1) in the SAN and that stable resting 
potential cannot be achieved, the role of IKr and its deactivation become even more important 
for pacemaker depolarization.
24,36,37
 Specifically, the degree to which IKr can drive the 
repolarization is critical considering it will directly influence the initial phase of the 
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pacemaker depolarization, i.e. If activation.
37,38
 As such, block of IKr will not only result in 
prolongation of AP duration but it will also depolarize the maximal diastolic potential (MDP), 
which is usually around -60 mV in SAN, and as a result reduce the necessary activation of If 
and the other currents, further contributing to a lower AP frequency.  
1.2.2.2 Ca2+-clock mechanisms 
Although the SAN expresses the same L-type Ca
2+
 channels and RyR isoforms as atrial or 
ventricular cells, the mechanisms and functional role of Ca
2+ 
in the SAN is somewhat 
different. Indeed, in working myocytes, Ca
2+
 plays a critical role in inducing mechanical 
contraction of the cells.
39
 The ultrastructure and organization of myocytes, featuring dense T-
tubules, juxtaposing L-type Ca
2+
 and RyR channels ensure a rapid, efficient and cell-wide Ca
2+
 
release to trigger contraction in a phenomenon termed Ca
2+
-induced Ca
2+
-release.
40
 On the 
other hand, as a pacemaker, the SAN has arguably evolved to play a mostly electrical role as 
seen by the lack of T-tubules and contractile filaments.
39
 Thus, the Ca
2+
-induced Ca
2+
-release 
by which L-type Ca
2+ 
channels trigger the release of Ca
2+
 from the SR becomes essential for 
cellular depolarization and automaticity. Furthermore, this mechanism has been tweaked in the 
SAN to feature an additional component that is based of spontaneous Ca
2+
 releases and sparks. 
These Ca
2+
 sparks or local Ca
2+
 releases (LCRs) represent spontaneous releases of Ca
2+
 from 
the sarcoplasmic reticulum (SR) via RyR.
41
 Collectively, the rhythmic oscillations of 
intracellular Ca
2+
 that contribute to automaticity are referred to as the Ca
2+
-clock. 
Similarly to other cardiomyocytes, the RyRs are sensitive to ryanodine-dependent block or 
caffeine-induced channel opening through lowering of the Ca
2+
 activation threshold.
42
 
Furthermore, SAN RyRs are particularly sensitive to cytosolic Ca
2+ 
which can modulate 
amplitude and frequency of the spontaneous sparks. Compared to ventricular myocytes, it was 
found in the SAN that Ca
2+
-spark frequency and amplitude were significantly higher, in 
support of a bigger role for LCRs in these cells.
43
 Indeed, following Ca
2+
 entry through 
activation of ICaT, there is a local rise in Ca
2+
 concentrations that increases the LCRs. As a 
result, the electrogenic Na
+
/Ca
2+
 exchanger (NCX1) activates in forward mode exchanging 1 
Ca
2+
  for 3 Na
+
,
 
resulting in a net positive charge that accelerates the late phase of the DD 
driving it faster towards threshold potential.
41,44
 Once threshold is reached, opening of ICaL and 
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subsequent phase 0 upstroke triggers a massive Ca
2+
 release from the SR, that is comparable to 
a Ca
2+
 -induced Ca
2+
-release mechanism in working myocytes. Ca
2+
 is subsequently 
recaptured by SERCA2a, pumped into the SR as the remaining cytosolic Ca
2+
 gets extruded by 
NCX1. Overall, RyR2, NCX1, SERCA2a and its regulatory subunit phospholamban (PLB) are 
major proteins involved in the intracellular Ca
2+
 cycling in SAN and are essential for rhythmic 
activity.
23,41
 Figure 6 summarizes these two pacemaking mechanisms and their related 
proteins.  
 
  
 Schematic representation of SAN cell with voltage and Ca2+ Figure 6.
clocks illustrated. Membrane-bound voltage gated ion channels are 
shown on the left while SR-Ca
2+
 cycling is shown on the right. 
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1.2.2.3 Coupled-clock model of pacemaking 
The coupled-clock model of SAN pacemaking proposes that both of the previously discussed 
mechanisms are important for automaticity. This model is most likely to be a concrete 
representation of physiological pacemaking as it integrates two large concepts and presents the 
SAN as sole pacemaker unit that can be finely regulated.
45
 While Figure 6 shows the various 
components of the two clocks, Figure 7 illustrates their functional interaction. This interlock 
of the two systems is particularly noticeable when altering either of the components and 
realizing that it results in termination or altered automaticity. For instance, ivabradine, the 
HCN selective-blocker, results in a reduction of AP rate while application of ryanodine also 
results in a similar effect.
46
  Another important aspect of the coupling relates to control of 
automaticity by external factors including sympathetic and parasympathetic tones, β-
 Schematic representation of SAN automaticity. Typical nodal action Figure 7.
potentials are shown on top, chronologically aligned with corresponding voltage-
gated ionic currents and Ca
2+
 mechanisms during AP each phase. LCR indicate 
local Ca
2+
 release; MDP, maximal diastolic potential; DD, diastolic 
depolarization. Modified from Choudhury et al. 2015.
20
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adrenergic and muscarinic agonist. Thus, second messengers such as Ca
2+
 and cAMP and 
cAMP-dependent pathways which include Protein Kinase A (PKA), Phosphodiesterase (PDE), 
Ca
2+
 /calmodulin-dependent protein kinase II (CaMKII), affect both membrane-bound ion 
channels and a big part of the Ca
2+ 
handling components, providing further evidence that it is 
essential that both mechanisms be regulated concomitantly to sustain an accelerated or slow 
pacing rate.
47,48
 
 
1.2.3 Molecular determinants of the SAN 
Following transition and maturation from the embryonic to the adult stage, the 
complex network of transcription factors and gene program would have been responsible for 
the regulation of thousands of genes including fundamental targets, such as ion channels, 
transporters and pumps that allow the SAN to fulfill its pacemaking function. Molecular 
analysis of these genes and proteins also reveal a distinct signature for various tissues 
surrounding the SAN. As a general observation, there is a striking contrast in the expression of 
various ion channels and transporters between the central SAN and the atria while the 
peripheral SAN is somewhat in between both, showing a mixed expression profile.
9
 
Interestingly, analysis of the human SAN showed high consistency with expression studies 
from smaller mammals including rabbit and mouse indicating great conservation of the basic 
pacemaking mechanism with the differences being mostly confined to voltage-gated K
+
 
channel isoforms. Indeed, compared to the right atria, the human SAN shows higher 
expression of pacemaker funny channel HCN4, L-type Ca
2+ channel α-subunit CaV1.3, T-type 
channel α-subunit CaV3.1 and slow conducting gap junction connexin 30.2. Conversely, it 
shows lower expression of L-type Ca
2+ channel α-subunit CaV1.2, cardiac Na
+
 channel α-
subunit NaV1.5, inward rectifier channel Kir2.1, ryanodine receptor RyR2, sarcoplasmic 
reticulum Ca
2+
 ATPase pump SERCA2a as well as the fast conducting gap junctions, 
connexin 40 and 43.
9,17
 The absence of fast conducting connexins in the SAN is thought to 
protect the SAN from the hyperpolarized adjacent atrial tissue where conduction velocity is 
much higher. Having low conduction connexins in the centre (Cx45 and 30.2) and gradually 
increasing expression of Cx40 and Cx43 towards the periphery, facilitates the unidirectional 
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exit of the cardiac impulse.
12
 Of note, although Cx45 expression is high in the SAN, it has also 
been shown to be equally high in the atria, thus, the overall conduction velocity is likely to be 
dependent on a balance of fast/slow connexins. Lastly, another interesting observation was the 
dramatic increase in RyR3 expression in the SAN compared to the atria.
9,49
 It has been 
hypothesized that in frog muscle RyR3 may act as a leak Ca
2+
 channel
50
  however, the 
functional consequence and role of RyR3 in the SAN remains completely unknown. 
It has been long been suspected that the distinct morphological features of the SAN 
arise from differential gene programming compared to other cardiac tissue such as the atrium. 
Over the last couple of decades, meticulous analyses have revealed a distinct molecular 
signature for the different subparts of the SAN. Recently, genetic lineage tracing revealed that 
the head, which comprises up to 75% of the total volume of the mouse SAN, retains the 
embryonic sinus venosus molecular signature from which it is initially derived.
51
 The function 
of the various transcription factors that were mapped within the SAN region will be discussed 
in more detail below, nonetheless, the classic signatures known today are Tbx3
+
, Tbx18
+
, 
Shox2
+
 and Nkx2.5
-
 in the SAN head, while the tail is Tbx3
+
, Tbx18
-
, Shox2
+
 and Nkx2.5
+/-
. 
The expression profile of these transcription factors is in striking contrast to that of the atrium 
which is Tbx3
-
, Tbx18
-
, Shox2
-
 and Nkx2.5
+
.
51,52
 Tbx, T-box family of transcription factors, 
are critical and absolutely necessary in early embryogenesis as they are responsible for 
organogenesis, tissue differentiation and even limb formation.
53
 As early transcription factors, 
they are upstream a wide range of genes and in the SAN, Tbx18 was shown to be necessary 
for the formation of the SAN head and its structure. On the other hand, Tbx3 was required for 
SAN differentiation by increasing expression of nodal (e.g. HCN4) and suppressing atrial 
genes including Nkx2.5, connexin 40/43, natriuretic peptide A (ANP) and NaV1.5.
51
 In short, 
while both Tbx18 and 3 control different developmental stages, both are required for full 
maturation and differentiation of the SAN. Interestingly, it was recently been shown that 
ectopic expression of Tbx18 into rodent adult cardiomyocytes, directly transforms them into a 
sinoatrial phenotype with pacemaker function and morphology through control of Shox2, 
Tbx3 and Tbx5, indicating that Tbx18 is likely upstream of all these targets.
54
 Tbx5 is also 
important in SAN development as it positively regulates Tbx3 and Shox2.
55
 Shox2 is a 
homeobox DNA-binding protein and transcription factor that controls morphogenesis, it is 
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known to be a negative regulator of Nkx2.5, and thus essential for SAN differentiation.
56
 
Indeed, Nkx2.5 is another cardiac transcription factor involved in encoding structural, 
functional and regulatory proteins of cardiomyocytes. During embryogenesis it actively 
participates in morphogenesis, septation and chamber differentiation and it is upstream a wide 
range of other transcription factors responsible for expression of contractile proteins and ion 
channels in working cardiomyocytes such as α-actin, MEF-2C, NCX1, connexin 40, and 
ANP.
57,58
 Inhibition of Nkx2.5 by Shox2 is, therefore, crucial for maturation of the SAN. The 
basic molecular signatures and transcription factor network are summarized in Figure 8. 
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 Transcription factor network of the SAN and right atria. Figure 8.
Schematic representation shows the basic molecular signature of each 
structure and corresponding downstream gene targets, which can include 
other transcription factors. E.g. MEF2 regulates hundreds of genes 
implicated in myocyte contractility and ion channels.  
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1.3 Regulation of automaticity in models of health and disease 
 Having now covered an important part of the SAN normal anatomy and function, the 
next sections will provide contextualization and essential knowledge on various subjects that 
revolve around on the main themes of this thesis. Regulation of cardiac automaticity is a 
critical process in the maintenance of a healthy cardiovascular system. Through a fine 
regulation of its rate, the heart can provide an appropriate response to a varying range of 
physiological demands such as exercise, resting or stress. One can thus, easily imagine how 
tipping the heart rate balance towards increased or decreased resting rate or even worse, losing  
this homeostatic control could prove to be detrimental.
59,60
 The SAN therefore remains the 
master controller of heart rate and in order to understand how the pacemaking mechanisms are 
affected by certain cases of health and disease we chose two models that illustrate these 
conditions. Specifically, we chose pregnancy as a model of healthy physiological adaptation 
and in this context, we were the first to examine the SAN and its pacemaking functions. 
Pregnancy is an important period during which the body goes through a complex array of 
changes to ensure sustained growth and wellbeing of the foetus.
61
 The changes that are 
brought about extend to the vasculature and the heart and are in big part thought to be 
triggered by major changes in hormonal levels. Although, the maternal heart has been 
morphologically and functionally examined during the various stages of pregnancy, much 
remains to be known, especially in terms of changes in electrophysiological parameters.
62
 
Indeed, cardiac electrophysiological properties in women are strongly influenced by 
pregnancy as they also need to adapt and function in tandem with the cardiac structural 
changes in order to cope with the larger blood volume and provide sufficient perfusion to the 
organs and foetus.
63
 These cardiac changes have often been paralleled to the changes observed 
in the athlete's heart, yet unfortunately, in some women pregnancy also results in electrical 
instability leading to several cardiac complications.
64
 The SAN being central to heart rate 
regulation and initiation of the cardiac impulse we thus, asked how does the SAN adapt to 
pregnancy and how are the pacemaking parameters altered accordingly? In addition, how can 
these changes relate to electrical instability and arrhythmia vulnerability in some cases and is 
there any role for hormones in this regulation? We believe understanding the pathways that 
regulate cardiac electrical activity in the context of pregnancy and hormones is essential as it 
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provides invaluable knowledge on a physiological adaptation that can affect close to half the 
population. This knowledge becomes a setting stone for also understanding how these 
mechanisms can become deregulated in some cases, thereby contributing to the advancement 
of women‟s health and paving the way for eventual novel therapies.  
At the other end of the spectrum, pathophysiology and disease drive a large part of 
cardiovascular research: heart failure, ischemia, hypertension, congenital heart disease and 
arrhythmias, to name a few topics, are still subjects of intense investigation. Worryingly, the 
SAN has been shown to be sensitive to several of these conditions that alter its function.
20
 
Although more of a process than a disease, we have chosen inflammation as a model to 
represent pathophysiology. Inflammation is today recognized as a key process implicated in 
countless conditions, including cardiovascular ailments. Indeed, heart failure, atherosclerosis, 
diabetes and several other diseases have been strongly linked to inflammation, which is 
characterized by the secretion of a complex array of cytokines, chemokines and immune 
system modulators.
65–67
 These factors have the ability to circulate systemically, binding to cell 
surface receptors on many cells and triggering a response. Although in the heart the role of 
inflammatory processes in hypertrophy and heart failure has been examined,
68
 very little is 
known on how these factors alter cardiac electrophysiological parameters. In one of our first 
studies, we have shown that pathophysiological levels of a cytokine (IL-1β) can alter 
ventricular ionic currents
69
 which lead us to ask the question, are cytokines able to alter the 
ionic current of the SAN, hence affect pacemaking? If yes, could it be the link between SAN 
dysfunction observed in patients suffering from inflammatory conditions or even ageing, a 
process now known to implicate chronic low-grade inflammation? Sinus node dysfunctions 
(SND) currently represent a group of pathologies with varied aetiologies that affect the SAN 
and the causes of SND remain largely unknown.
20
 In our studies, we propose that 
inflammation might be central to the development of SND by contributing to electrical 
remodelling of the SAN and perhaps even its senescence.  
By using these two models, we hope to be able to understand how the SAN responds to 
various stimuli and how dynamic it is. Specifically, we will be able to analyse and compare 
the electrophysiological remodelling that could occur in both of these instances and conclude 
on the regulation of pacemaking function. By including in vivo and human cells in our studies, 
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we also hope that this work will further in help identifying pathways that could be targeted in 
order to prevent SAN dysfunction. 
 
1.3.1 Physiological adaptations of pregnancy 
Pregnancy is an important time during which the body undergoes important 
adaptations in preparation and in order to support of a new life. The mother‟s body goes 
through several adjustments including changes in hormonal balance, weight gain due to 
acquisition of fat, water and muscle as well as metabolic changes that need to be supported by 
appropriate nutrition and supplementation. Almost every organ system and functions from 
respiratory to gastrointestinal are affected including of course, the cardiovascular system 
which also witnesses an increase in its overall functional capacity and efficiency.
70,71
 These 
changes will be discussed below in more detail.  
1.3.1.1 Cardiovascular changes associated with pregnancy 
Within the early stages of pregnancy, the cardiovascular system begins undergoing 
extensive remodelling. These changes are essential in order to ensure adequate supply of 
oxygen and nutrients to the uteroplacental regions and the growing foetus while preserving an 
uncompromised function to the mother.
61
 Hemodynamic measurements have shown that 
during pregnancy blood volume increase (up to 40%), cardiac output is nearly doubled and 
arterial compliance is increased by ~30%.
62,64,72,73
 Furthermore, total vascular resistance, a 
measure that depends on blood viscosity and flow rate through small calibre vessels, is 
decreased while systolic and diastolic blood pressures are mostly maintained normal or with a 
tendency towards a slight (10 mm Hg) reduction in some instances.
74
 The larger blood 
volumes, outputs and overall cardiac work require the heart to adapt as well and accordingly, 
there is significant structural remodelling of the atria and ventricles. Indeed, left atrial 
diameter and ventricular wall thickness are increased by up to 25% while the left ventricular 
mass is increased by 50%.
75,76
 Of note, this cardiac hypertrophy has been shown to be highly 
correlated with body mass index and body surface. Furthermore, in pregnant rats heart-to-body 
weight ratios were actually reduced, indicating efficient cardiac function and overall 
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adaptation. This is in clear contrast to heart failure for example, where the heart-to-body ratio 
is much higher since for a same -or even declining- body weight, the heart keeps growing 
larger in an attempt to counteract its inherent inefficiency.
77,78
 Interestingly, with the increased 
capacity to pump blood, the resting heart rate is also increased during pregnancy by up to 
25%.
79,80
 Although physiologically essential, this increase in resting heart rate can have 
several electrophysiological impacts. As stated earlier, tipping the homeostatic balance of 
heart rate control in either direction can be detrimental and in this case sustaining fast rates has 
been known to increase the risk of electrical disturbances.
81
 Perhaps unsurprisingly, numerous 
studies have shown that during pregnancy there is a significant increase in the risk of a wide 
range of arrhythmias.
64,80,82,83
 
1.3.1.2 Arrhythmias during pregnancy 
It is now well established that during pregnancy, there is a significant increase in the 
risk of certain types of arrhythmias. The fast heart rates associated with sinus tachycardia are 
commonly observed disturbances and throughout pregnancy more than half of the pregnant 
women will have manifestations of some form of electrical disturbance including ectopic 
beats, palpitations and other non-sustained arrhythmias.
80
 Although rarely life-threatening, the 
frequency of arrhythmias remains relatively high and can cause complications. Indeed, 
premature ventricular and supraventricular ectopic beats are observed in nearly 60% of 
patients while the incidence of paroxysmal supraventricular tachycardia also increases, 
making it one of the most common arrhythmias during pregnancy.
84,85
 Supraventricular 
arrhythmias refer to a group of electrical disturbances that affects the heart‟s upper chambers 
i.e. the atria and their conduction pathways and studies show that pregnancy increases the risk 
of de novo supraventricular arrhythmias notably tachycardia, by 34% while also exacerbating 
pre-existing supraventricular tachycardia cases by about 50%.
64,79,86
 On the other hand, 
ventricular tachycardia and ventricular arrhythmias, with the exception of ectopic beats, are 
uncommon in otherwise healthy young women and only appear when underlying structural 
problems such as congenital heart disease, exist.
87
  For instance, ventricular arrhythmias 
become problematic in women suffering from congenital long QT syndrome; as the fast heart 
rate of pregnancy provides temporary relief from the syndrome, a sudden loss of protection 
and complications are induced following delivery thus, appropriate screening becomes 
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essential for management of these patients.
88
 Lastly, arrhythmias such as bradycardia and 
ventricular tachycardia leading to sudden cardiac death have also been reported in pregnancy 
however due to their peculiar aetiologies and rarity they will not be further discussed.
82
 
1.3.1.3 Mechanisms underlying arrhythmias in pregnancy 
Despite the frequency of electrical disturbances during pregnancy, the underlying 
cellular and molecular mechanisms have been rarely explored and instead, arrhythmias have 
been attributed to factors such as changes in autonomic tone, electrolyte balance, 
hemodynamic alterations and effects of hormones on ion channels.
89
 Several of these factors 
will be evaluated in this work and discussed in the subsequent chapter where they were 
investigated. Nonetheless, hormones have an important role and have long been known to alter 
expression and function of various ion channels. During pregnancy the surge of oestrogen, 
progesterone and thyroid hormones is likely to modulate cardiac electrical properties by 
exerting specific effects on individual channels. Several studies have shown that oestrogen is 
able to regulate K
+
 channel Kv4.3 in the heart, affecting repolarization. Furthermore, 
oestrogen was also shown to alter the excitability of neurones through modulation of HCN, L- 
and T-type Ca
2+ 
channel expression. 
78,90–93
 It is therefore possible that a similar regulation 
exists in the heart and specifically in the SAN which sees its automaticity modulated through 
an oestrogen-dependent change in ion channel function or expression. Although the role of 
progesterone is less defined and requires further investigation, thyroid hormones have also 
been shown to regulate a broad range of ion channel α and β subunits in the heart including 
those of K
+
, Ca
2+
 and HCN channels and may therefore be highly implicated in the electrical 
remodelling observed during pregnancy.
94,95
 
In conclusion, pregnancy represents a complex state of physiological adaptations that 
dramatically affect the cardiovascular system. The heart becomes subject to a wide range of 
external factors that affect it structurally, mechanically and electrically. Although, these 
changes are normal and essential they do come with some potential complications, notably 
arrhythmias. Unfortunately, with the increase in comorbidities, cardiovascular disease and 
median age of pregnancy, the magnitude of these complications is estimated to become 
progressively bigger. The SAN being the dominant pacemaker and controller of heart rate 
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therefore becomes a key player in regulating electrical stability and arrhythmia risk. With two 
pregnancy-related studies, the aim of a major part of this work will therefore be to try to 
understand how pregnancy alters the SAN and pacemaking and how these changes can lead to 
arrhythmia vulnerability. 
 
1.3.2 Pathology of the SAN and its dysfunctions  
The second important part of the work presented here will be focused on the pathology 
of the SAN. SAN disease or SAN dysfunction (SND) also referred to as sick sinus syndrome 
(SSS)  is a group of SAN disorders clinically characterized by poor SAN function related to 
either deficient impulse formation, i.e. the SAN is incapable of pacing, or has trouble in 
conducting electrical impulse outside the SAN, also known as SAN exit block.
96
 The 
mechanisms of SND remain elusive and have begun only recently to be investigated. It is 
thought that intrinsic and/or extrinsic factors play a role in the development of SND however, 
the aetiology and molecular underpinnings of the disease are still vague. In the next sections, a 
summary of current SND knowledge will be presented. 
1.3.2.1 Clinical presentation, epidemiology and risk factors 
The single most important manifestation of SND is bradycardia (heart rate < 60 bpm) 
with a sluggish return to sinus rhythm pacemaking following electrophysiological right atrial 
pacing. The time it takes to resume spontaneous automaticity can be measured on the ECG 
and reported as a corrected SAN recovery time (cSNRT).
97,98
 As such, low heart rates along 
with an increased cSNRT represent the most robust and widely used parameters to diagnose 
SND. The diagnosis of SND usually involves a general clinical examination, enquiring about 
symptoms which might include fatigue, lethargia, syncope and hypoperfusion. The presence of 
such symptoms can then be correlated with 12 lead ECGs or Holter data which might uncover 
SAN arrhythmias, predominantly bradycardia in addition to sinus pauses, sinus arrests, exit 
blocks and surprisingly even supraventricular tachycardia, in a phenomenon now termed 
tachy-brady syndrome.
97,99
 Additional electrophysiological, exercise and pharmacological 
testing might also be performed for further validation, especially when multiple confounding 
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variables and symptoms exist. These tests should reveal a high cSNRT as well as a lack of 
chronotropic response to exercise while pharmacological testing will determine if the SND is 
related to modifications in autonomic activity.
100
  
Owing to the complexity, presence of intrinsic and extrinsic factors and the 
overlapping symptoms of the disease, the epidemiology of SND is difficult to assess. For 
instance most patients with a cardiovascular condition are already taking some form of 
treatment consisting of antiarrhythmics, β-blockers, Ca2+ channel blockers, etc., which are 
known to induce bradycardia. In these instances, SND will be considered due to extrinsic 
factors if it can be corrected following removal of drugs that are interfering with 
pacemaking.
96,100
 However, this would require the aforementioned additional testing in order 
to reveal the root cause of SND, a feat that is unfeasible for already multifaceted studies. 
Nonetheless, in a pooled analysis of about 20000 individuals followed over 17 years, 291 
cases of SND were confirmed with a positive correlation with body mass index, prior 
cardiovascular events, hypertension and advanced age which was in fact, the highest risk 
factor for SND.
97
 It is very likely that the study has missed many cases of SND due to difficult 
and inappropriate diagnosis as stated earlier, meaning the incidence of SND in the general 
population is probably higher. However, age has been confirmed to be a major contributor to 
the development of SND and in patients over the age of 65, SND affects 1 in every 600 
individuals.
96
 Indeed, even in the otherwise healthy population the correlation between age 
and lower heart rate has already been observed, as shown on Figure 9.
101
 
  
 Analysis of intrinsic heart rate in men and women. Heart rates Figure 9.
obtained by pharmacological autonomic blockade reveal an age-dependent 
decrease in rate that is similar between both sexes, hinting at a potential age-
induced development of SND (see mechanisms below). Modified from Jose et 
al. 1970.
101
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1.3.2.2 Mechanisms of Sinus Node Dysfunction 
Currently, the only available treatment for SND is the invasive implantation of 
electronic pacemaker.
102
 SND and associated bradycardia can not only result in 
hypoperfusion, syncope, dizziness and chronotropic incompetence but can also favour the 
development of threatening supraventricular tachyarrhythmias such as atrial fibrillation 
(AF).
100
 Indeed, in some SND patients, structural and electrical remodelling notably, atrial 
enlargement and decrease in conduction velocity have been observed. These changes are 
thought to increase the risk of re-entry and consequently AF.
103
 The complications associated 
with SND are therefore wide-ranging and with the single invasive current treatment that is 
available, understanding the mechanisms of SND is becoming increasingly important. As 
pointed out earlier, SND is thought to develop through the influence of intrinsic or extrinsic 
factors. Extrinsic factors include medication that alters pacemaking mechanisms such as 
antiarrhythmic drugs, electrolyte imbalance or changes in autonomic tone which may favour 
parasympathetic stimulation
104,105
 thereby inducing bradycardia. Although these extrinsic 
causes are frequent in SND patients they are mostly observed in individuals taking rate-
altering medication as well as younger patients with no organic heart disease and purely 
extrinsic cases are often reversible or treatable. We will therefore discuss in the following 
section the so-called idiopathic cases of SND that remain mostly elusive mechanistically. In 
these complex cases although extrinsic factors can to some extent contribute to the disease, it 
appears nonetheless, that intrinsic factors weigh much heavier on the development of the 
pathology. 
Genetic causes of SND- The coupled-clock model for pacemaking is a robust yet finely 
regulated mechanism consisting of multiple key players that rely on each other for precise and 
flawless pacemaking. It is therefore expected that mutations affecting any of the individual 
components of the clocks might result in faulty pacemaking and subsequent development of 
SND. Indeed, in several families with idiopathic SND, genetic screening has revealed 
mutations in ion channel and Ca
2+ 
handling genes.
100
 Subsequent introduction of these 
mutations in vitro and in vivo recapitulated the SND phenotype of patients revealing potential 
mechanisms of SND. Congenital SND cases represent a small fraction of idiopathic SND, 
featuring relatively straight-forward mechanisms and will not be discussed in broad details. 
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Accordingly, only a highlight of the most characterized mutations will be presented. Several 
Na
+
 channel mutations have been associated with SND and patients with loss-of-function 
mutations also have multiple ECG and rhythm abnormalities considering NaV1.5 channels are 
widely expressed in the heart.
106
 Although Na
+
 channels are not found in the centre, they are 
expressed at the periphery of the SAN where they help in impulse propagation towards atrial 
tissue. Mutations in NaV1.5 therefore lead to SAN exit block and arrest in addition to the other 
complications in impulse conduction.
20
 Another set of widely recognized SND-related 
mutations that have previously been described are in the HCN4.
107–109
 Unsurprisingly, 
mutating a hallmark in SAN pacemaking mechanism does leads to SND. These mutations alter 
various biophysical properties of HCN4 channels including channel activation kinetics, 
voltage-dependence, activation, cAMP-regulation and current density. Overall, the lower 
conductance results in deficient pacemaking, bradycardia and several associated arrhythmias. 
Lastly, mutations in calsequestrin 2 and ankyrin-B that directly or indirectly affect Ca
2+
 
handling have also been described. These mutations known to cause catecholaminergic 
polymorphic ventricular tachycardia were also shown to induce bradycardia through 
inappropriate Ca
2+
 handling and subsequent reduction in expression of several channels 
including CaV1.3 in the SAN.
110,111
 
Congestive Heart Failure and Myocardial Infarction- In patients suffering from heart 
failure, there is a significant increase in the risk of SND. Electrophysiological and anatomical 
mapping of the SAN and surrounding atrial region revealed important shifts in leading SAN 
pacemaker, sinus arrests, and increases in conduction and recovery time in these tissues.
112,113
 
Subsequent animal studies using both ischemic and non-ischemic models of heart failure 
recapitulated some of these phenotypes and reported a reduction in expression of HCN and 
repolarizing K
+
 channels along with altered Ca
2+
 handling in the SAN.
114–116
 Of note, not all 
heart failure patients will suffer from SND and while a correlation exists, the exact pathways 
in which heart failure induces electrophysiological changes in the SAN remain unknown and 
will require further elucidation. In patients suffering from acute myocardial infarction in the 
inferior wall, angiogram analysis combined with electrophysiological testing revealed a strong 
correlation between degree of sinus node artery occlusion and reduction in intrinsic heart 
rate.
117
 This highlights the particular importance of the SAN artery in maintaining normal 
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sinus rhythm and its occlusion through poor compliance, emboli, or atherosclerotic events may 
lead to an ischemia of the SAN leading to bradycardia and SND.
118
 
Ageing and fibrosis- Considering SND affects in a large proportion the elderly 
population, one of the earliest causes of SND was hypothesized to be a fibrosis of the SAN 
and its senescence as it ages. Indeed, some of the initial studies confirming this hypothesis 
were conducted in 1977 and featured post-mortem histological analysis of patient hearts 
clinically diagnosed with chronic SND.
119,120
  The results of these studies revealed not only 
increased fibrosis, but atrophy of the SAN. In addition, there was a decrease in SAN volume 
and SAN cell count, a report of amyloid depositions, fatty tissue infiltration within the SAN 
and narrowing of coronary sinus artery.
121
 In the most severe cases of SND this remodelling 
and lesions also affected the AV node and other parts of the conduction system and additional 
fibrosis in adjacent atrial tissue was also observed, in correlation with tachy-brady 
arrhythmias. It is important to mention that these histological observations were not 
widespread across every analysed tissue sample. While there were strong correlations between 
the histological changes and SND, some patients with fibrotic or atrophied SAN had normal 
sinus rhythm and some with normal SAN structure had sinus rhythm problems. It is therefore 
concluded that the aetiology of SND appears to be multifactorial and it will be important to 
separate normal ageing-induced remodelling from the one that causes pathological SND.  
Accordingly, studies comparing young and old animals were subsequently performed 
in order to examine the specific changes occurring within the SAN. In old rats and guinea 
pigs, studied at 24 and 38 months of age respectively (24 is thought to be the equivalent of ~70 
years of age in humans while 38 months corresponds to the near end of lifespan) there was a 
significant down-regulation of NaV1.5 and Cx43 in the periphery of the SAN.
122,123
 These 
changes were responsible for a decrease in conduction velocity and SAN exit block. 
Furthermore, in aged rodents a hypertrophy of SAN cells was noted along with a reduction in 
expression of CaV1.2, RyR2 as well as If, T- and L-type Ca
2+
 currents associated with 
increased SNRT, decreased conduction velocity and diastolic depolarization slope. 
Structurally, increased interstitial fibrosis attributable to decreased matrix metallopeptidase 
expression was also observed.
123–127
 It appears thus, that ageing brings about an 
electrophysiological and structural remodelling that causes perturbation in action potential 
 42 
generation and propagation from the SAN and towards atrial tissue. It should be mentioned 
that in some of these studies hypertrophy of SAN cells and enlargement of the SAN were 
observed, which is inconsistent with human data that mostly suggests ageing-induced atrophy 
of the SAN and although the electrophysiological changes of ageing seem consistent with 
SND, their mechanisms remain unknown. In other words, how does ageing trigger all of these 
changes? Why is there such variability between different human tissues analysed and why do 
experimental studies show variable changes in expression/function of ion channels? How does 
one differentiate normal SAN ageing from remodelling that favours the development of SND?  
Inflammation- Inflammation can play an important role in regulating automaticity of 
the SAN. Inflammatory mediators through complex pathways can affect various parts of the 
cardiovascular system, directly or indirectly impacting the SAN. For instance, through its role 
in plaque formation in atherosclerotic disease and its effects on coronary arteries, 
inflammation can potentially compromise SAN artery function or even cause its occlusion 
leading to SAN ischemia and SND.
118
 However, inflammation and inflammatory factors, 
notably cytokines and specific antibodies, have been reported in several studies to have much 
more direct roles in altering pacemaking. Indeed, in the case of infectious diseases, including 
diphtheritic myocarditis, Chagas‟ disease and Lyme disease, severe arrhythmias associated 
with bradycardia and conduction blocks have been reported in infected patients.
128–131
 
Interestingly, we previously reported that in an HIV mouse model, bradycardia and sinus 
pauses were present along with several other electrophysiological changes.
132,133
 Although 
these mice suffer from HIV symptoms that are very similar to HIV patients, they are pathogen 
free and not infected with the virus; instead, they simply express a small fragment of the HIV-
1 genome which is enough to trigger the immune inflammatory response. We were then able 
to recapitulate several of the electrophysiological phenotypes of these HIV mice through in 
vitro treatments and injection in healthy control mice of pro-inflammatory cytokines that were 
upregulated in the model (i.e. IL-1β and TNFα).69,134 Overall, these clinical observations along 
with the experimental data strongly support a role for inflammation and cytokines in 
regulating electrophysiological properties of the heart, including those of the SAN, thereby 
contributing to the development of SND. 
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While a case was made for SND in inflammation associated with infectious diseases, 
other notable examples of SND in sterile inflammatory conditions also exist. Indeed, in 
patients suffering from systemic lupus erythematosus (SLE), an autoimmune disease featuring 
multi-systemic inflammation of various tissues and the production of antibodies to 
components of the cell nucleus, bradycardia, SND and conduction disturbances have been well 
documented and are considered to be an important cardiac complication of adult SLE.
135,136
 
Since bradycardia can be completely resolved with anti-inflammatory treatment, the elevated 
level of various cytokines in SLE patients is thought to be essential in the etiopathology of the 
disease although the underlying mechanisms of cardiac dysfunction have not been completely 
clarified. Interestingly, gene expression data have shown significant changes in expression 
profile of the IL1 family genes in SLE patients, namely in IL1β, suggesting its involvement in 
SLE.
137–139
 We have previously shown that IL-1β to be a potent suppressor of L-type Ca2+ 
current and thus, it is likely that inflammation causes bradycardia and SND, at least in one 
way, through suppression of SAN Ca
2+ 
currents that are essential for the DD and upstroke 
phase of the AP.  
A global working hypothesis that we are testing through multiple projects in our 
laboratory is that inflammation might be the common culprit between various pathologies that 
will result in SND. While bradycardia is clearly visible in inflammatory diseases, we believe 
that in conditions not classically strongly linked to inflammation such as heart failure or even 
ageing, chronic low grade inflammation might also be responsible for remodelling of the SAN 
both structurally and electrically. For instance, pro-inflammatory cytokines such as TGF-β are 
well known to induce fibrosis
140
 and can be upregulated in various heart disease conditions. 
However, several other cytokines are also released in the circulation and we believe they can 
exert multiple effects on ion channels. In ageing, the presence of low-grade inflammation 
correlates with higher level of IL-1β and a higher incidence of sinus bradycardia and SAN 
dysfunction.
124,141,142
 Thus, based on clinical and experimental evidence it appears that 
inflammation and notably IL-1β is a common feature of seemingly unrelated diseases that end 
up affecting cardiac electrical properties and predisposing individuals to arrhythmias. 
  
 44 
Accordingly, the third study presented in this thesis will be focused specifically on the 
role of IL-1β in inducing SAN dysfunction. The strong clinical associations between 
bradycardia and IL-1β levels warrant such investigation and in addition, in a previous study, 
we demonstrated that IL-1β is a potent regulator of ion channel function in the ventricle.69 
This study will represent the foundation work of the larger SND/inflammation project that will 
eventually explore the role of other cytokines and pathways in SND. The data of this project 
was obtained from a new in vitro model, consisting of human cardiomyocytes and nodal cells 
derived from induced pluripotent stem cells. The ability to work with human myocytes 
provides a novel and exciting opportunity and in the next section we will present an overview 
of stem cells and their potential and how biotechnology and cell culture techniques permitted 
the procurement of cardiomyocytes from these cells. 
 
1.4 Pluripotent stem cells: biotechnology and cardiac applications 
Pluripotent stem cells have two main characteristics that differentiate them from all 
other cells: the ability for constant self-renewal and a capacity to differentiate into any of the 
three germ layers: endoderm, mesoderm and ectoderm.
143
 Pluripotent stem cells are formed 
not long after fertilisation of the egg with the sperm. First, the resulting zygote goes into a 
division cycle forming a morula. The morula is a very early stage of mammalian embryonic 
development and is formed of blastomeres contained in a glycoprotein membrane termed zona 
pellucida. Blastomeres are totipotent stem cells, meaning a single cell can give rise to all the 
different cell types of the body. As the morula continues to mature it forms the blastocyst: a 
200-300 cellular structure composed of an inner cell mass (embryoblast) in a cavity 
surrounded by a cellular membrane known as the throphoblast. This inner cell mass or 
embryoblast subsequently forms the embryo and the throphoblast becomes the placenta.
144
 
Since the inner cell mass gives rise to an embryo in later stages it therefore contains all the 
cells required to form an organism. These cells are thus classified as pluripotent stem cells and 
are subject to manipulation in order to create transgenic animals for instance. Alternatively, 
they are also the source of embryonic pluripotent stem cells (ePSC or eSC) that can be used 
for biotechnology purposes. As such, the pluripotency of the cells can be used to our 
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advantage. By driving their differentiation into specific fates it is possible, at least 
theoretically, to obtain any desired cell type of the body by applying of the right protocols and 
conditions. The development of cell culture techniques using complex media often containing 
proprietary mixes of growth factors, hormones and cytokines allows these ePSC to retain their 
pluripotency and divide in vitro. Furthermore, it is possible, although development of the 
technology is still needed, to favour their reprogramming and differentiation into any of the 
three germ layers: endoderm that forms intestinal tract and lung cells, the mesoderm that 
differentiates into muscle, bone and blood tissues and finally the ectoderm, the precursor of 
epidermal tissues and nervous system.
145
 Our focus will however be on cardiac cells, which 
will be discussed in the next section. 
1.4.1 Pluripotent Stem Cells and their Derived Cardiomyocytes 
Mouse ePSC were one of the first to be isolated. They are readily available and can 
relatively be cheap to obtain. It is of course also possible to isolate human ePSC, albeit this 
comes with substantial ethical concerns and fierce debate related to issues such as whether the 
inner cell mass is already a living human. Nevertheless, when cultured using special protocols 
such as hang-drop protocol where 20 μL drops of ePSC are seeded on a plastic cover dish and 
reversed upside down, an “artificial” development takes place. The ePSC drops contain media 
supplemented with high foetal bovine serum and other additives such as bone morphogenic 
factor 4 to favour mesoderm and cardiac lineage development. Within five days embryoid 
bodies (EB), which are aggregates of cells, form. These EB can then be collected, plated and 
cultured on adhesive substrates with addition of factors such as retinoic or ascorbic acid for a 
few more days where eventually local spontaneously contracting foci will be observed. 
Manual picking of these foci and subsequent re-culturing gives rise to a cardiomyocyte 
population that has therefore developed from the ePSC. Of note, since the differentiation 
technique is rather to assist spontaneous differentiation and not fully or exclusively favour 
cardiac cells development, the rest of the EB also contains cells with neuronal and intestinal 
markers considering the EB gives rise to the three germ layers. In a good preparation, and 
technique optimization up to 30% cardiomyocytes could be observed at day 12.
145
 
Alternatively, is it also possible to induce differentiation into cardiomyocytes through co-
culture of the PSCs on mouse visceral-endoderm-like cells (END-2). These END-2 cells 
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secrete several endodermal factors, including bone morphogenetic factors, nodal/activin A, 
fibroblast growth factors, and repressors of Wnt/𝛽-catenin pathways thereby favouring cardiac 
lineage development nevertheless the efficiency of this protocol is rather low.
146
 Lastly, it is 
possible to combine these two techniques, for instance ePSC can be were plated into drops to 
form EBs then these EBs can be subsequently plated on END-2 cells.
147
 Beating aggregates, 
containing cardiomyocytes, 15-18 days post plating could then be isolated and dispersed with 
collagenase and used for experimentation. 
1.4.2 Induced Pluripotent Stem Cells (iPSC) 
In 2012, the Nobel Prize for Physiology or Medicine was awarded to Shinya 
Yamanaka and Sir John B. Gurdon for their discovery of iPSC technology that allowed 
reprogramming of mature somatic cells, such as fibroblasts, into pluripotent stem cells hence, 
the “i” in iPSC refers to the induction of somatic cells to stem cells.148 First discovered nearly 
ten years ago, the discovery was essentially about reintroducing a handful of genes into a 
mature somatic cell which were enough to reprogram its fate and re-activate pluripotency. 
Since different stages in embryonic development are characterized by strikingly different 
expression profiles of transcription factors, the required transcription factors to induce 
pluripotency were discovered by assaying gene expression during various developmental 
stages. It was found that as early as 3.5 days post-coitum markers and transcription factors 
such as Oct4 (octamer-binding transcription factor 4 or POU5F1), Sox2 (sex determining 
region Y-box 2), FGF-2 (Basic fibroblast growth factor) and SSEA-1 (stage-specific 
embryonic antigen 1 or CD15) are highly expressed and are sufficient to reverse the fate of 
somatic cells back to pluripotency. Today, these factors are available commercially in ready to 
go vectors in order to induce pluripotency in all kinds of terminally differentiated cells. The 
main transcription factors used are Oct4, Sox2, Klf4 (Kruppel-like factor 4), NANOG 
(Homeobox Transcription Factor) and c-Myc. While different combinations of these factors 
have been used, one study showed that Oct4 alone was sufficient to induce pluripotency, 
although in most instances varying combination of Oct4, Sox2, Kfl4 and NANOG have been 
routinely used with avoidance of c-Myc due to its oncogenic potential.
149
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 Briefly explained, these transcription factors act as very broad regulators of early stage 
embryogenesis. Oct4 and Sox2 are essential and critical in self-renewal of undifferentiated 
ePSC and insuring pluripotency, together they can also induce the gene expression of NANOG 
and  Rex-1 (zfp-42; zinc finger protein 42). Thus, in a rather poorly understood mechanism, 
these genes act cooperatively within a regulated network to control global gene expression and 
favour genetic events that reverse cell fate back to its embryonic stages of pluripotency while 
promoting an autoregulatory-loop that sustains their pluripotency.
145
 
Investigators working on iPSC need to go through stringent quality control tests to 
prove the pluripotency state of their cells. Consequently, experiments such as in vitro 
differentiation and screening or injection of these iPSC into immunodeficient mice typically 
non-obese diabetic (NOD mice) followed by teratoma analysis through staining for markers of 
the three germ layers are essential.
143
  
1.4.3 Induced and embryonic PSC-derived cardiomyocytes (iPSC-CM, 
ePSC-CM) 
The remarkable finding that cardiomyocytes could be generated from iPSC sparked a 
big interest in the cardiac research community since the long sought-after source of 
cardiomyocytes could have potentially been found. Since iPSC technology was going through 
rapid development it was now possible to obtain patient specific cardiomyocytes, generated 
from a skin graft, known as hiPSC-CM. This paved a new road for cardiac regenerative 
medicine pushing the field to new limits of tissue engineering and patient-specific cellular 
therapies. When differentiated into cardiomyocytes, these clusters of hiPSC-CM exhibited an 
interesting spontaneous electrical activity and beating
145,147
  but also raised several 
fundamental questions. Do these cells resemble actual adult human cardiomyocytes 
electrically and mechanically? Which ion channels are expressed and what about the Ca
2+
 
handling and contractile machinery? In essence, it was important to determine whether these 
cells constitute a good model to study electrophysiological or even contractile parameters of 
human cardiomyocytes. Over the last few years, investigational work and characterization of 
these cells reached the conclusion that overall, these cells are relatively immature and 
resemble mostly embryonic or foetal cardiomyocytes. Structurally and morphologically, iPSC-
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CMs do not resemble adult cardiomyocytes. They are flat, often spread out widely, mostly 
polygonal in shape and heterogeneous in sizes and shape unlike rod-shaped adult 
cardiomyocytes. Furthermore, ultrastructure analyses reveal that these cells lack highly 
developed T-tubules. They have underdeveloped and relatively disorganized sarcomeres and 
also rely on IP3 Ca
2+
 mechanisms instead of excitation-contraction coupling with Ca
2+
-induced 
Ca
2+
-release. Mitochondrial numbers are also much lower therefore indicating overall, that 
these cells are not the structurally organized powerhouse adult cardiomyocytes.
145
  
 Electrophysiologically, these cells became more interesting as they expressed all the 
human ion channels responsible for generation of AP that are consistent with adult human 
myocyte AP durations even though the expression level for several channels including Na
+
 
and Ca
2+
 is not identical to the adult heart.
150
 Furthermore, AP and ionic current analysis of 
these iPSC-CMs revealed that the cell population is composed of cardiomyocytes with 
different electrical properties and action potential configurations allowing their classification 
into nodal-, atrial- and ventricular-like cells.
151,152
 Electrophysiological data showed that 
nodal-like cells had a spontaneous diastolic depolarisation phase in their action potentials with 
presence of If, indicating HCN expression. On the other hand quiescent cells, found in much 
larger proportions, had either long or short plateau phases which were used to determine 
whether they fell into the atrial or ventricular-like groups, respectively. While AP duration and 
shape can be somewhat useful, it is arguable that there are too many intermediate phenotype 
cells with AP duration at the limits of the designated cut-off values. Thus, simply AP 
durations are not sufficient to classify cells into an atrial or ventricular category. Instead, 
several groups, including our own, prefer to call these myocytes working myocardial cells. 
Interestingly, to date there has been tens of studies investigating arrhythmia-related 
pathologies in iPSC-CM with the large majority of these, especially the ones investigating 
LQTS, finding results consistent with animal and human data. This indicates that these cells 
could be useful to investigate human mutations of electrical disturbances.
153
 While these 
findings have not specifically led to discovery of new mechanisms they did confirm previous 
findings from animal and cell culture models. This step is essential in validating the functional 
impact of these cells. By having a benchmark or standard for comparison, hiPSC-CMs are 
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starting to fill an important missing gap in cardiac experimental models: cultivable and 
manipulable terminally-differentiated human cardiomyocytes. 
To summarize, hiPSC-CM appear to be immature cardiomyocytes. Nonetheless, they 
express all the adult ion channels and Ca
2+
 handling proteins albeit, at different levels from the 
adult cardiomyocyte. Their use as a model for LQTS and drug discovery has been warranted 
and validated several times already however, much more development and research is still 
needed in order for these cells to reach full potential. For instance, several groups are 
exploring ways to mature these iPSC-CMs in order to faithfully recapitulate the adult 
myocyte.
154,155
 
It was previously mentioned that AP analysis of these cells revealed some nodal-like 
AP configuration. Indeed, these cells usually constitute about 10% of the entire iPSC-CM 
population and have been largely overlooked.
152
 While efforts have been focused on getting 
working myocardium cells to resemble as much as possible adult cardiomyocytes or 
regenerative therapies for the ventricles and LQTS studies, we are particularly interested in the 
minority of cells within this population. It appears that this minority does not require 
maturation or complex protocols and accordingly, we are exploring the potential of these 
nodal-like cells as a relatively easy and robust human in vitro cellular model of the adult SAN. 
The broad scheme of this project, of which a part will be presented here, is to obtain a full 
characterization of these cells. This will include determining the molecular signatures, 
electrophysiological and Ca
2+
 handling properties of the cells and compare them to mouse and 
human SAN. Should the results be entirely favourable, these cells, as human SAN-like, 
provide a highly interesting potential to study the mechanisms of different SAN diseases and 
effects of various molecules on pacemaking. Furthermore, if we were to parallel the ever-
growing interest in regenerating the myocardium, these cells could perhaps one day constitute 
a source of SAN cells useful for repair of sick SANs. Our interest in the pathology of the SAN 
has led us to begin the studies in nodal hiPSC-CM cells.  
Overall, as an in vitro model, nodal hiPSC-CM cells constitute an excellent starting 
point from an investigational standpoint. It will allow for a reasonable amount of cells to go 
through testing of multiple inflammatory mediators of interest (e.g. IL-1β) while facilitating 
the subsequent mechanistic work. As a human cell model, it provides the advantage of a 
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human molecular machinery thus, an increased translational potential for the data. Certainly, 
these cells cannot replace in vivo models and validation; however they will provide a highly 
interesting and valuable complement to experimental studies. 
1.5 Hypothesis and Objectives  
As demonstrated throughout the introduction, the SAN appears to be a complex and 
dynamic tissue that is subject to a wide range of regulatory signals that modulate its function. 
The overall aim of this work was to shed light on some of the key changes that affect the SAN 
during states of health and diseases. Specifically, three studies are presented. The first two 
studies employ pregnancy as a model of physiological adaptation where we hypothesized that 
intrinsic electrophysiological changes to the SAN occur. The objective was to determine and 
characterize these changes while establishing how they relate to heart rate control and 
arrhythmia susceptibility. The first study presents the mouse model of pregnancy and 
examines changes in the pacemaker current and channels, the second examines the role of 
Ca
2+
 homeostasis in the SAN and how they are modulated in pregnancy.  
The subject of the third study was the pathological regulation of the SAN and its 
relation to poor pacemaking and bradycardia. The objective here was to determine how 
cytokines, which are elevated in numerous disease states, are capable of affecting pacemaking. 
Specifically, the pro-inflammatory mediator IL-1β was tested and the adverse 
electrophysiological remodelling it induces and its relation to bradycardia were presented and 
discussed. Furthermore, a molecular and electrophysiological characterization of a relatively 
new human SAN cell model in which the effects of IL-1β were tested is also presented. 
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Outline- The first study presented explores the role of pacemaker current (If) in the heart rate 
increase during pregnancy. This is the first study to our knowledge to demonstrate that an 
electrophysiological remodelling of the SAN is an adaptive mechanism of pregnancy. The 
study also evaluates the contribution of previously suspected mechanisms to heart rate 
increase and introduces the mouse model of pregnancy. Presenting a wide array of data and 
techniques including in vivo, ex vivo and cellular electrophysiology, along with associated 
molecular work this study was accompanied by an editorial featuring a mathematical model of 
accelerated SAN automaticity based on the study data. (Circulation, 2013, 21;127(20):2003-
5).  
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2.1 Résumé 
La grossesse est associée à une fréquence cardiaque (FC) plus rapide, qui est un facteur 
de risque d‟arythmies. Toutefois, les mécanismes sous-jacents à cette augmentation de la FC 
demeurent mal compris. Ainsi, l‟objectif de cette étude était d‟obtenir une base mécanistique 
expliquant l'augmentation de la FC induite par la grossesse. 
En étudiant des ECG de surface, nous avons observé que les souris gestantes (SG) ont 
une FC plus rapide (531 ± 14 battements par minute (bpm) comparativement aux souris non 
gestantes (SNG) (470 ± 27 bpm, P<0,03). Les résultats obtenus avec des cœurs perfusés en 
mode Langendorff ont montré que cette différence persistait en l'absence d'une innervation par 
le système nerveux autonome (SNG, 327 ± 16 bpm ; SG, 385 ± 18 bpm, P<0,02). Les 
potentiels d'action spontanés des cellules du nœud sinusal (NS) des souris gestantes présentent 
une automaticité plus élevée (SNG, 292 ± 13 bpm, SG, 330 ± 12 bpm, P = 0,047) et une pente 
de dépolarisation diastolique plus forte (SNG, 0,20 ± 0,03 V/s ; SG 0,40 ± 0,06 V/s, P = 
0,004). La grossesse augmente la densité du courant activé par l'hyperpolarisation (If) (à -
90mV: SNG, -15,2 ± 1,0 pA / pF; G, -28,6 ± 2,9 pA / pF; P = 0,0002) dans les cellules du NS. 
La dépendance au voltage de la courbe d'activation de If et les concentrations intracellulaires 
d'AMPc restent inchangées dans les cellules du NS des SG. En outre, l'expression protéique du 
canal HCN2 est augmentée sans que l'expression de HCN4 ne soit changée. Le déplacement 
maximal de la courbe d‟activation de If induit par l'isoprotérénol était atténué pendant la 
grossesse. Cette réponse réduite à l'isoprotérénol peut être attribuable à une moindre sensibilité 
à l'AMPc de l'isoforme HCN2 par rapport à HCN4. 
Cette étude montre qu'une augmentation de la densité de If contribue à l'accélération de 
l'automaticité du NS et explique en partie la FC plus rapide observée durant la grossesse. 
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2.2 Study 
ABSTRACT 
Background - Pregnancy is associated with a faster heart rate (HR), which is a risk factor for 
arrhythmias. However, the underlying mechanisms for this increased HR are poorly 
understood. Therefore, this study was performed to gain mechanistic insight into the 
pregnancy-induced increase in HR. Methods and Results - Using surface ECG we observed 
that pregnant (P) mice have faster HR (531±14bpm) compared to non-pregnant (NP) mice 
(470±27bpm, p<0.03). Results obtained with Langendorff-perfused hearts showed that this 
difference persisted in the absence of autonomic nervous innervation (NP: 327±16bpm, P: 
385±18bpm, p<0.02). Spontaneous action potentials of sino-atrial node (SAN) cells from 
pregnant mice exhibited higher automaticity (NP: 292±13bpm, P: 330±12bpm, p=0.047) and 
steeper diastolic depolarization (NP: 0.20±0.03V/s, P: 0.40±0.06V/s, p=0.004). Pregnancy 
increased the density of the hyperpolarization-activated current (If) (at -90mV, NP:  
-15.2±1.0pA/pF, P: -28.6±2.9pA/pF, p=0.0002) in SAN cells. Voltage-dependence of the If 
activation curve and the intracellular cAMP levels were unchanged in SAN cells of pregnant 
mice. However, there was a significant increase in HCN2 channel protein expression with no 
change in HCN4 expression. Maximal depolarizing shift of the If activation curve induced by 
isoproterenol was attenuated in pregnancy. This reduced response to isoproterenol may be 
attributable to the lower cAMP sensitivity of HCN2 isoform compared to that of HCN4. 
Conclusions - This study shows that an increase in If current density contributes to the 
acceleration of SAN automaticity and explains, in part, the higher HR observed in pregnancy. 
 
Keywords: Heart rate; ion channels; pacemakers; pregnancy; sino-atrial node.
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INTRODUCTION  
In women, cardiovascular function is strongly influenced by pregnancy and undergoes 
significant changes such as alterations in cardiac electrical function and higher vulnerability to 
arrhythmias.
1, 2
 During pregnancy, there is an increased risk of onset of new supraventricular 
tachycardia or exacerbation of pre-existing arrhythmia, which may compromise the wellbeing 
of the mother and the fetus.
3-5
 Furthermore, pregnancy is also associated with a higher resting 
heart rate (HR), which is a known risk factor for arrhythmias.
4, 6, 7
 This increase in HR 
suggests an influence of pregnancy on cardiac autonomic regulation and/or the automaticity of 
the heart. 
 
Changes in cardiac autonomic
 
modulation play a central role in the adaptation of the 
cardiovascular system to various hemodynamic changes required for a normal pregnancy.
8-10
 
The heart is innervated by both the sympathetic and parasympathetic divisions of the 
autonomic nervous system. Stimulation of the sympathetic nerve fibers results in the release of 
norepinephrine that increases the automaticity of the sino-atrial node (SAN), the cardiac 
pacemaker. This is reflected on the electrocardiogram (ECG) by a faster HR. In contrast, 
parasympathetic stimulation by means of the vagus nerve releases acetylcholine and slows the 
pacemaker activity of the SAN.
11
 
 
The automaticity of the SAN is responsible for initiating heart rhythm. The diastolic 
depolarization phase of the spontaneous action potential (AP) generated in SAN cells is a 
major determinant of cardiac automaticity. Multiple mechanisms are involved in the diastolic 
depolarization of SAN cells. These include a hyperpolarization-activated current (If), T- and 
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L-type calcium currents (IcaT, ICaL), the delayed rectifier K
+
 current (IKr), Na
+
-Ca
2+
 exchanger 
current (INCX) and spontaneous Ca
2+
 release from the sarcoplasmic reticulum.
12-14
 While 
intracellular Ca
2+
 signaling is important in the generation of the late diastolic depolarization,
15
 
If plays a crucial role in the early phase of the diastolic depolarization of SAN cells.
15
 In 
mouse SAN, the hyperpolarization-activated cyclic nucleotide-gated (HCN) channel isoforms, 
HCN1, HCN2 and particularly HCN4, contribute to the native If current.
16, 17
 Regulation of 
HCN by sympathetic and parasympathetic stimulation represents one of the main mechanisms 
by which the autonomic nervous system controls HR.
18
 A direct interaction of cyclic AMP 
(cAMP) with an intracellular cyclic nucleotide binding domain is known to regulate the 
voltage dependence of HCN channels. Indeed, -adrenergic agonists increase the levels of 
cAMP, which positively shifts the HCN voltage dependence. The positive shift in the I f 
activation curve results in an increase in current density. In contrast, muscarinic stimulat ion 
decreases cAMP levels and has the opposite effect on If voltage dependence.
19
 
 
Elevated HR can increase the susceptibility to arrhythmias; therefore, a better understanding 
of the mechanisms responsible for the increased cardiac automaticity associated with 
pregnancy is clinically important. As mentioned above, several mechanisms are involved in 
the automaticity of the heart. Since If initiates the first part of the diastolic depolarization, the 
present study focused on the regulation of this ionic current during pregnancy. We therefore 
hypothesized that the increased physiological demands during pregnancy may lead to changes 
in If channel expression and/or current density as well as If response to stimulation by the 
autonomic nervous system. In turn, these modifications could increase the automaticity of the 
SAN and, in part, explain the mechanisms of elevated HR associated with pregnancy. 
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Accordingly, the objectives of the present study were (1) to investigate the effect of pregnancy 
on HR in mice under control conditions and in the absence of autonomic nervous tone, and (2) 
to examine the effects of pregnancy on the automaticity of single SAN cells, and (3) to explore 
the mechanisms underlying the HR changes and how they relate to If.  
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MATERIAL AND METHODS 
Animals 
All experiments were performed on adult female CD1 mice (2-3 months old) obtained from 
Charles River (St-Constant, QC, Canada). Non-pregnant (NP) and late pregnant (P: 18-19 
gestation days, gd) mice were used. All experiments were performed in accordance to the 
guidelines of the Canadian Council on Animal Care and the Guide for the Care and Use of 
Laboratory Animals published by the US National Institutes of Health (NIH Publication No 
85-23, revised 1996). Experiments were also approved by the Montreal Heart Institute Animal 
Care Committee (approval reference number 2009-80-02). 
Surface electrocardiograms (ECG) 
Lead I surface ECGs were conducted in anaesthetized NP and P mice for 5 minutes at a rate of 
2kHz after baseline period. Additional surface ECG recordings were obtained on mice before 
and after intravenous (IV) injection of isoproterenol (0.1ng/g) through the right jugular vein.
20
 
Further information is presented in the online supplemental material. 
Langendorff-perfused heart 
Experiments were performed as previously described.
21
 After rapid excision, the heart was 
hung on a modified Langendorff apparatus and retrogradely perfused through the aorta. ECG 
recordings were obtained after an equilibration perfusion period; ECG parameters were 
calculated as explained in the supplemental material. 
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Hemodynamic measurements 
Mice were anaesthetized with isoflurane before a pressure catheter was inserted into the right 
carotid artery. Systolic, diastolic and mean arterial blood pressures were measured by a Millar 
Mikro-Tip Catheter Transducer (model SPR-671, 2F, Millar Instruments, TX, USA) and data 
were analyzed with the program IOX, version 2.5.1.6 (EMKA Technologies).  
Catecholamine and cAMP measurements 
Plasma epinephrine and norepinephrine levels were measured using the 2-cat (A-N) Research 
ELISA kit (Rocky Mountain Diagnostics, CO, USA) following the manufacturer's 
instructions. SAN intracellular cAMP concentrations were measured using a LANCE
® 
cAMP 
384 ELISA kit (PerkinElmer, Waltham, MA, USA) following the manufacturer's instructions.  
Sino-atrial cell isolation 
Mice were anaesthetized by inhalation of isoflurane and then sacrificed by cervical 
dislocation. The SAN cells were isolated using an adaptation of the protocol previously 
described by Mangoni et al.
22
 Briefly, SANs were dissected in normal HEPES-buffered 
Tyrode‟s and digested by enzymatic dissociation. Cells were then obtained by trituration and 
kept in “Kraft-Brühe” (KB) solution until use. Isolated mouse SAN cells were identified as 
small spindle-type cells spontaneously beating in normal Tyrode‟s solution.22 Details on the 
digestion protocol are presented in the supplemental material. 
Electrophysiological data 
Current- and voltage-clamp recordings. For If recordings, 1 mM BaCl2 (Sigma) was added to 
the external solution to block the inward rectifier K
+
 current, IK1. All recordings were carried 
out at 35±1
o
C. Pipette resistance was between 3-5M. The If IV curve was obtained in whole-
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cell configuration while the action potential and activation curves were obtained using 
perforated patch-clamp technique with nystatin (350ng/ml). To account for differences in cell 
size, current amplitudes were normalized to cell capacitance and expressed as densities 
(pA/pF). Solution composition and protocols are available in the supplemental material.  
 
Current- and voltage-clamp protocols and data analysis. Current-voltage relationships for the 
hyperpolarized current (If) were constructed using records elicited by 2-s voltage steps from -120 
to -20mV in 10mV increments from a holding potential of -30mV at a frequency rate of 0.2Hz. 
The density of If was measured at the end of the hyperpolarizing steps. Activation curves were 
obtained using a protocol in which 2-s voltage steps from -35 to -130mV were applied from a 
holding potential of -35mV, followed by a 1.5-s step at -90mV and a 1-s step at +5mV. To 
obtain voltage dependent steady-state activation curves, tail currents were determined as the 
difference between the peak current and the steady-state current (tail current at -90mV). Tail 
currents were normalized by the maximal tail current (Imax) and plotted against test voltage. 
The normalized plot of tail currents versus test voltages were fitted with a Boltzmann 
equation: I/Imax=1/(1+exp[V−V1/2]/k), where V is the test voltage, V1/2 is the mid-activation 
voltage and k is the slope factor.
23, 23, 24
 
 
Real time RT-PCR 
Total RNA extraction and real-time PCR (qPCR) for the HCN channels were conducted using 
previously published protocols,
16, 25
 which are detailed in the online supplemental material. 
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Western blot 
Protein samples were extracted from 3 SANs of non-pregnant and pregnant mice. Protocols 
used for protein isolation and Western blot analysis are described in the online supplemental 
material. 
Statistical analysis 
All data are presented as mean ± SEM. “n” refers to the number of experiments and “N” the 
number of mice. p<0.05 was considered significantly different. Statistical analyses are detailed 
in the online supplemental material. 
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RESULTS 
Surface ECG parameters 
To determine whether pregnancy in mice is associated with an increase in HR as seen in 
humans, lead I surface ECG data were obtained from anaesthetized non-pregnant and pregnant 
female mice under baseline conditions. ECG parameters were compared between both groups 
and representative examples are illustrated in Figure 1A. Pregnant mice exhibit a significantly 
higher resting HR compared to non-pregnant mice (NP: 470±27bpm and P: 531±14bpm, 
p=0.03). HR was also assessed in pregnant mice at gd 12-13 to determine whether the 
increased HR observed in late pregnancy was present at an earlier stage of gestation. 
Interestingly, the HR was already increased in pregnant mice at gd 12-13 (514±15bpm, n=9). 
These findings are consistent with reports in humans which show that the change in resting 
HR begins in early pregnancy.
5, 6, 9, 26, 27
 Mean data for the PR, QT and QTc intervals are also 
summarized in Figure 1A. The PR interval was significantly shorter in pregnant mice without 
any change in P wave duration (data not shown). The QT interval was on average 10ms 
shorter in pregnant mice; however, after adjustment for the difference in HR, this trend was no 
longer present as illustrated by the comparable QTc intervals measured in the two groups. 
 
Arterial blood pressure 
Using a Millar catheter we compared arterial blood pressure in anaesthetized non-pregnant and 
pregnant mice to confirm that the increase in HR associated with pregnancy was not secondary 
to a reduction in blood pressure. Results summarized in Table 1 show that systolic, diastolic 
and mean arterial blood pressures were similar in both groups. 
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Stimulation by the autonomic nervous system 
Catecholamine levels. The contribution of the autonomic nervous system to the pregnancy-
induced increase in HR was then explored. Data presented in Table 1 indicate that plasma 
concentrations of norepinephrine and epinephrine were not increased in pregnant mice. 
ECG parameters on Langendorff-perfused heart. Additional ECG recordings were 
performed on Langendorff-perfused hearts isolated from non-pregnant and pregnant mice. As 
illustrated in Figure 1B, the HR measured in the Langendorff-perfused heart preparation was 
significantly slower than that obtained with surface ECGs. The slower HR measured in the 
Langendorff-perfused heart preparation reflects the intrinsic HR and is explained by the 
absence of sympathetic stimulation. Similar to what was seen in the surface ECG studies, the 
HR measured in the Langendorff experiments was significantly faster in pregnant 
(385±18bpm) compared to non-pregnant (327±16bpm, p=0.02) mice, indicating that the 
increased HR seen in pregnant mice was not due to alterations in the autonomic tone. The 
table in Figure 1B presents mean data for PR, QT and QTc intervals obtained from both 
groups. The PR interval was also significantly shorter in pregnant mice and this faster AV 
conduction time was still independent of atrial conduction since the P wave duration was 
unaltered (data not shown). Similar to the surface ECG data, the shorter QT interval in 
pregnant mice was also explained by a faster HR as there was no difference in QTc intervals 
between non-pregnant and pregnant mice. Results presented thus far indicate that HR is 
altered in pregnant mice and that this difference does not result from changes in blood 
pressure, circulating levels of catecholamines or autonomic nervous tone but rather reflects a 
change intrinsic to the heart. 
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Influence of pregnancy on the spontaneous automaticity of the SAN cells 
Accordingly, the next series of experiments were performed to explore the cellular mechanism 
underlying the increased HR observed in pregnant mice. Spontaneous APs were recorded 
using freshly isolated single SAN cells from non-pregnant and pregnant mice. The 
morphology of the SAN cells was similar between both groups and had comparable cellular 
capacitance (NP: 30.2±1.5pF, n=42 and P: 29.4±1.1pF, n=46, p=0.66). Figure 2A compares 
spontaneous APs and the corresponding first derivative of the AP (dV/dt) waveform recorded 
from SAN cells obtained from a non-pregnant and pregnant mouse. Detailed analysis of the 
AP parameters is summarized in Figure 2B. The frequency of spontaneous SAN AP was 
increased in cells from pregnant mice (330±12bpm) compared to non-pregnant mice 
(292±13bpm, p=0.047). Diastolic depolarization rate (DDR) was increased in cells from 
pregnant mice. As also reported in Figure 2B, pregnancy was also associated with a more 
positive AP threshold (Eth). On the other hand, the maximum diastolic potential (MDP), the 
maximal velocity of the AP upstroke (Vmax), the AP amplitude (APA), the AP duration 
(APD) and the waveform of dV/dt during AP repolarization were not affected by pregnancy.  
 
Influence of pregnancy on If density and its voltage-dependence of activation 
Considering the importance of If for the initiation of the diastolic depolarization of the SAN 
we then compared the density of If in SAN cells from non-pregnant and pregnant mice. Data 
reported in Figure 3 (A-B) show that the density of If was significantly higher in the SAN cells 
of pregnant mice compared to non-pregnant mice from voltages of -40 to -120mV (at -90mV, 
NP: -15.2±1.0, P: -28.6±2.9pA/pF, p=0.0002). Of note, If was recorded in Tyrode‟s solution 
containing BaCl2 to eliminate the inwardly rectifying K
+
 current, IK1 (see Methods). It is worth 
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mentioning that only a very small Ba
2+
-sensitive K
+
 current was activated in SAN cells from 
non-pregnant mice (at -90 mV, -4.5±0.9pA/pF, n=7). Furthermore, there was no influence of 
pregnancy on the density of IK1 (-4.8±1.0pA/pF, n=8, p=0.83) which is consistent with the 
absence of differences in the MDP of the spontaneous SAN AP. We then compared the 
voltage-dependence of the If activation curve and found that neither the voltage at half-
maximal activation (V1/2) (NP: -102.8±1.5mV and P: -103.6±1.5mV, p=0.69) nor the slope 
factor (NP: 10.2±0.4 and P: 9.7±0.3, p=0.33) significantly differed between either group, 
suggesting that a change in the If activation kinetics cannot explain the increased density of If.  
 
If response to relaxin and SAN cAMP levels are unchanged in pregnancy 
In the next series of experiments, we compared the voltage-dependence of If activation in SAN 
cells from non-pregnant and pregnant mice in the presence of relaxin (80nM), which has been 
reported to modulate other ionic currents by increasing intracellular cAMP.
28
 Data presented 
in Figure 4A and B show that relaxin shifted the activation curve to more depolarized 
potentials; however, the If voltage-dependence of activation and the change (ΔV1/2= relaxin 
V1/2 – baseline V1/2) was similar between the two groups (NP: ΔV1/2 2.8±0.6mV and P: ΔV1/2 
2.3±0.3mV, p=0.46). The effect of relaxin on the slope factor was also comparable (NP: 
Δ1.3±0.3mV and P: Δ1.4±0.1mV, p=0.73). Thus, the data suggests that the basal cAMP level 
is not elevated in SAN from pregnant mice. These results are in agreement with the cAMP 
data reported in Figure 4C, where similar intracellular cAMP content was found in SANs 
isolated from non-pregnant and pregnant mice. Together these findings indicate that the 
increased If density in SAN cells of pregnant mice cannot be explained by a positive shift in 
the If voltage-dependence due to higher intracellular cAMP levels. 
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The sensitivity of If to isoproterenol is blunted during pregnancy 
To determine whether the responses of If to β-adrenergic stimulation was modified by 
pregnancy, we measured the voltage-dependence of the If activation curve in the presence of 
the β-adrenergic agonist, isoproterenol (100nM). We found that the maximal isoproterenol-
induced shift to more positive voltages was attenuated in pregnancy (NP: ΔV1/2 4.8±0.6mV 
and P: ΔV1/2 2.8±0.5mV, p=0.02) (Figure 5A-D). Isoproterenol did not affect the slope factor 
in non-pregnant mice, (Δ0.1±0.5mV, p=0.75) but the slope was slightly increased in SAN 
cells from pregnant mice (from 9.6±0.6 to 10.9±0.6mV, Δ1.4±0.3mV, p=0.007) although this 
change did not reach statistical significance compared to the change (Δ0.1±0.5mV) in non-
pregnant mice (p=0.06 NP vs P). In addition, another set of surface ECG experiments was 
performed on non-pregnant and pregnant mice before and after IV injection of isoproterenol 
(Figure 5E). Consistent with a lower If isoproterenol-induced response, data presented in 
Figure 5F indicates that although isoproterenol significantly accelerated the heart rate in both 
groups, the increase was lower in pregnant (Δ72±15bpm) compared to non-pregnant mice 
(Δ132±24bpm). 
 
If response to muscarinic stimulation is unchanged during pregnancy 
We then examined the effect of pregnancy on the voltage-dependence of the If activation curve 
after the application of acetylcholine (1µM). Figure 6 shows that the hyperpolarizing shift in If 
activation caused by acetylcholine was similar in non-pregnant and pregnant mice (NP: ΔV1/2 
-1.3±0.4mV, P: ΔV1/2 -1.7±0.3mV, p=0.52). No change in slope was found in the presence of 
acetylcholine in either group (NP: Δ -0.1±0.3mV, P: Δ -0.1±0.2mV, p=0.89). 
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Influence of pregnancy on HCN channel expression 
To further explore the mechanisms for the increased If current density in pregnancy, we 
measured the mRNA levels of the three HCN channel isoforms expressed in mouse SAN 
(HCN1, HCN2 and HCN4) using qPCR analysis (Figure 7A). Results of these experiments 
reveal that the transcript levels of the three HCN isoforms did not differ between non-pregnant 
and pregnant animals. Additionally, we performed Western blot analysis to examine the 
protein expression of the HCN isoforms and found that although the protein level of HCN4 
was not altered, the expression of HCN2 was significantly increased in pregnancy (Figure 7B). 
Taken together with the electrophysiological data described above, these expression studies 
indicate that an increase in HCN2 protein expression, with no change in the voltage-
dependence of the If activation curve, contributes to the increased If density in pregnancy. 
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DISCUSSION 
Summary of main findings. In the present study, we provide the first mechanistic insight into 
the increase in HR associated with pregnancy. First, we show that in a mouse model of 
pregnancy the increased HR is not secondary to alterations in autonomic tone, arterial blood 
pressure or circulating catecholamine levels. We then demonstrate that the higher HR in 
pregnancy is associated with accelerated automaticity of SAN cells, steeper diastolic 
depolarization rate, and enhanced density of If, one of the major ionic currents modulating 
pacemaker activity of the heart. The increased If density could be explained by higher protein 
expression of HCN2 channels with no change in the voltage-dependence of the If activation 
curve. Together, these findings demonstrate that If upregulation is a major mechanism in the 
increase in HR during pregnancy. 
 
Our mouse model of pregnancy reproduces the increased HR observed during pregnancy in 
humans. This effect is present even in the absence of autonomic nervous system input, 
suggesting that the pregnancy-induced increase in HR reflects changes intrinsic to the heart. 
Similar explanations have also been proposed for the increased HR observed in pregnant 
women.
9, 29
 In addition, clinical studies have shown that women have a higher resting HR than 
men,
2, 30-33
 and this difference is preserved after autonomic blockade.
34
 Interestingly, the faster 
HR in pregnant mice is accompanied by a shorter PR interval with no change in P wave 
duration. A shorter PR interval could be a direct consequence of the increased HR. However, 
since the SAN and AV node share similar ion channels, it is possible that the AV node also 
undergoes remodelling mechanisms similar to the SAN. However, further studies will be 
required to assess the effects of pregnancy on AV node. 
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Elevated levels of cAMP lead to a positive shift in the If activation curve and hence increase 
its current density. However, this study rules against a cAMP-dependent regulation of If as a 
potential explanation for the enhanced If density in pregnancy. Indeed, there was no change in 
the voltage-dependence of the If activation curve or cAMP levels in SAN cells from pregnant 
mice. Results obtained with relaxin also support this conclusion. As mentioned above, relaxin 
has been shown to rapidly elevate cAMP content in various tissues.
28, 35, 36
 Therefore, if SAN 
cells from pregnant mice had a higher basal cAMP level, addition of relaxin should only 
minimally increase cAMP content. This would result in a much smaller shift in the I f 
activation curve. However, the similar response of If to relaxin obtained in both groups does 
not support this hypothesis. Thus, it appears that mechanisms independent of cAMP 
participate in the upregulation of If in the SAN during pregnancy. 
 
In the present study, the higher density of If is associated with an increased protein expression 
of HCN2 channel isoform. Previous studies have shown that HCN4 is the most highly 
expressed HCN isoform in mouse SAN whereas HCN2 and HCN1 are detected at moderate 
and low levels, respectively.
37
 HCN4 is considered to be the main component of If in murine 
SAN; however, evidence also supports a functional role, although to a lesser extent, for 
HCN2.
37
 Findings reported here show that HCN2 protein level is increased in SAN from 
pregnant mice suggesting that the contribution of this channel isoform to mouse SAN I f would 
be enhanced during pregnancy. In support of this notion, the maximal isoproterenol-induced 
shift in the If activation curve was attenuated in pregnancy. This observation agrees with an 
increased expression of HCN2 since this channel isoform is known to have a lower cAMP 
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sensitivity than HCN4.
37
 Considering that HCN2 channels have faster activation kinetics 
compared to HCN4, it is tempting to speculate that an increase in HCN2 channels is essential 
in order to support the elevated HR needed to compensate for the greater physiological 
demand associated with pregnancy. Indeed, exponential fits of the I f activation trace at -60 mV 
reveal that the activation time constant was significantly reduced in pregnant mice (NP: 
883±120 ms and P: 596±73 ms p=0.04). This is consistent with an increase in the HCN2 mole 
fraction in HCN heteromultimers of pregnant mice. As a result, a more rapid activation of the 
current near the diastolic potentials is observed. It is also worthwhile mentioning that the 
frequency of cells where If was not activated at -60 mV was much higher in the non-pregnant 
mice. Although we were able to detect HCN1 transcripts, this isoform was not detectable at 
the protein level in SAN isolated from either experimental groups. This could be due to low 
sensitivity of the antibody used or reflects a low expression level of HCN1 in the mouse SAN 
as previously reported,
37
 suggesting that this isoform may not make an important contribution 
to If in mouse SAN. 
 
Besides the increased HCN2 expression, other factors could also contribute to the increase in 
If density. In fact, various factors are known to modulate If in SAN cells, such as auxiliary 
subunits and cytoskeletal proteins, which functionally interact with HCN channels.
15, 38, 39
 
Interestingly, the expression of HCN1 and HCN2 was upregulated when these isoforms were 
co-expressed with MinK-related protein 1 (MiRP1).
38
 Therefore, future studies are required to 
explore the contribution of these factors on the upregulation of If in pregnancy. 
 
It is plausible that the increase in HR itself may lead to an upregulation of If. Consistent with 
this idea, previous studies have shown that in response to HR acceleration, other cardiac ionic 
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currents, such as L-type calcium currents (ICaL) and ATP-sensitive K
+
 current (IKATP), are also 
upregulated.
40, 41
 For instance, in human cardiac myocytes it has been reported that the density 
of ICaL can be increased by high rates of cell stimulation. This increase was attributed to an 
incomplete inactivation of ICaL at rapid pacing frequencies, which may also involve 
phosphorylation of Ca
2+
 channels. This process was thought to be crucial in the adaptation of 
the beating heart to stress and exercise.
40
 Pregnancy is also associated with accelerated HR as 
part of the adaptive response to the increased physiological requirements. Therefore, rate-
dependent upregulation of If may also be mediated by similar mechanisms where an initial 
increase in the frequency of activation of ICaL, as well as changes in ICaL gating kinetics, (e.g., 
slowing of ICaL decay) increases Ca
2+
 influx. The elevated intracellular Ca
2+
 levels could then 
trigger intracellular events upregulating If. In support of this hypothesis, a report in rat 
hippocampal CA1 cells showed that a Ca
2+
-dependent modulation of the hyperpolarization-
activated current (Ih, the neuronal equivalent of If) controls the synchronized thalamocortical 
rhythms.
42
 Thus, a rise in intracellular Ca
2+
 may promote the If–dependent pacemaker 
mechanisms and in addition modulate the Ca
2+
-dependent pacemaker process referred to as the 
“Ca2+ clock,” in which the rhythmic SR Ca2+ release plays a major role in the SAN 
automaticity. These functional interactions between the two pacemaker mechanisms may 
provide additional means to accelerate HR as part of the adaptation to pregnancy. 
 
Hormonal changes that occur during pregnancy are likely to be involved in the increased 
automaticity of the heart during pregnancy.
28, 43, 44
 It is also noteworthy that sex-specific 
hormonal fluctuations increase the inducibility of arrhythmias, which has been correlated with 
gestation, menopause, and even changes in the menstrual cycles.
26, 45, 46
 In other cell types, 
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pregnancy or sex steroid hormones have been shown to regulate hyperpolarization-activated 
inward currents. For instance, during pregnancy, uterine smooth muscle cells also exhibit a 
hyperpolarization-activated inward current similar to If in SAN cells. This current is believed 
to contribute to the spontaneous automaticity and enhanced myometrial contractility that 
occurs near parturition.
47
 In the brain, Ih also plays a critical role in many rhythmic neurons. 
Specifically, 17β-estradiol regulates the density of Ih in GnRH neurons. In these cells, rising 
levels of 17β-estradiol also increase mRNA expression of multiple ion channels, such as HCN, 
T- and L-type Ca
2+
 channels, which increase the overall excitability of GnRH neurons.
48
 
Additionally, ovariectomy was shown to reduce the number of action potentials in 
hippocampal CA1 pyramidal neurons, supporting a role for female hormones on neuronal 
automaticity.
49
 Taken together, these data support the notion that hormonal changes occurring 
during pregnancy can contribute to the higher HCN2 channel expression and increased If 
density. 
 
Upregulation of If is most likely not the only change associated with enhanced automaticity of 
the heart during pregnancy. In fact, regulation of other ionic currents by pregnancy-related 
hormonal changes has been previously reported.
28
 It is therefore plausible that other 
mechanisms involved in the diastolic depolarization could also contribute to the steeper 
diastolic depolarization. Furthermore, the fact that the AP threshold was more positive in 
pregnant mice also suggests that additional mechanisms are involved in the AP remodelling of 
the SAN during pregnancy. Conceivably, alterations in ionic mechanisms such as Ca
2+
 
currents, Na
+
-Ca
2+
 exchanger and spontaneous SR Ca
2+
 release could also contribute to these 
changes. Interestingly, Elzwiei F. et al recently reported that the α1 isoform of the Na+-K+ 
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pump expression and flux are reduced in pregnant rats. The consequences were an 
accumulation of Na
+
 which drove the Na
+
-Ca
2+
 exchanger into reverse mode, thereby 
increasing intracellular Ca
2+
.
50
 Thus, it is possible that a similar scenario occurs in the SAN 
where increases in intracellular Ca
2+
 cycling would act in concert with an enhanced If density 
in order to sustain the elevated HR during pregnancy. Future studies will be required to 
explore the contribution of these ionic and Ca
2+
 mechanisms on the increased HR in 
pregnancy. 
 
Conclusion 
In conclusion, our data provide evidence that the accelerated heart rate in pregnant mice is 
associated with higher HCN2 channel protein expression leading to increased I f density and 
automaticity of SAN. Our results demonstrate novel and functionally important ionic 
mechanisms, which contribute to the well-known pregnancy-induced increase in HR. 
Additional work will be directed toward examining how these changes in If may predispose 
the heart to initiation of arrhythmias during pregnancy. 
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Figure 1. Pregnancy is associated with increased HR and shortened PR interval in 
surface ECG and Langendorff-perfused heart experiments. (A) Typical examples of 
surface ECG traces from anaesthetized NP and P mice. Table comparing mean data for HR, 
PR, QT and QTc intervals in NP and P mice show that HR is significantly increased and PR 
interval shortened in P mice (NP; N=10 and P; N=15). (B) Representative epicardial ECG 
recordings from Langendorff-perfused hearts in NP and P mice. Table comparing mean ECG 
parameters reveals a faster HR and a shorter PR interval in P mice (NP; N=10 and P; N=11). 
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Figure 2. Pacemaker activity of isolated SAN cells is increased in pregnant mice. (A) 
Representative spontaneous APs (top) and their first derivative (bottom) recorded using 
perforated patch-clamp configuration in SAN cells isolated from NP (left) and P (right) mice. 
Arrows indicate diastolic depolarization while the hatched line indicates 0 mV in this and 
subsequent figures. (B) Measurements of the intrinsic cycle length (CL), diastolic 
depolarization rate (DDR), AP threshold (Eth), maximum diastolic potential (MDP), maximal 
velocity of AP upstroke (Vmax), AP amplitude (APA) and AP duration (APD) of SAN cell APs 
were made as shown by the dotted lines and arrows on the AP (left). Summary table of AP 
parameters from NP (n=17, N=9) and P mice (n=12, N=8). 
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Figure 3. Electrophysiological properties of If in SAN cells of non-pregnant and pregnant 
mice. (A) Typical examples of If current recorded in whole-cell configuration in SAN cells 
isolated from NP and P mice. Insets depict recording protocols. (B) Mean data for the current-
voltage (I-V) relationship for If in SAN cells of NP (n=26, N=18) and P (n=26, N=17) mice 
(*p<0.05). (C) Typical examples of If current recorded in perforated patch configuration using 
a tail current protocol (shown in inset) in SAN cells isolated from NP and P mice. (D) Mean 
data for the steady-state If activation curves of SAN cells in NP (n=18, N=12) and P (n=17, 
N=8) mice. Tail currents were determined by substracting the peak current from the steady-
state current (tail current at -90mV), normalized and plotted against test voltage. The 
relationships were fitted with the Boltzmann equation.  
 
  
 87 
 
 88 
 
Figure 4. If response to relaxin is similar in pregnant and non-pregnant mice. (A) Typical 
examples of If current traces from NP mice (left) and corresponding steady-state If activation 
curves (right) before and after application of relaxin (RLX, 80nM). (B) Typical examples of If 
current traces from P mice (left) and corresponding steady-state If activation curves (right). 
Similar results were obtained in n=5 SAN cells from N=3 mice for each group. (C) Bar graph 
summarizing cAMP assay results on SAN derived from NP and P mice (N=10 in both groups, 
p=0.07). 
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Figure 5. Effect of isoproterenol on If is not affected by pregnancy. (A) Representative 
examples of If recorded in SAN cells of a NP mouse in the absence or presence of 
isoproterenol (ISO, 100nM). (B) Corresponding If activation curve. (C) Representative 
examples of If recorded in SAN cells of a P mouse in absence or presence of isoproterenol 
(ISO, 100nM). (D) Corresponding If activation curve. Similar results were obtained from n=5, 
N=4 in NP and n=6, N=3 in P groups. (E) Typical surface ECG recordings from anaesthetized 
NP (top) and P mice (bottom) in presence of ISO. (F) Bar graphs presenting the mean data for 
HR obtained on surface ECGs from anaesthetized NP and P mice before and after ISO (NP: 
ΔHR +132±24, N=6 and P: ΔHR +72±15, N=7). 
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Figure 6. Response of If to acetylcholine is similar in SAN cells of pregnant and non-
pregnant mice. (A) Representative examples of If recorded in SAN cells of a NP mouse in 
absence or presence of acetylcholine (ACH, 1µM). (B) Corresponding If activation curve. 
Similar results were obtained in n=8 SAN cells from N=4 mice. (C) Representative examples 
of If recorded in SAN cells of a P mouse in absence or presence of acetylcholine (ACH, 1µM). 
(D) Corresponding If activation curve. Similar results were obtained in n=6 SAN cells from 
N=2 mice. 
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Figure 7. qPCR and Western blot analysis of HCN channel isoforms from pregnant and 
non-pregnant mouse SAN. 
(A) Mean qPCR data showing relative mRNA expression of HCN1, HCN2 and HCN4 in SAN 
of NP and P mice. Each bar graph represents mean data of 6 samples, each analyzed in 
triplicate. 10-12 SAN were pooled per sample (HCN1, p=0.88, HCN2, p=0.55, HCN4, 
p=0.14). 
(B) Western blot analysis for HCN2 and HCN4 on SAN from P and NP mice (top) and bar 
graph summarizing mean data for relative protein expression (bottom) (n=3 for both groups, 3 
SANs were pooled per n, *p=0.04). 
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Table 1. Arterial Blood Pressure and Catecholamine Levels in Non-Pregnant and 
Pregnant Mice. 
 
 Non-Pregnant Pregnant p-value 
Arterial Blood Pressure 
Systolic pressure (mm Hg) 99.5 ± 1.4 (8) 100.8 ± 3.1 (7) 0.68 
Diastolic pressure (mm Hg) 70.0 ± 1.8 (8) 70.3 ± 3.0 (7) 0.95 
Mean blood pressure (mm Hg) 79.0 ± 1.5 (8) 79.7 ± 3.0  (7) 0.85 
    
Plasma Catecholamines 
Epinephrine level (ng/ml) 2.0 ± 0.5 (6) 2.8 ± 0.8 (5) 0.37 
Norepinephrine level (ng/ml) 9.8 ± 1.0 (6) 10.8 ± 1.3 (7) 0.55 
 
Numbers in parenthesis represent numbers of mice 
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Clinical Perspectives 
An increased incidence of cardiac arrhythmias is observed during pregnancy. This may have 
significant consequences on the wellbeing of the mother and the fetus. In fact, during 
pregnancy the heart rate significantly increases thus raising the susceptibility to arrhythmias. 
This is particularly true in the third semester where sinus tachycardia becomes very common. 
Indeed, more than 50% of pregnant women exhibit a form of arrhythmia and ectopic beats. 
The mechanisms for the increase in heart rate and subsequent arrhythmia risks have been 
largely unexplored. In the present study we used a mouse model of pregnancy to explore the 
positive chronotropic effect in pregnancy and we report one of the main underlying ionic 
mechanisms responsible for heart rate increase. First, we show that our mouse model of 
pregnancy reproduces the increased heart rate observed in pregnancy in humans and 
importantly that this increase is intrinsic to the heart and not secondary to alterations in 
autonomic tone, arterial blood pressure or circulating catecholamine levels. We then 
demonstrate that pregnancy is associated with accelerated automaticity of the sino-atrial node 
cells through enhanced density of the funny current (If), one of the major ionic currents 
modulating pacemaker activity of the heart. Our results thus, provide novel and functionally 
insight into mechanisms of pregnancy-induced increase in heart rate. Additional work will be 
directed toward examining how these changes may initiate arrhythmias during pregnancy. As 
the number of pregnancies in women at an advanced maternal age, -with more comorbidity- 
continues to rise, this issue is becoming even more relevant. 
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Online data Supplement 
Upregulation of the hyperpolarization activated channels increases pacemaker activity of 
the sinoatrial node and heart rate during pregnancy in mice 
 
Corresponding author: C. Fiset 
MATERIAL AND METHODS 
Surface electrocardiograms (ECG) 
Mice were anaesthetized with isoflurane. Body temperature was maintained at 37°C using a 
heating pad. Platinum electrodes positioned subcutaneously were connected to a Biopac 
System MP100 (EMKA Technologies, France). Surface ECGs were recorded in
 
lead I 
configuration at a rate of 2 kHz and performed for 5 minutes of continuous experimental 
recording at the end of a baseline period. The signal was filtered at 100Hz (low pass) and
 
60kHz (notch filter). Data were analyzed using ECG-auto 1.7 (EMKA Technologies). RR, PR, 
and QT intervals were calculated manually by a blinded observer from signal averaged ECG 
recordings (500-1000 cardiac cycles). QT intervals were corrected (QTc) for HR using the 
correction formula for mice (QTc=QT/(RR/100)
1/2
).
1
 Additional surface ECG recordings were 
obtained on anaesthetized mice before and after intravenous (IV) injection of isoproterenol 
(0.1ng/g) through the right jugular vein.
2
 After the maximal isoproterenol effect occurred 
(within 1-2 minutes), ECG parameters were measured as described above. 
Langendorff-perfused heart 
Experiments were performed as previously described.
3
 Mice were heparinized (1 U/kg, IP) 20 
minutes prior to sacrifice. They were then anaesthetized with isoflurane and sacrificed by 
cervical dislocation. The heart was rapidly excised and hung on a modified Langendorff 
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apparatus and retrogradely perfused through the aorta at a constant perfusion pressure of 
75mmHg with a Krebs-Henseleit buffer at 37
o
C and constantly gassed with 95% O2/ 5% CO2 
containing (mM) 11.2 glucose, 118.5 NaCl, 25 NaHCO3, 4.7 KCl, 2.45 MgSO4, 1.2 KH2PO4, 
1.2 CaCl2. Epicardial ECG recordings were obtained by placing one silver electrode at the 
base of the heart under the right atrium and another in the apex of the left ventricle. After an 
equilibration perfusion period, epicardial ECG measurements were recorded and ECG 
parameters were calculated as above. 
Sino-atrial cell isolation 
Mice were anaesthetized by inhalation of isoflurane and then sacrificed by cervical 
dislocation. The SAN cells were isolated using an adaptation of the protocol previously 
described by Mangoni et al.
4
 Briefly, SANs were dissected in normal HEPES-buffered Tyrode‟s 
solution containing (mM): 140 NaCl, 5.4 KCl, 1.8 CaCl2, 1 MgCl2, 5 HEPES and 5.5 glucose 
(pH=7.4 with NaOH). SAN tissue was cut into small pieces and rinsed twice for 4 minutes in a 
Ca
2+
-free Tyrode‟s solution containing (mM) 0.5 MgCl2, 1.2 KH2PO4, 50 taurine and 0.1% 
bovine serum albumin (BSA Fraction V, Sigma, St. Louis, MO, USA) (pH=6.9 with NaOH). 
The tissue strips were then digested at 36±1
o
C for 20-30 minutes with the same solution 
supplemented with collagenase type IV (229U/ml, Worthington, Lakewood, NJ, USA), elastase 
(1.9U/ml, Worthington), protease type XIV (0.9U/ml, Sigma) and 200µM CaCl2. The SAN 
tissue was then washed three times and transferred into “Kraft-Brühe” (KB) solution (mM): 100 
K
+
-glutamate, 10 K
+
-Aspartate, 25 KCl, 10 KH2PO4, 2 MgS04, 20 taurine, 5 creatine, 0.5 
EGTA, 5 HEPES, 0.1% BSA, 20 glucose (pH=7.2 with KOH). The tissue was triturated gently 
with a Pasteur pipette until single SAN cells were obtained, usually within 2-3 minutes. 
Physiological extracellular Ca
2+ 
concentration was gradually restored. Isolated mouse SAN 
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cells were identified as small spindle-type cells spontaneously beating in normal Tyrode‟s 
solution.
4
  
Electrophysiological data 
Current- and voltage-clamp recordings.  An aliquot of SAN cell solution was placed in a 
recording chamber (volume 200µl) mounted on the modified stage of an inverted microscope and 
superfused with a normal Tyrode‟s solution containing (mM): 140 NaCl, 5.4 KCl, 1.8 CaCl2, 1 
MgCl2, 5 HEPES and 5.5 glucose (pH=7.4 with NaOH). For If recordings, 1 mM BaCl2 (Sigma) 
was added to the external solution to block the inward rectifier K
+
 current, IK1.Bath was 
perfused with continuously gassed (100% O2) at 35±1˚C. Current- and voltage-clamp recordings 
were obtained using the Axopatch 200B patch-clamp amplifier (Molecular Devices, Sunnyvale, 
CA, USA). Pipettes were pulled from borosilicate glass (World Precision Instruments, 
Sarasota, FL, USA), and had resistance of 3-6 M when filled with the following solution 
(mM): 100 K
+
-aspartate, 30 KCl, 10 NaCl, 2 MgATP, 6.6 Na2phosphocreatine, 0.1 Na2GTP, 
0.04 CaCl2, 1 MgCl2 and 5 HEPES (pH=7.2 with KOH). Voltage-clamp recordings were low-
pass filtered at 10kHz (4-pole Bessel), digitized and analyzed using pCLAMP 10.2 software 
(Molecular Devices). Capacitive transients were elicited by a 10-ms voltage step of  10 mV 
from a holding potential (HP) of -30mV. Cell capacitances were measured by integrating the 
area of the capacitive transients. Junction potential was not corrected. 
Real time RT-PCR 
Total RNA extraction and real-time PCR (qPCR) for the HCN channels were conducted using 
previously published protocols.
5, 6
 For each sample, 10-12 SANs were pooled and used to 
isolate total RNA from NP and P mice. Total RNA was isolated using TriReagent
®
 and treated 
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with DNase I as previously described.
5
 cDNA was then synthesized with SuperScript
TM
 III 
Reverse Transcriptase (Life Technologies). mRNA was transcribed using pdN6 random 
primers. Gene specific primers and conditions for PCR reactions were used for HCN1 and 
HCN4 as previously described.
6
 The following primers specific to HCN2 were designed 
(forward: GCTGGGTGTCCATCAACAAC, reverse: AGATGTCTGTCATGCTCTCG) and 
the PCR reactions were cycled using a 3-step procedure (denaturation at 95ºC for 30s, 
annealing at 55ºC for 60s, elongation at 72ºC for 60s). The qPCR was performed with Platinum 
SYBR Green qPCR Supermix (Life Technologies) using a real-time PCR system (MX3005P 
QPCR system, Stratagene). Quantitative measurements were performed in triplicate and 
normalized to the average of three housekeeping genes (18S, lamin C, and succinate 
dehydrogenase complex subunit A (SDHA)). 
 
Western blot 
The protein samples were extracted from SAN tissues of non-pregnant and pregnant mice for 
Western blot analysis. For each sample, 3 SANs were pooled for protein isolation. SANs were 
pulverized in liquid nitrogen and were then resuspended in ice cold extraction buffer 
containing 1% Triton-X100 and a cocktail of protease and phosphates inhibitors and agitated 1 
hour at 4
o
C. Samples were subsequently centrifuged at 12,000g and the supernantant 
containing the proteins was recovered, quantified using the Bradford assay and stored at -80
o
C 
for later use. Proteins (25 μg) were loaded and separated on 10% SDS-PAGE, blotted on a 
PVDF membrane (Millipore) and probed with anti-rabbit HCN2 and HCN4 specific antibody 
(1:1000) (Alomone Labs, Israel). After secondary antibody incubation, chemiluminescence 
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analysis using an ECL system (PerkinElmer) was performed. All bands were normalized to 
GAPDH (Fitzgerald, Acton, MA, USA). 
Drugs 
Recombinant Human Relaxin-2 (H2 Relaxin; B-29/A24) was purchased from R&D Systems, 
Minneapolis, MN USA. All other compounds were obtained from Sigma. Isoproterenol and 
acetylcholine were prepared in water while relaxin was prepared in sterile PBS. Stock 
solutions of all drugs were then diluted in Tyrode‟s solution to achieve their respective final 
concentration. Isoproterenol was protected from degradation by the addition of ascorbic acid 
(100µM) to the final solution. 
 
Statistical analysis 
All data are presented as mean ± SEM. “n” refers to the number of experiments and “N” the 
number of mice. Descriptive statistics were used to compare ECG parameters. A Mann-
Whitney Test was used to either compare data between NP and P mice obtained with ECG 
recording methods under control conditions and after treatment with isoproterenol. A 
Wilcoxon Signed Ranks test was used to compare HR in the same group before and after 
isoproterenol (Fig. 1,5F). Unpaired t-tests were used to compare blood pressure, 
catecholamine and cAMP levels, cellular electrophysiology, mRNA and protein data between 
NP and P mice (Table 1, Fig. 2-4 and 7). Electrophysiological data in NP and P mice obtained 
before and after pharmacological manipulations were compared using two-way ANOVA for 
repeated measures, no adjustment was used for multiple comparisons (Fig. 3-6). Non 
parametric analyses were conducted using SAS9.2. T-tests and ANOVA were performed with 
Origin 8.0 (OriginLab, MA, USA). p<0.05 was considered significantly different. 
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Outline- The second study has been completed and is in the last stages of preparation and 
proofing. It will be submitted to Circulation shortly. Based on the previous paper, this study 
explores the role of Ca
2+ 
in contributing to the heart rate increase during pregnancy. Featuring 
in vivo and cellular electrophysiology, Ca
2+ 
imaging, and gene expression data we demonstrate 
how SAN Ca
2+
 homeostasis and regulation, that is critical to pacemaking function, adapts to 
sustain an elevated heart rate. Additionally, new evidence relating to arrhythmia risk and the 
reversal of the SAN adaptations following delivery is presented.  
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3.1 Résumé 
L‟augmentation de la fréquence cardiaque (FC) pendant la grossesse est 
potentiellement associée à un risque accru d'arythmies ou d'exacerbation de conditions 
cardiaques préexistantes, mettant en danger à la fois la mère et le fœtus. L'homéostasie 
calcique joue un rôle important dans la régulation de l'automaticité du nœud sinusal (NS), 
toutefois, sa contribution à l‟accélération de la FC pendant la grossesse demeure inconnue. En 
utilisant des cellules isolées du NS, nous démontrons que le courant de Ca
2+
 de type L (ICaL), 
qui joue un rôle majeur dans l'automaticité du NS, est augmenté de 42% chez les souris 
gestantes (SG) par rapport aux non gestantes (SNG) tandis que le courant Ca
2+
 de type T 
demeure inchangé. Conformément à ces résultats, l'analyse de qPCR du gène codant CaV1.3 
montre une expression presque doublée chez les SG comparées aux SNG.  
Nous avons également étudié l'homéostasie calcique dans les cellules du NS en 
évaluant les oscillations du Ca
2+
 intracellulaire qui dépendent des récepteurs à la ryanodine 
(RyR2), de la pompe Ca
2+
 du réticulum sarcoplasmique (SERCA2a), du phospholamban 
(PLB) et de l'échangeur Na
+
/Ca
2+
 (NCX1). Les données montrent que la fréquence des 
transitoires Ca
2+
 et la vélocité de la phase ascendante étaient significativement plus élevées 
chez les SG et elles étaient à une associées une plus forte expression génique de RyR2 tandis 
que l‟expression celle de SERCA2a, PLB et NCX1 restait inchangée. L'évaluation de la 
susceptibilité aux événements arythmiques, déterminée à l'aide de protocoles de stimulation 
électrique programmée a permis de mettre en évidence que les SG étaient plus susceptibles 
(25%) de souffrir d'arythmies que les SNG. Enfin, nous avons montré que toutes les 
modifications observées pendant la grossesse étaient réversibles après la parturition.  
Ces résultats suggèrent que des modifications de l'homéostasie Ca
2+
 intracellulaire du 
NS particulièrement, une augmentation de ICaL et la libération spontanée de Ca
2+
 du réticulum 
sarcoplasmique par les RyR2 peuvent contribuer à l'accélération de l'automaticité chez les SG. 
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3.2 Study 
ABSTRACT 
During pregnancy there is a significant increase in heart rate (HR) potentially associated with 
an increased risk of arrhythmias or exacerbation of pre-existing cardiac conditions 
endangering both mother and fetus. Calcium homeostasis plays an important role in regulating 
automaticity of the sinoatrial node (SAN) however, its contribution to the accelerated HR 
during pregnancy remains unknown. Using isolated SAN cells, we show that L-type Ca
2+
 
current (ICaL), which plays a major role in SAN automaticity, is increased by 42% in pregnant 
(P) compared to non-pregnant (NP) mice, while T-type Ca
2+
 current was unchanged. 
Congruent with these results, qPCR analysis for Cav1.3 was increased approximately 2 fold in 
P compared to NP mice. Ca
2+
 homeostasis in SAN cells mediated by oscillations of 
intracellular Ca
2+ 
concentrations by means of ryanodine receptors (RyR2), sarcoplasmic 
reticulum (SR) Ca
2+
-ATPase (SERCA2a), phospholamban (PLB) and the Na
+
/Ca
2+
 exchanger 
(NCX1) was examined. Data shows that Ca
2+ 
transient frequency and Ca
2+
 release were 
significantly higher in P mice along with a higher mRNA expression of RyR2. SERCA2a, 
PLB and NCX1 expression remained unchanged. Assessment of arrhythmic events using 
programmed electrical stimulation protocols revealed that P mice are more likely to suffer 
from supraventricular arrhythmias compared to NP. Lastly, we showed that all of the reported 
modifications associated with pregnancy are rapidly reversible following delivery. Together, 
these results suggest that an increase in ICaL and spontaneous Ca
2+
 release from the SR through 
RyR2 in SAN cells contribute to the acceleration in SAN automaticity in pregnant mice by 
altering intracellular Ca
2+
 homeostasis. 
Keywords: Heart rate; Ca
2+
 handling; pacemaker; pregnancy; sinoatrial node. 
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INTRODUCTION 
Pregnancy brings about drastic changes to physiological functions of many organ systems 
including the vasculature and the heart that undergo extensive remodeling.
1
 Indeed, 
throughout normal pregnancy in women, the substantial increase in blood volume, metabolism 
and fetal needs require the cardiovascular system to undergo major adjustments to meet the 
growing demand of both the mother and the fetus.
2,3
 During the second to fifth week of 
pregnancy, the heart rate (HR) can increase up to 25% and remain elevated throughout the 
remainder of gestational period. Elevated HR or sinus tachycardia are often seen in pregnant 
women and are a known risk factor for arrhythmias notably supraventricular arrhythmias.
2,4–7
 
During pregnancy, the prevalence of arrhythmias is high and they may occur de novo or 
become exacerbated if an underlying cardiac condition exists, thereby posing an increased risk 
to both the mother and the fetus.
5,7
 
 
This HR increase in women suggests that pregnancy directly influences the automaticity of the 
heart. Indeed, cardiac automaticity is regulated by the sinoatrial node (SAN), which is 
responsible for initiating and controlling the HR making it a fundamental aspect of normal 
cardiac physiology.
8,9
 A major determinant of cardiac automaticity is the spontaneous diastolic 
depolarization phase of the action potential (AP) in SAN cells where the rate of firing is 
determined by the slope of the diastolic depolarization.
8–10
 Two main mechanisms are thought 
to regulate spontaneous activity of SAN cells: a voltage-sensitive component comprised of 
several voltage-gated membrane ion channels including the L-type and T-type Ca
2+ 
channels 
along with the pacemaker channels that encode the pacemaker current (If). These channels 
work in concert with a Ca
2+
 cycling mechanism that relies on a spontaneous and rhythmic 
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release of Ca
2+ 
from the sarcoplasmic reticulum (SR) during the late diastolic depolarization in 
the form of Ca
2+
 sparks and transients.
9,11–14
 The localized increase in intracellular Ca
2+
 
initiates membrane depolarization largely through activation of the sodium-calcium exchanger 
(NCX1).
12,13
 The small electrogenic current produced by forward-mode NCX1 contributes to 
an acceleration of the late diastolic depolarization phase and spontaneous activity of the SAN. 
Recent evidence from numerous studies has shown that intracellular Ca
2+
 handling and 
membrane voltage-gated ion channels are locked in together and subject to crosstalk forming a 
complex pacemaking mechanism.
15,16
 Specifically, in SAN cells, T- and L-type Ca
2+
 currents 
(ICaT and ICaL) and their underlying voltage-gated channels CaV3.1 and CaV1.2/1.3 
respectively, play a critical role in the second half of the diastolic depolarization. Indeed, the 
activation of ICaT then ICaL following the spontaneous If-mediated depolarization, causes a 
localized Ca
2+
 release from the SR and therefore both currents are important in the late 
diastolic depolarization phase and pacemaking.
8,17,18
 Intracellular Ca
2+
 cycling in SAN cells is 
also tightly regulated by various Ca
2+
 handling proteins. The major players include the SR-
bound ryanodine receptor (RyR2), the SR Ca
2+
-ATPase pump (SERCA2a) as well as the 
NCX1, which in concert, regulate SAN automaticity and HR. 
 
In order to explain the increase in HR during pregnancy several hypotheses related to 
hemodynamic changes and catecholamines have been put forth. Nonetheless, the exact 
mechanisms underlying this increase in HR and the underlying molecular mechanisms of this 
adaptation have been, until recently, largely unexplored. We proposed the hypothesis that 
pregnancy leads to an intrinsic electrophysiological remodeling of the SAN resulting in an 
increased automaticity. Consequently, in our previous study examining the influence of 
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pregnancy on the SAN, we have shown that pregnancy induces an important upregulation of 
the pacemaker current If in SAN and contributes to faster automaticity of the SAN in mice.
19
 
However, we now report that although block of If reduces AP rate, it fails to completely 
eliminate the increase observed in SAN cells of pregnant mice, suggesting that other 
mechanisms are at play and hinting a possible role for Ca
2+
 in regulating HR during 
pregnancy.  
 
Accordingly, in light of the fundamental importance of Ca
2+
 in automaticity of the SAN, we 
sought to determine in this study the role that intracellular Ca
2+
 cycling plays in regulating HR 
during pregnancy. In the first objective, we aimed to determine whether pregnancy alters ICaT 
and ICaL in isolated SAN cells. We then examined the effects of pregnancy on global Ca
2+
 
transient homeostasis, identifying affected Ca
2+
 handling proteins and we tested how these 
changes can relate to an increased HR and arrhythmia vulnerability. Finally, we also explore 
in this study the effects of delivery on the various pacemaking mechanisms and we show that 
post-partum is an important period that triggers a rapid reversal of the changes in SAN 
automaticity induced by pregnancy. 
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MATERIALS AND METHODS 
Animals 
This study was performed in accordance to the guidelines of the Canadian Council on Animal 
Care (Ottawa, ON, Canada) and the Guide for the Care and Use of Laboratory Animals 
published by the US National Institute of Health (NIH Publication No 85-23, revised 1996); 
the Montreal Heart Institute Animal Care Committee approved all experiments (approval 
reference number 2012-80-02 and 2015-80-04). Adult CD1 female non-pregnant (NP, 2-3 
months old), pregnant (P, 18-19 gestation days) and post-partum (PP, 1-2 days post-delivery) 
mice were used for all experiments and were purchased from Charles River (St-Constant, QC, 
Canada).  
 
Sinoatrial cell isolation 
For several experiments, isolated mouse sinoatrial (SAN) cells were obtained using previously 
published protocols.
19
 Briefly, mice were anaesthetized with isoflurane and killed by cervical 
dislocation. Hearts were rapidly excised and placed in normal HEPES-buffered Tyrode‟s 
solution gassed with 100% O2 containing (in mM): 140 NaCl, 5.4 KCl, 1 CaCl2, 1 MgCl2, 5 
HEPES and 5.5 glucose (pH = 7.4 with NaOH). Atrial tissue was excised, exposing the SAN. 
A cut, running parallel to the crista terminalis, was then performed in order to isolate the SAN. 
SAN pieces were rinsed twice for 4 minutes in a modified Ca
2+
-free Tyrode‟s solution 
containing (in mM): 140 NaCl, 5.4 KCl, 0.5 MgCl2, 5 HEPES, 1.2 KH2PO4 and 50 Taurine. 
(36 ± 1
o
C, pH = 6.9 with NaOH). The SAN tissue was then placed in the same Ca
2+
-free 
Tyrode‟s solution supplemented with 0.1% bovine serum albumin (BSA Fraction V, Sigma, 
St. Louis, MO, USA), collagenase type IV (229 U/mL, Worthington, Lakewood, NJ, USA), 
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elastase (1.9 U/mL, Worthington), protease type XIV (0.9 U/mL, Sigma) and 200 M CaCl2 
for 25-30 minutes. After the digestion period, the tissue was removed, rinsed three times and 
transferred into Kraft-Brühe (KB) solution containing (in mM): 100 K
+
-glutamate, 110 K
+
-
Aspartate, 25 KCl, 10 KH2PO4, 2 MgSO4, 20 taurine, 5 creatine, 0.5 EGTA, 5 HEPES, 0.1% 
BSA, and 20 glucose (36 ± 1
o
C, pH = 7.2 with KOH) for 4 minutes. The tissue was then 
gently triturated with a glass-fired Pasteur pipette for approximately 3-5 minutes until single 
SAN cells were obtained. The SAN cell suspension was then stored at 4
o
C until use. 
Individual mouse SAN cells were identified as small, spindle-like cells that were 
spontaneously beating in normal Tyrode‟s solution. 
 
Electrophysiological data 
Current-clamp recordings. A drop of SAN cells containing solution was placed in a recording 
chamber (volume 200 µL) mounted on the modified stage of an inverted microscope and 
superfused with a normal Tyrode‟s solution containing (mM): 140 NaCl, 5.4 KCl, 1.8 CaCl2, 1 
MgCl2, 5 HEPES and 5.5 glucose (pH = 7.4 with NaOH). Bath was perfused with the solution 
that was continuously gassed (100% O2) at 36 ± 1˚C. Pipettes were pulled from borosilicate 
glass (World Precision Instruments, Sarasota, FL, USA), and had resistance of 2-4 M when 
filled with the following solution (mM): 100 K
+
-aspartate, 30 KCl, 10 NaCl, 2 MgATP, 6.6 Na2-
phosphocreatine, 0.1 Na2GTP, 0.04 CaCl2, 1 MgCl2 and 5 HEPES (pH = 7.2 with KOH). 
Spontaneous AP recordings using perforated-patch clamp technique with nystatin (350 ng/mL) 
in current-clamp mode were obtained using the Axopatch 200B patch-clamp amplifier and 
digitized using Digidata 1550 (Molecular Devices, Sunnyvale, CA, USA). For some 
experiments, the same external solution containing ivabradine (3 μM) was perfused while 
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spontaneous APs were being recorded. Effects of ivabradine on a rate were assessed following 
a stabilization period of 3-5 minutes.   
 
Ca
2+
 Current recordings. SAN cell suspension was placed in a recording chamber (200 L) 
and perfused with external Ca
2+
 solution containing (in mM): 10 CsCl, 0.5 MgCl2, 1 CaCl2, 5 
HEPES, 145 TEA-Cl and 5.5 glucose (pH = 7.4 with CsOH). All recordings were performed 
at 36 ± 1
o
C. Currents were recorded with borosilicate microelectrodes that had a resistance of 
2-4 MΩ when filled with the following solution (in mM): 130 CsCl, 10 EGTA, 25 HEPES, 3 
Mg-ATP and 0.4 Na-GTP (pH = 7.2 with CsOH). Capacitive transients, elicited by a 10 ms 
step of ±10 mV, were used to calculate cell capacitance and normalize current amplitudes 
expressed as current densities (pA/pF). Data acquisition was performed using the same 
Axopatch 200B patch-clamp amplifier and Digidata 1550 digitizer (Molecular Devices). 
 
Current recording protocols and analysis. Current-voltage (I-V) relationships were all 
obtained in whole-cell configuration. ICaL I-V curves were obtained using stimulation protocol 
eliciting 250 ms voltage steps in 5-10 mV increments from -50 mV to +50 mV from a holding 
potential of -50 mV. ICaT I-V relationships curves were obtained by subtraction of ICaL from 
total Ca
2+
 current traces (ICaTotal). ICaTotal was obtained using stimulation protocols with 250 ms 
voltage steps from -90 to +50 in 5-10mV increments from a holding potential of -90mV. 
Current protocols were generated and analyzed using the Axon pCLAMP 10 
electrophysiology data acquisition and analysis Software (Molecular Devices). 
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In vivo heart rate assessment. HRs were obtained from anesthetized NP, P and PP mice using 
RR intervals obtained from surface ECGs in lead I configuration. Details can be found in the 
online supplemental data. 
 
Programmed in vivo electrophysiological stimulation protocols (EPS). Arrhythmia risk was 
assessed using EPS in anaesthetized mice (2% isoflurane). Body temperature of the mice was 
monitored and kept at 37°C by use of a heating pad. An octapolar electrophysiology catheter 
(1.9F) designed for rodent electrophysiology (Transonic Scisense Inc.) was introduced into the 
heart via the right jugular vein and bipolar recordings were obtained from the distal two 
electrode pairs. Right atrial pacing was performed by triggering a stimulus at twice diastolic 
threshold using a custom-built computer-based stimulator (509 Stimulator, Grass-Telefactor). 
The induction of supraventricular arrhythmias was tested using 8 consecutive burst stimulation 
protocols (5 s at S1S1: 50-10 ms, 10 ms stepwise reduction). Pacing stimulation duration was 
set at 1 ms. Arrhythmias of supraventricular type featuring rapid, irregular rhythm, lasting for 
at least 1s were quantified and analyzed.
20–22
 All mice underwent the identical pacing 
stimulation protocol in the same controlled conditions. 
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Quantitative real-time PCR (qPCR) 
RNA Extraction. Extraction of RNA and (qPCR were performed using protocols that were 
previously published.
19
 RNA isolation was performed using the NucleoSpin RNA XS isolation 
kit (Macherey-Nagel, Bethlehem, PA, USA) following manufacturer instructions. RNA 
quantity was assessed using NanoDrop spectrophotometric analysis. Superscript™ III Reverse 
Transcriptase (Life Technologies, Carlsbad, CA, USA) and pdN6 non-specific primers were 
used to synthesize cDNA. A total of 5-6 SANs were used for each sample to isolate RNA from 
NP, P and PP mice.  
 
Quantitative PCR. Primers for CaV1.2, CaV1.3 and CaV3.1, RyR2, SERCA2a, PLB and NCX1 
were designed and sequences are presented in the data supplemental. PCR reactions were 
performed with a three steps cycle of denaturation (95
o
C for 30s), annealing (55
o
C for 60s) 
and elongation (72
o
C for 60s). Quantitative PCR was performed using Platinum SYBR Green 
qPCR Supermix (Life Technologies) and a real-time PCR system (MX3005P qPCR, Agilent 
technologies, Mississauga, ON, Canada). In all experiments, quantitative analysis was 
performed in triplicate and the geometric mean of three housekeeping genes (18S, succinate 
dehydrogenase complex subunit A (SDHA) and hypoxanthine-guanine 
phosphoribosyltransferase (HPRT)) was used for normalization. Expression data were 
obtained following the 2
-ΔΔCt
 method. 
 
Calcium Transients 
Spontaneous Ca
2+
 transients were obtained using adaptation of previously published 
protocol.
23
 Briefly, isolated SAN cells loaded for 20 min with 5 μM of Fluo-4 AM (Molecular 
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Probes) were placed in a bath perfused with 36
o
C Tyrode‟s solution and mounted on a Zeiss 
LSM 710 confocal microscope. Following a washout period, spontaneous activity was 
observed and transients were recorded by live imaging. Following a 10-second recording of 
spontaneous transients, a 10 mM caffeine solution was applied to the SAN cell via a precision 
perfusion stylus in the bath to evoke large SR Ca
2+
 release. Spontaneous and caffeine 
transients were then analyzed using ImageJ software and various transient parameters were 
calculated by adapting formulas from previously published studies.
24
 Specifically, we reported 
rate of spontaneous release, time-to-peak, Ca
2+ 
transient amplitude (F-F0)/F0, time to 90% 
decay as well as SR fractional release, defined as ratio of spontaneous transient to caffeine-
induced transient (F-F0)/F0 transient / (F-F0)/F0 caffeine).  
 
Chemicals 
All chemicals were purchased from Sigma-Aldrich, unless otherwise stated. Fluo-4 AM and 
nystatin were first dissolved in anhydrous DMSO.  
 
Statistical analysis 
Analyses were performed with Origin 8.0 (OriginLab, MA, USA). The value of „n‟ represents 
the number of cells or experiments and „N‟ the number of mice. All data are presented as 
mean ± SEM. Data were compared using unpaired t-test or one-way ANOVA with Tukey or 
Fisher LSD post-hoc comparison where appropriate. p-values <0.05 were considered 
significantly different. 
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RESULTS 
Pregnancy accelerates action potential frequency 
We have previously reported that upregulation of If during pregnancy contributes to an 
acceleration of spontaneous action potential (AP) firing rate in isolated SAN cells.
19
 In order 
to determine the functional impact of If on pacing frequency of SAN cells, we applied the 
specific HCN channel blocker ivabradine. Results presented on Figure 1 show that ivabradine 
reduced AP pacing rate in both P and NP mice, however, the reduction in pacing rate was 
significantly larger in NP group. Since AP frequency is higher in P group
19
 and was reduced to 
a lesser extent by ivabradine application, we conclude that when If is blocked, cardiac 
automaticity is still faster in P mice suggesting that mechanisms other than If are playing an 
important role in the pregnancy-induced enhanced automaticity. Considering Ca
2+
 homeostasis 
is a fundamental mechanism of pacemaking in the SAN, we devised accordingly the next 
series of experiments to determine the role of Ca
2+
 currents and Ca
2+
 handling function in 
contributing to the increased SAN automaticity and consequent acceleration of HR during 
pregnancy.  
 
Influence of pregnancy on Ca
2+
 currents 
As previously stated, Ca
2+
 currents play an important role in the late diastolic depolarization 
phase of the sinoatrial node AP, thereby contributing to automaticity of the heart. To 
determine if pregnancy resulted in any change in Ca
2+
 current density, ICaL and ICaT from P and 
NP isolated SAN myocytes were recorded and compared. The typical recordings and I-V 
curves on Figure 2A and B respectively, show that peak ICaL was significantly increased in 
SAN cells from P compared to NP mice (at -10 mV in pA/pF, NP: -5.3 ± 0.3, P: -7.5 ± 0.5, 
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*p<0.01). On the other hand, ICaT, which was obtained through subtraction of ICaL from total 
Ca
2+
 currents, remained comparable between the two groups (Figure 2C and D). Furthermore, 
we subsequently measured ICaL in post-partum (PP) mice in order to determine whether 
delivery would reverse the increase in current density. Recordings on Figure 2A and the mean 
I-V curve (Figure 2B) demonstrate comparable current densities between the PP and the NP 
group. Overall, the voltage-clamp data show that pregnancy specifically increases L-type Ca
2+
 
current in the SAN, making it a likely contributor to faster automaticity of the SAN during 
pregnancy. In addition, this upregulation was completely reversible 24h following delivery, 
returning to NP values.  
 
Transcriptional upregulation of L-type Ca
2+
 channels by pregnancy 
In the following set of experiments mRNA expression of Ca
2+
 channel α-subunits in whole 
SAN tissue was evaluated. Specifically, we examined the two isoforms of L-type Ca
2+
 
channels (CaV1.2 and CaV1.3) as well as the major isoform of T-type Ca
2+
 channels CaV3.1. 
Results shown on Figure 3 indicate that mRNA expression of CaV1.3 but not CaV1.2 was 
significantly increased in the P group compared to NP. Congruent to the previous voltage-
clamp data on ICaT, mRNA abundance of CaV3.1 was not affected by pregnancy (Figure 3) 
thereby indicating that pregnancy induces a selective transcriptional upregulation of CaV1.3 
leading to increased ICaL in the SAN. Interestingly, qPCR analysis in PP mice (Figure 3) also 
reveals that following delivery CaV1.3 expression reverts to NP levels indicating, in clear 
concordance with the voltage-clamp data, a key role of pregnancy in transcriptionally 
regulating CaV1.3 L-type Ca
2+
 channels in the SAN.  
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Pregnancy accelerates spontaneous Ca
2+
 transient rate 
Following these observations we sought next to determine whether pregnancy altered 
intracellular SAN Ca
2+
 handling. Using SAN cells isolated from P, NP and PP mice that were 
loaded with the Ca
2+
 probe Fluo-4AM, we examined spontaneous Ca
2+
 transients in the 
various groups. Data in Figure 4 shows that the rate of spontaneous transients in SAN cells 
from P mice were significantly increased (19%). Furthermore, there was a decrease in the Ca
2+ 
transient time-to-peak and time to 90% decay in the P group (Figure 4). The results also show 
that these adaptations, specifically, rate and time-to-peak but not the time to 90% decay were 
also reversed in the PP group highlighting yet again the specific effect of pregnancy in 
regulating Ca
2+
 homeostasis. The PP group also showed a tendency for higher spontaneous 
Ca
2+
 transient amplitude ((F-F0)/F0) although it did not reach statistical significance. Of note, 
similarly to the time-to-peak parameter during spontaneous pacing, it was found that in the P 
group the time-to-peak in the caffeine-induced transient was also smaller and caffeine-induced 
Ca
2+
 transient amplitude in the PP group became significantly different from NP and P groups 
(Figure 5). Furthermore, data on Figure 5 shows no changes in fractional release or time to 
90% decay. Thus, these data indicate that pregnancy results in changes in multiple Ca
2+
 
handling parameters notably, a faster Ca
2+
 transient rate associated to a faster SR- Ca
2+
content 
release. 
 
Influence of pregnancy on Ca
2+
 handling proteins gene expression 
In order to determine the molecular mechanisms responsible for the increase in Ca
2+
 transient 
rate during pregnancy we conducted qPCR experiments on isolated SAN tissues from the 
various groups. The mRNA levels of the major Ca
2+
 handling proteins expressed in mouse 
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SAN were analyzed to determine which components were altered. Figure 6 shows that while 
mRNA expression of NCX1, SERCA2a and PLB were all unaffected by pregnancy, 
expression of RyR2 was significantly increased in SAN from P mice compared to NP mice. In 
addition, we noted that the effects of pregnancy on increased RyR2 expression were also 
reversed to pre-pregnancy levels following delivery while all the other examined genes 
remained stable in PP mice (Figure 6). Taken together, the findings of the last experiments 
suggest that pregnancy enhances the rate of SR Ca
2+
 release as indicated by the smaller time-
to-peak values through a transcriptional upregulation of RyR2 in the SAN. The faster time to 
90% decay was not associated with transcriptional upregulation of SERCA2a nor PLB in the P 
group indicates that the pump is most likely functionally modulated through second 
messengers. 
 
Cellular and in vivo electrophysiological studies  
In order to evaluate how the cellular and molecular changes observed thus far translated 
functionally we started by comparing heart rates between NP, P and PP mice. The in vivo HR 
analysis by ECG measurements shown on Figure 7A revealed that P mice had a significantly 
higher HR compared to the NP, consistent with our previous study. Furthermore, we report 
that the PP had HR values comparable to the NP, indicating a return to baseline rates shortly 
after delivery. Interestingly, a similar observation was made on the cellular level. When AP 
frequency of isolated SAN cells were measured, as expected P group had the highest 
frequency and 24h following delivery there was a rapid reversal in automaticity of the SAN as 
seen by the slower AP frequency in PP that was comparable to the NP group (Figure 7B; in 
bpm, NP: 292 ± 13, n=17; P: 330 ± 12*, n=12; PP: 306 ± 27, n=7, *p<0.05 vs NP and PP). 
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Furthermore, following the ECG measurements, programmed in vivo electrophysiological 
stimulations were used to determine whether the increase in SAN automaticity we observed in 
P mice might contribute to an increased arrhythmia risk, a well observed phenomenon in 
pregnant women. Our in vivo EPS data on Figure 7C shows that the probability of inducing a 
sustained supraventricular arrhythmia, expressed as incidence of arrhythmia, was increased by 
~50% in P mice compared to NP. Data also shows that arrhythmia risk in PP mice was 
reduced, indicating that the near complete reversal in the increased SAN automaticity 
mechanisms and HR translated into reversal to baseline arrhythmia inducibility (Figure 7C). 
Collectively, results from this set of experiments indicate that pregnancy induces changes in 
several Ca
2+
 handling parameters that result in faster SAN automaticity and HR that are 
associated with significant increase in the risk of arrhythmias and remarkably these parameters 
were reversed within 24h following delivery. 
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DISCUSSION 
During pregnancy, cardiac remodeling is considered an essential physiological adaptation that 
helps provide adequate delivery of nutrients and oxygen to the growing fetus.
2
 Along with the 
structural changes such as hypertrophy, there is an up to 25% increase in resting HR,
25
 
indicating that effects of pregnancy also extend to electrophysiological parameters. While 
investigating these changes, we have previously found that the increase in HR in pregnant 
mice was independent of changes in autonomic tone, blood pressure or circulating 
catecholamines and was instead attributable to cardiac electrical remodeling. Specifically, we 
showed that there was a significant increase in the density and expression of the pacemaker 
current If that was associated with faster automaticity of the SAN
15
. In the present study, we 
show that blockade of If, using the selective HCN channel blocker ivabradine, affected 
differently P and NP mice. Indeed, while the SAN cells firing frequency was reduced in both 
groups, P mice had a rate that remained significantly higher after application of ivabradine, 
indicating that pacemaking mechanisms other that If are contributing to HR control during 
pregnancy and sustaining elevated rates. We report here that Ca
2+
 homeostasis is also 
regulated to support an accelerated HR. Our data shows that, in the SAN, pregnancy induces a 
transcriptional upregulation of CaV1.3 and RyR2 channels. This upregulation resulted in an 
increase in ICaL current along with a faster Ca
2+ 
extrusion from the SR measured during 
spontaneous and caffeine-induced Ca
2+
 transients. This increase in both CaV1.3 and RyR2 may 
be critical to sustain the faster HR by allowing a quicker spontaneous transient rate through 
accelerated Ca
2+
 entry and subsequent intracellular Ca
2+
 release. Interestingly, in the SAN of 
pregnant mice, there was no increase in CaV1.2 and the L-type Ca
2+
 current peaked at a 
relatively hyperpolarized -10 mV, consistent with the greater role for CaV1.3 in the SAN. 
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Indeed, as previously reported CaV1.3 constitutes the major L-type Ca
2+ 
channel isoform in the 
mouse SAN and in support of this observation, recent studies have shown that deletion of 
CaV1.3 in the SAN results in bradycardia and dysrhythmic SAN pacemaking. Furthermore, 
CaV1.3 was demonstrated to play a critical role in modulating intracellular Ca
2+
 dynamics by 
regulating Ca
2+
 release from the SR.
26–28
 Since it was shown that CaV1.3 deletion resulted in 
an inhibition of Ca
2+
 transients, it is very likely that the increase in CaV1.3 we observed here, 
along with the increase in RyR2, serves the opposite purpose: increasing Ca
2+
 transient rate 
and robustness of the CaV1.3/RyR2 coupling, thereby sustaining the elevated HR during 
pregnancy. Interestingly, this upregulation in the molecular underpinnings of HR control 
occurs early on in pregnancy. In women, the increase in HR is observed as early as 12 
weeks,
29,30
 while we previously reported an increase in HR in pregnant mice at earlier 
pregnancy days (12-13).
19
 The mechanisms behind these rapid changes remain to be examined 
however, pregnancy is a time during which important fluctuations in hormonal levels occur, 
including changes in estrogen, progesterone, thyroid and relaxin which might contribute to the 
electrophysiological remodeling.
19
 In support of this notion, it was previously shown that 
increased levels of 17β-estradiol can upregulate various ion channels including L-type Ca2+ 
channels in the ventricle and other cell types.
31–33
  Additionally, in the SAN, relaxin was 
shown to cause rapid increases in pacemaking rate attributable to an increase in Ca
2+ 
current
34
, 
while thyroid hormone has also been known for many years to have a  role in regulating 
cardiac ion channels.
35–37
 
 
It is noteworthy to mention that the substantial fluctuations in the levels of these hormones 
that take place in various phases of pregnancy, such as during early, late pregnancy and the 
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early postpartum period, coincide with important changes in cardiac automaticity. For 
instance, following delivery, there is a sharp drop in estrogen and progesterone levels and pre-
pregnancy HR level is restored within the first two weeks.
1
 In this study, we also report a 
novel finding that HR in pregnant mice reverts to control values as early as 24h following 
delivery. The reversal in HR was also observed at the cellular and molecular level of the SAN 
with a return of Ca
2+
 current density to control levels and a normalization of transient rate, 
CaV1.3 and RyR2 expression levels. Of note, time to 90% decay in the PP group remained 
lower indicating that SERCA2a activity is still high. Since transcriptionally, SECRA2a and 
PLB were not affected, it appears that the functional modulation of SERCA2a requires more 
than 24h to revert to baseline function. Interestingly, we also examined the pacemaker current 
If in PP mice, and we found that its density also reverted to pre-pregnancy values, becoming 
comparable to that of control recordings we previously obtained (Supplemental Figure 1).
19
 
This rapid reversal of electrophysiological and several critical Ca
2+
 handling parameters to 
baseline levels would be therefore consistent with a hormonal effect on ion channels during 
pregnancy.  
 
Understanding the mechanisms underlying the electrophysiological changes during pregnancy 
is becoming increasingly important. Indeed, as the average maternal age and proportion of 
pregnant women suffering from comorbidities including diabetes, hypertension and various 
cardiovascular conditions increase,
38,39
 pregnancy-related complications and mortality are 
becoming complex issues requiring fundamental understanding of their underlying 
mechanisms. For instance, as previously noted, the increase in HR is a known risk factor for 
arrhythmias and during pregnancy there is a significant increase in the risk of electrical 
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disturbances notably supraventricular and sinus node arrhythmias, comprising more than 70% 
of  total arrhythmia occurrences.
40
 While changes in sympathetic tone, hormones and stress 
have been thought to contribute to the increased arrhythmia susceptibility,
39
 little mechanistic 
evidence has been proposed. In our study and previous report
19
 we showed that the HR during 
pregnancy increases due to major electrophysiological remodelling of the SAN. Furthermore, 
we showed that the murine model of pregnancy was also associated with an increased risk of 
arrhythmias and although it was previously demonstrated that reversal of structural changes is 
relatively slow, the modifications in electrophysiological parameters we observed were rapidly 
reversed following delivery, similarly to women. These observations are consistent with the 
idea that electrophysiological changes due to direct regulation of ion channels and not cardiac 
structural remodeling are a major cause of arrhythmic events. In further support to this notion, 
it was previously reported that the increase in HR during pregnancy is protective in women 
with long QT syndrome and is associated with lower arrhythmia risk. However, in postpartum 
women, with the reduction of HR comes a loss of the protective effect of pregnancy and a 
significant increase in arrhythmia susceptibility and torsades de pointes.
41
 
 
CONCLUSION 
In conclusion, our study highlights an important role for pregnancy in regulating SAN 
function and pacemaking. Specifically, we demonstrated a major role for Ca
2+
 homeostasis, as 
well as pacemaker current, in the increased HR during pregnancy. This illustrates a notable 
case where key players in the SAN Ca
2+
 and voltage clocks are mutually entrained and 
regulated. These findings also portray the SAN as a dynamic pacemaker that can intrinsically 
and rapidly adjust to changing physiological requirements as witnessed by the rapid reversal 
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of pacemaking function following delivery. In conclusion, understanding the cellular and 
molecular mechanisms that drive the SAN, HR control and arrhythmias during pregnancy is 
essential not only for expanding our knowledge of the regulatory pathways within the SAN 
but also for appropriate management of pregnant women and a step forward in progressing 
women‟s health. 
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DATA SUPPLEMEMENT 
 
SUPPLEMENTAL FIGURE 1 
Supplemental Figure 1. If current in SAN cells of post-partum CD-1 mice: Left panel; Typical 
example of If current recorded in whole-cell configuration in SAN cells isolated from PP mice. Insets 
depict recording protocol. Right panel; Mean data for the current-voltage (I-V) relationship for If in 
SAN cells from PP (n=7, N=6) mice shows current densities that are similar to previously obtained 
values from control mice.3 
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SUPPLEMENTAL MATERIAL AND METHODS 
Surface electrocardiograms (ECG) 
Surface electrocardiograms were performed in order to determine heart rate. Mice were 
anaesthetized with 2% isoflurane. Body temperature was maintained at 37°C using a heating 
pad. Platinum electrodes positioned subcutaneously were connected to a Biopac System 
MP100 (EMKA Technologies, France). Surface ECGs were recorded in
 
lead I configuration at 
a rate of 2 kHz and performed for 5 minutes of continuous experimental recording at the end 
of a baseline period. The signal was filtered at 100Hz (low pass) and
 
60kHz (notch filter). 
Data were analyzed using ECG-auto 1.7 (EMKA Technologies). RR intervals were calculated 
manually by a blinded observer from signal averaged ECG recordings (500-1000 cardiac 
cycles).  
 
Real time RT-PCR 
Total RNA extraction and real-time PCR (qPCR) for the Ca
2+
 handling channels were 
conducted using adaptation of previously published protocols.
1,2
 For each sample, 5-6 SANs 
were pooled and used to isolate total RNA from NP, P and PP mice. Total RNA was isolated 
using TriReagent
®
 and treated with DNase I as previously described.
3
 cDNA was then 
synthesized with SuperScript
TM
 III Reverse Transcriptase (Life Technologies) using pdN6 
random primers. Gene-specific primers and conditions for PCR reactions were used for the 
genes figuring in table below. The qPCR was performed with Platinum SYBR Green qPCR 
Supermix (Life Technologies) using a real-time PCR system (MX3005P QPCR system, 
Stratagene). Quantitative measurements were performed in triplicate and normalized to the 
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average of three housekeeping genes (18S, hypoxanthine-guanine phosphoribosyltransferase 
(HPRT), and succinate dehydrogenase complex subunit A (SDHA)). 
Table 1. Primer List 
Primers Sequences 
Cav1.2 
Forward: 5‟ACAACCTGGCTGATGCGGA3‟ 
Reverse: 5‟TCACTGGGCTGGAGGTCATC3‟ 
Cav1.3 
Forward: 5‟TCCGAAGAGCCTGCATTAGT3‟ 
Reverse: 5‟ATGCAGCAACAGTCCATACG3‟ 
Cav3.1 
Forward: 5‟GTCTCCGCACGGTCTGTAAC3‟ 
Reverse: 5‟ CCACAGCAAAGAAAGGCAAAG3‟ 
RyR2 
Forward: 5‟CATGAGAATGCTGGCCTTGT3‟ 
Reverse: 5‟TAGCAGTATCGCTGGAGGTT3‟ 
SERCA2a 
Forward: 5‟GTCCTGGCAGATGACAACTT3‟ 
Reverse: 5‟ATGTCCAGGTCTGGAGGATT3‟ 
PLB 
Forward: 5‟TCTCCCTACTTTTGCCTTCCTG3‟ 
Reverse: 5‟GATGCAGATCAGCAGCAGACATA3‟ 
NCX1 
Forward: 5‟AGAGGAGGAGAGGCGCATTG3‟ 
Reverse: 5‟CGCTGACAGTGATGGCTTCG3‟ 
HPRT 
Forward: 5‟TGAATCACGTTTGTGTCATTAGTGA3‟ 
Reverse: 5‟TTCAACTTGCGCTCATCTTAGG3‟ 
18s 
Forward: 5‟TTGACGGAAGGGCACCACCAG3‟ 
Reverse: 5‟GCACCACCACCCACGGAATCG3‟ 
SDHA 
Forward: 5‟GAGGAAGCACACCCTCTCATA3‟ 
Reverse: 5‟GCACAGTCAGCCTCATTCAA3‟ 
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FIGURES  
 
Figure 1. Ivabradine differentially reduces AP frequency in isolated SAN cells. A. The 
effects of ivabradine (3 μM) on AP frequency are shown for SAN cells isolated from NP mice. 
B. Mean Δ decrease in frequency was obtained by averaging the Δ frequencies from individual 
cells before and after application of ivabradine to SAN cells from NP and P (NP: n=7, N=3; P: 
n=6, N=3) (* p<0.05).  Recordings were all obtained by whole-cell perforated current-clamp 
technique and a t-test on log transformed values of Δ change was performed. 
 137 
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Figure 2. Pregnancy selectively increases L-type Ca
2+
 currents in isolated SAN cells. A. 
Typical ICaL traces recorded from SAN cells of NP, P and PP mice (inset shows protocol). B. 
Mean data for the I-V relationship for ICaL in SAN cells from P (n=11, N=9) mice show 
increased current density compared to NP (n=12, N=9) and PP mice (n=8, N=2) (*p<0.05 vs 
NP; †p<0.05 vs PP, ANOVA with Fisher LSD post-hoc test). C. Representative examples of 
T-type Ca
2+
 currents (ICaT) traces recorded from SAN cells of NP and P mice were determined 
by subtracting ICaL from the total Ca
2+
 current trace for each cell. D. Mean I-V relationship 
data from ICaT recordings show no effect of pregnancy on current density (NP: n=12, N=7; P: 
n=11, N=6). 
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Figure 3. qPCR analysis of Ca
2+ 
channel isoforms from isolated SAN shows a selective 
increase in CaV1.3 mRNA expression in the pregnant mice.  
Mean qPCR results showing relative mRNA expression of CaV1.2 (left) and CaV1.3 (middle) 
in SAN from NP, P and PP mice (*p<0.05). While CaV1.2 is unchanged, pregnancy 
significantly increases mRNA expression of CaV1.3. Right- Consistent with voltage-clamp 
data, mRNA expression results show that α subunit of T-type Ca2+ channel CaV3.1 is 
unaffected by pregnancy (n=3, N=5-6 SAN per sample, analyzed in triplicate, ANOVA with 
Tukey post-hoc test). 
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Figure 4. Spontaneous Ca
2+
 transient parameters obtained from NP, P and PP mice.  
Top left panel shows typical examples of spontaneous Ca
2+
 transients recorded by confocal 
microscopy that were obtained from individual SAN cells loaded with Fluo-4AM and beating 
spontaneously. Mean data for computed parameters from spontaneous Ca
2+
 transient 
recordings include transient rate, spontaneous Ca
2+
 transient amplitude ((F-F0)/F0), time-to-
peak and time to 90% decay are shown for NP (n=16-17, N=6), P (n=16-18, N=7) and PP 
(n=14-16, N=6-7) groups (*p<0.05, ANOVA with Tukey post-hoc test). 
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Figure 5. Caffeine-induced Ca
2+
 transient parameters obtained from P, NP and PP mice. 
Mean data for caffeine-induced Ca
2+
 transient parameters are shown for the 3 groups. 
Application of caffeine (10 mM) resulted in SR-Ca
2+
 depletion and the following parameters 
were calculated: amplitude of caffeine-induced transient, fractional release, time-to-peak and 
time to 90% decay (NP: n=10-12, N=5; P: n=10-12, N=5; PP: n=10-11, N=6, *p<0.05, 
ANOVA with Tukey post-hoc test). 
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Figure 6. qPCR analysis of Ca
2+
 handling genes from SAN of NP, P and PP mice.  Mean 
qPCR data for relative mRNA expression of RyR2, NCX1, SERCA2a and PLB in whole SAN 
from P, NP and PP mice are shown. (*p<0.01, ANOVA with Tukey post-hoc test). All bar 
graphs represent n=3-5 samples from 5-6 pooled SANs, all analyzed in triplicate. 
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Figure 7. In vivo electrophysiological studies and arrhythmia susceptibility in NP, P and 
PP mice. 
A. The HR of PP mice obtained by lead I surface ECG was compared to that of previously 
obtained values from NP and P mice.
19
 Data shows similar HR between PP and NP however 
there was a significant difference in HR between PP and P mice. PP, N=9, *p<0.05). B. 
Typical examples of spontaneous AP recordings of obtained from SAN cells of NP, P and PP 
mice reveal a comparable rate between PP and NP, compared to P. Mean AP rate for PP was 
comparable to previously obtained values from NP.
19
 C. Left-Representative surface and 
intracardiac ECGs showing programmed electrical stimulations using burst protocol to trigger 
supraventricular arrhythmia followed by restoration of normal sinus rhythm (NSR). Right- 
Mean arrhythmia incidence data shows that the increased HR in P group was associated with a 
higher susceptibility to arrhythmias that was normalized following delivery, as seen by 
comparable arrhythmic events between the NP and PP groups (NP, N=14; P, N=15; PP, N=6). 
 
 
 
  
 147 
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Outline- This study represents the second theme of the thesis focused on pathology of the 
SAN. Inflammation being a key player in the development of diseases and ageing, we provide 
evidence on how inflammatory mediators can be implicated in adverse remodelling of 
pacemaker cells. Indeed, based on our previous study (El Khoury N. et al J Biol Chem, 2014), 
we show here that IL-1β is a pro-inflammatory cytokine with potent electrophysiological 
effects. In addition, we provide a novel characterization of human nodal like myocytes derived 
from pluripotent stem cells and demonstrate their potential in serving as a novel in vitro model 
of human SAN. More data is currently being generated and will be added to this study shortly 
in order to further consolidate its current results. 
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4.1 Résumé 
La maladie du sinus (MS) regroupe différentes maladies complexes affectant le nœud 
sinusal (NS) et entraîne des troubles de l‟automaticité. Les mécanismes sous-jacents à la forme 
idiopathique de la MS demeurent largement inconnus et nous avons émis l'hypothèse que 
l'inflammation chronique associée au vieillissement et à diverses pathologies contribue à la 
détérioration de l‟activité pacemaker, conduisant finalement à la MS. Nous avons 
précédemment montré que l‟interleukine-1 bêta (IL-1β) était un puissant modulateur des 
courants ioniques. En utilisant des cardiomyocytes de type nodal dérivés de cellules souches 
pluripotentes induites humaines (N-hiPSC-CM), préalablement caractérisés afin de valider 
leur phénotype, nous avons examiné l'influence de l'IL-1β sur les mécanismes de l‟activité 
pacemaker de ces cellules.  
Les N-hiPSC-CMs ont une morphologie distincte et les qPCR sur cellule unique y 
révèlent une plus grande abondance en ARNm des gènes marqueurs du NS: HCN4, HCN2 et 
Cx45 et une expression moindre des gènes ANP, Nkx2.5, Cx43 et NaV1.5 comparativement 
aux hiPSC-CMs de type ventriculaires. Les potentiels d'action (PA) spontanés des N-hiPSC-
CM présentaient une grande similarité avec les propriétés de PA du NS humain adulte. Dans 
les N-hiPSC-CMs traités à l‟IL-1β, une réduction significative de la fréquence des PA est 
associée à une pente de dépolarisation diastolique (DD) plus lente et une hyperpolarisation du 
potentiel diastolique maximum. Les enregistrements des courants pacemaker (If) et Ca
2+
 de 
type L (ICaL), deux acteurs clés de la DD, ont montré que l'IL-1β entraîne une réduction 
drastique de la densité de ICaL et If. De plus, l‟IL-1β induit un déplacement de la courbe 
d'activation de If vers des voltages plus hyperpolarisés, concordant avec une DD plus lente. 
Enfin, les effets de l'IL-1β étaient indépendants de l'expression de l'ARNm des canaux sous-
jacents, suggérant une régulation post-transcriptionnelle.  
En conclusion, les N-hiPSC-CM représentent un modèle approprié de cellules 
humaines du NS dans lesquelles un traitement à l‟IL-1β est capable d‟induire des troubles de 
l‟automaticité. 
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4.2 Study 
ABSTRACT: Sinus node dysfunction (SND) is a group of complex diseases that affect the 
sinoatrial node (SAN) resulting in pacemaking disorders. The mechanisms underlying 
idiopathic form of SND remain largely unknown and we hypothesized that chronic 
inflammation associated to various pathologies and ageing contributes to deterioration of 
pacemaking, eventually leading to SND. Previously, we showed IL-1β to be a potent 
modulator of ionic currents. Accordingly, using nodal-like cardiomyocytes derived from 
human-induced pluripotent stem cells (N-hiPSC-CM) that were first characterized in order to 
validate their phenotype, we examined the influence of IL-1β on pacemaking mechanisms of 
these cells.  Results show that, compared to working myocardium cells (WM-hiPSC-CM), N-
hiPSC-CMs have a distinct morphology while single-cell qPCR revealed higher mRNA 
abundance of hallmark SAN genes HCN4, HCN2 and Cx45 with repressed expression of 
ANP, Cx43 and NaV1.5. Electrophysiologically, N-hiPSC-CM spontaneous action potentials 
(AP) exhibited high resemblance to properties of adult human pacemaker AP. Furthermore, in 
IL-1β-treated N-hiPSC-CMs, a significant reduction in AP frequency associated with slower 
diastolic depolarization rate (DDR) and hyperpolarized maximum diastolic potential was 
noted. Recordings of L-type Ca
2+
 (ICaL) and pacemaker (If) currents, two key contributors to 
the DDR, showed that IL-1β induces a dramatic reduction in density of ICaL and If. . In 
addition, IL-1β negatively shifted the If activation curve, consistent with slower DDR. Effects 
of IL-1β were independent of mRNA expression changes of underlying channels suggesting 
post-transcriptional regulation. We conclude that N-hiPSC-CMs represent a suitable model of 
human SAN cell in which IL-1β was shown to induce pacemaking disturbances. 
Keywords: sinus node disease, pacemaking, inflammation, hiPSC-CM.   
 150 
INTRODUCTION 
The sinoatrial node (SAN) is a crescent-shaped structure located at the junction of the right 
atrium and superior vena cava representing the uppermost point of the conduction system that 
features a spontaneous electrical activity and acts as the dominant pacemaker in the heart.
1
 
Within the SAN, clusters of individual pacemaker myocytes are densely packed into collagen 
rich, fibrous connective tissue and a fatty outer matrix surrounding the peripheral SAN cells 
that interlock with some atrial myocytes. These features provide shielding from the 
automaticity-suppressing effects of the hyperpolarized atrial membrane potentials and favour 
impulse propagation towards the atrium.
2,3
 Pacemaking relies on a complex interplay of 
membrane ion channels and intracellular Ca
2+ 
cycling mechanisms found in every SAN cell. 
Considering there is no substantial expression of inward rectifying channels (Kir2.x) or 
currents in the SAN, no stable resting membrane potential can be achieved
4,5
 and the lowest 
hyperpolarized level is defined as the maximum diastolic potential (MDP). The MDP is a 
critical parameter in pacemaking since it can alter the required time to reach threshold, 
noticeable through either a prolonged or shortened spontaneous diastolic depolarization (DD) 
phase. Indeed, the diastolic depolarization  rate (DDR) is a major determinant of automaticity 
that controls SAN AP frequency hence, heart rate.
6
 Hyperpolarization-activated cyclic 
nucleotide–gated (HCN) channels encoding the funny current If drive the early DDR phase of 
the AP. The progressive membrane depolarization results in activation of T-type Ca
2+
 channels 
that facilitate the attaining of depolarization threshold and subsequent activation of L-type 
Ca
2+
 channels (CaV1.2/1.3) that trigger the rapid AP upstroke.
7,8
 The DD depolarization is also 
facilitated by spontaneous Ca
2+ 
release from the sarcoplasmic reticulum (SR) that drives an 
electrogenic current through the Na
+
/Ca
2+ 
exchanger (NCX1) contributing to the DDR. 
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Ultimately, an SR Ca
2+ 
release synchronized with the AP upstroke is elicited. This bringing 
soon after the AP into its repolarization phase that is driven by K
+
 extrusion and Ca
2+
 
reuptake.
9
 Owing to the importance of proper heart rate control, the pacemaking system can be 
finely tuned by a wide range of factors including autonomic input and second messengers that 
convey the necessary cardiac response to varying physiological needs.
1
 Unfortunately, there 
are numerous conditions that can adversely affect the SAN leading to deficient pacemaking, 
trouble in SAN impulse exit, chronotropic incompetence, bradycardia and other arrhythmias 
including atrial fibrillation. These conditions are collectively referred to as sinus node 
dysfunction (SND).
10
 Although both extrinsic and intrinsic factors are thought to cause SND, 
intrinsic cases are irreversible, mostly idiopathic and severe cases have very limited treatment 
options mostly restricted to the invasive implantation of electronic pacemaker.
11
 Idiopathic 
SND has therefore been the subject of investigation recently in order to grasp the underlying 
mechanisms which remain largely elusive. Idiopathic SND correlates well with age and is 
highly prevalent in the elderly where fibrosis and electrical remodelling have been shown to 
depress pacemaker function.
4,10
 Indeed, in aged rodents, an age-dependent decline in several 
membrane ionic currents including L-type Ca
2+ 
(ICaL), T-type Ca
2+
 (ICaT) and If has been 
previously reported to cause bradycardia, lowering shifts in lead pacemaker and depressed 
excitability of the SAN.
12–14
 Interestingly, in autoimmune inflammatory conditions such as 
systemic lupus erythematous and rheumatoid arthritis, severe complications in conduction and 
SAN function have also been reported.
15–17
 Furthermore, in infectious pathologies, where 
inflammatory cascades are highly activated, including Chaga‟s and Lyme disease, bradycardia 
and SND has also been observed and previously, we showed rhythm irregularities and sinus 
pauses in a mouse model of HIV.
10,18
 Together, these observations indicate that inflammation 
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might play a major role in the development of SND. In this study, we propose the notion that 
inflammation, be it elevated as seen in autoimmune and inflammatory disease or the chronic 
low grade type associated with ageing, may be a common factor between these pathologies 
that contributes to the development of SND.
19
  
Inflammation is intrinsically linked to production of various active immunomodulating 
peptides such as cytokines. In particular, pro-inflammatory cytokines have been well known to 
affect the heart in various ways including extracellular matrix remodelling and regulation of 
ion channels.
20–24
 Moreover, interleukin 1β (IL-1β) a key pro-inflammatory cytokines at the 
top of the inflammatory cascade is classically known to be implicated in the development of 
chronic diseases associated with low-grade systemic inflammation.
25,26
 However, IL-1β also 
appears to be highly implicated in the pathogenesis of several heart diseases such as 
myocardial infarction and atherosclerosis and its blockade has even been tested in patients.
27–
30
 Recently, we showed that IL-1β is a potent suppressor of ventricular ICaL, a current that also 
plays a critical role in SAN AP depolarization and triggering.
31,32
 Considering the important 
role of IL-1β in cardiac disease and its high circulating levels in inflammatory conditions 
where bradycardia is observed we tested in this study the effects of chronic IL-1β treatment on 
pacemaking function of nodal-like human induced pluripotent stem cells-derived 
cardiomyocytes (hiPSC-CM). The development of hiPSC-CM has been shown to produce the 
three major myocyte types referred to as nodal-, atrial and ventricular-like in unequal 
proportions with nodal-like constituting the minority of cells.
33
 While various efforts have 
been focused on enriching and maturing ventricular-type, little attention has been given to 
nodal-like cells. Accordingly, in this study we provide an electrophysiological and molecular 
characterization of these cells and demonstrate their similarity to adult human SAN cells. 
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Considering the extremely limited availability of human SAN tissues and relatively low yield 
of SAN cells from animals compared to atrial and ventricular preparations, nodal like hiPSC-
CM (N-hiPSC-CM) may represent a highly interesting in vitro human model of SAN cells that 
can be maintained in culture in high numbers for relatively long periods of time. Thus, our 
objectives were to validate and characterize N-hiPSC-CMs and subsequently determine the 
effect of a chronic IL-1β treatment on the pacemaking function of these cells in order to 
uncover the potential role of this cytokine inducing SND. 
 
MATERIALS AND METHODS 
Cell culture of hiPSC-CM  
Vials of hiPSC-CM (iCell
®
 Cardiomyocytes
2
) and their maintenance medium that was 
purchased from Cellular Dynamics International were thawed and plated following 
manufacturer‟s instructions. Briefly, hiPSC-CM were rapidly thawed and resuspended in 
provided plating media then plated on fibronectin coated glass coverslips. Cells were cultured 
in a water-jacketed incubator at 37°C/5% CO2 for a maximum of two weeks. Media was 
refreshed every day for control (CTL) and recombinant human IL-1β (1 ng/mL, Life Sciences) 
groups. Treatments were performed for a 72h prior to experimentation. 
 
Single-cell qPCR 
Single cell qPCR was performed with Single Cell-to-CT™ qRT-PCR Kit following 
manufacturer‟s instruction and protocol (Thermofisher, # 4458237). Briefly, two to five N-
hiPSC-CMs and WM-hiPSC-CMs were individually collected using a large tip glass micro-
pipet and then deposited in a 0.2 mL PCR micro-tube containing the lysis solution. A stop 
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solution was applied to the samples that were subsequently stored at -20°C until the next step. 
A retro-transcription step was then performed, followed by a gene-specific pre-amplification 
of the cDNA. The qPCR was run with the pre-amplified cDNA and Taqman probes and 
primers for genes of interest. Real-time PCR reactions were completed on a Stratagene 
MXPro3005 system with a two-steps amplification phase (Denaturation 95°C, 5s; annealing 
and elongation 60°C, 1 min). Tested genes included HCN4 (Hs00975492_m1), HCN2 
(Hs00606903_m1), Cx45 (Hs00271416_s1), Cx43 (Hs00748445_s1), ANP (Hs00383230_g1), 
CaV1.2 (Hs00167681_m1), CaV1.3 (Hs00167753_m1) and NaV1.5 (Hs00165693_m1). All 
genes have N=3-5 consisting of n=2-5 pooled cells in each N. All the reactions were done in 
duplicates and HPRT1 (Hs99999909_m1) and 18S (Hs99999901_s1) were used as a reference 
genes. All data represent expression values analyzed according to the 2
-Δct
 method. 
 
Human tissue RNA Extraction and qPCR  
Human tissues (left atria, left ventricle and SAN) were obtained from the Montreal Heart 
Institute tissue bank (Research Ethics Committee approval #2007-43, 924). Isolation of total 
RNA was performed using TriReagent® and treated with DNase I. A purification step was 
added using the Macherey-Nagel Total RNA isolation kit following manufacturer instructions. 
RNA quantity was assessed using NanoDrop spectrophotometric analysis. Maxima First 
Strand cDNA synthesis kit (ThermoFisher Scientific) was used to synthesize cDNA. Real-time 
PCR (qPCR) was performed using protocols that were previously published.
34
 Briefly, qPCR 
was performed with Platinum SYBR Green qPCR Supermix (Life Technologies) using a real-
time PCR system (MX3005P QPCR system, Stratagene). PCR reactions were performed with 
a three steps cycle of denaturation (95°C for 30s), annealing (50°C for 60s) and elongation 
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(72°C for 60s). Quantitative measurements were performed in duplicate and normalized to the 
geometric mean of three housekeeping genes (hypoxanthine-guanine 
phosphoribosyltransferase (HPRT), Beta2-microglobulin (B2M) and GAPDH). Expression 
data were obtained following the 2-ΔCt method. 
 
Electrophysiological data 
AP recordings. Spontaneous APs were recorded from N-hiPSC-CM placed in recording 
chamber (200 L) on a modified stage of an inverted microscope and perfused with Tyrode‟s 
solution containing (mM): 140 NaCl, 5.4 KCl, 1.8 CaCl2, 1 MgCl2, 5.0 HEPES and 5.5 
glucose (pH=7.4 with NaOH). All recordings were carried out at 35±1
o
C using perforated 
patch-clamp technique with nystatin (350 ng/mL). Pipettes were pulled from borosilicate glass 
(World Precision Instruments, Sarasota, FL, USA) and had a resistance between 3 to 5 MΩ 
when filled with the following solution (mM): 100 K
+
-aspartate, 30 KCl, 10 NaCl, 2 Mg-ATP, 
6.6 Na2-phosphocreatine, 0.1 Na2-GTP, 0.04 CaCl2, 1.0 MgCl2 and 5.0 HEPES (pH=7.2 with 
KOH). All current protocols, data acquisitions and analysis were conducted on the ClampEx 
suite featuring pClamp 10.3 and Clampfit 10.3 software using an Axopatch 200B patch-clamp 
amplifier and Digidata 3000 digitizer (Molecular Devices, Sunnyvale, CA, USA).  
If recordings. The If recordings from N-hiPSC-CMs were acquired following AP recordings 
keeping the same conditions. Current-voltage (IV) relationship curves for If were obtained by 
eliciting 2-s voltage steps from −120 to −20 mV in 10 mV increments from a holding potential 
of −30 mV at a frequency rate of 0.2 Hz. The density of If was measured at the end of the 
hyperpolarizing steps. Macroscopic activation curves were generated by normalizing current 
density at a given voltage by maximal current density. Data were plotted against test voltage 
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and fitted with a Boltzmann equation I/Imax=1/(1+exp[V−V1/2]/k), where V is the test voltage, 
V1/2 is the mid-activation voltage, and k is the slope factor.  
 
Ca
2+
 Current recordings. L-type Ca
2+
 currents (ICaL) were obtained in whole-cell 
configuration using the extracellular solution containing (in mM): 10 CsCl, 0.5 MgCl2, 2.0 
CaCl2, 5 HEPES, 145 TEA-Cl and 5.5 glucose (pH = 7.4 with CsOH) while the pipettes were 
filled with the following solution (in mM): 130 CsCl, 10 EGTA, 25 HEPES, 3 Mg-ATP and 
0.4 Na-GTP (pH = 7.2 with CsOH). IV relationship curves for ICaL were obtained using 
stimulation protocol eliciting 250 ms voltage steps in 5-10 mV increments from -50 mV to 
+60 mV from a holding potential of -80 mV with a 50 ms prepulse at -50 mV. To account for 
differences in cell size, current amplitudes for all recordings were normalized to cell 
capacitance and expressed as densities (pA/pF).  
 
RESULTS 
Morphological characteristics of N-hiPSC-CMs 
The use of N-hiPSC-CM as an in vitro model is a potentially interesting prospect that could 
allow the study of cellular and molecular mechanisms governing human SAN pacemaking. 
However, most of the actual studies have been focused on working-myocardium type cells and 
except for few spontaneous AP measurements and some ionic currents recordings, modest 
information related to the nodal-like myocyte exists. Accordingly, in the first series of 
experiment we characterized the N-hiPSC-CM population. Morphologically, individual 
cultured N-hiPSC-CMs appear very different from the other cell types and have a particular 
shape that allows them to be relatively easily detectable within the WM-hiPSC-CM 
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population. As shown on Figure 1A, compared to WM-hiPSC-CMs, N-hiPSC-CMs cells are 
smaller, round, with a large darker central zone corresponding to the nucleus. Their smaller 
size translates into smaller cellular capacitance, averaging 77.8 ± 8.6 pF, n=20, compared to 
WM-hiPSC-CMs at 284.5 ± 24.5 pF, n=18, p<0.01 (Figure 1B). N-hiPSC-CMs were noted to 
be relatively poorly developed structurally with no visible evidence of striation or T-tubules. 
They were flat, except over the central nucleus, with a smooth round shape and overall 
differing strikingly from the polygonal shaped WM-hiPSC-CMs. Furthermore, under normal 
physiological conditions they beat spontaneously although contractions are mostly limited to a 
twitchy motion. 
 
Molecular characteristics of N-hiPSC-CMs 
Using single-cell qPCR technique, gene expression of individual N-hiPSC-CMs and WM-
hiPSC-CMs was then performed and the results compared. Specific and robust markers that 
were previously demonstrated to be positive or negative for human SAN were tested.
5
 
Specifically, data on Figure 2A shows that in N-hiPSC-CMs there is a significant enrichment 
in expression of three hallmark human SAN genes, pacemaker channels HCN4 and HCN2 and 
slow conducting connexin 45 (Cx45). Furthermore, N-hiPSC-CMs were shown to be negative 
for working myocardium markers atrial natriuretic peptide (ANP), fast conducting Cx43 and 
Na
+
 channel NaV1.5 that was higher expressed in working myocardium cells. Interestingly, 
qPCR analysis on ventricular, atrial and SAN tissues isolated from a freshly explanted human 
heart, we also observed the expected enrichment in HCN isoforms, including HCN4 and 
HCN2 in the SAN compared to both atrial and ventricular tissues (Figure 2B). 
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Electrophysiological characteristics of N-hiPSC-CM 
Analysis of spontaneous APs recorded from individual N-hiPSC-CM cells reveal very similar 
AP configuration to mathematical model predictive of human SAN with comparable 
maximum diastolic potential (MDP), depolarization rate, amplitude and lack of atrial or 
ventricular-like plateau phase which can be observed in paranodal and SAN peripheral 
zones.
5,35
 The basic AP configuration also resembles murine SAN APs
34
 although cycle length 
and duration of different parameters varies drastically, consistent with the divergent heart rates 
between mice and humans. The various analyzed parameters including frequency, DDR, 
MDP, threshold of activation (Eth), AP amplitude (APA) and AP duration (APD) are 
summarized in Figure 3B. Of note, mean AP frequency of N-hiPSC-CM of 91.5 ± 4.2 bpm 
was found to be consistent with adult human intrinsic heart rates determined by either 
pharmacological autonomic blockade or complete denervation of SAN, thereby supporting the 
pacemaker role of N-hiPSC-CM cells.
36,37
  
 
IL-1β depresses pacemaking in N-hiPSC-CM cells 
Following the characterization and validation of molecular and electrophysiological phenotype 
of N-hiPSC-CMs, in the next series of experiments we tested the effects of a chronic IL-1β 
treatment on pacemaking mechanisms of these cells. Spontaneous APs from N-hiPSC-CM 
cells were obtained and typical AP recordings from control (CTL) and IL-1β-treated (IL-1β), 
shown on Figure 3A, indicate that IL-1β causes a significant reduction in AP frequency. Mean 
data for the various analyzed AP parameters (Figure 3B) reveal that IL-1β significantly 
reduces AP rate while slowing the DDR and hyperpolarizing MDP and Eth. Furthermore, in 
IL-1β-treated cells, an increase in overall APA and AP duration (APD) was also noted. 
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Overall, these data show that IL-1β reduces AP frequency and induces multiple changes to the 
AP configuration that are consistent with decreased automaticity, suggesting that IL-1β has a 
substantial effect on pacemaking mechanisms of N-hiPSC-CMs.  
 
IL-1β reduces pacemaker current If in N-hiPSC-CMs. 
Since the DDR is a critical determinant of AP rate, two major contributors to the DDR, If and 
ICaL, were subsequently analyzed. Indeed, If is a main contributor to the early phase of the 
DDR and has a fundamental role in pacemaking.
6
 If currents recordings from N-hiPSC-CM 
under CTL and IL-1β-treated conditions were obtained and typical examples of recordings are 
illustrated on Figure 4A while panel B shows the mean IV curve data for both groups. 
Although no change in maximal current density was noted, there was a dramatic reduction in 
current density close to the MDP range. In fact, very significant current reductions varying 
between 64 to 71% were observed at the -40 to -60 mV range. A strong tendency for reduction 
persisted beyond the MDP range down until -80 mV and thereafter current densities became 
comparable. This reduction in If is very consistent with a change in the channel‟s voltage 
dependency that is also observed when decreasing cAMP levels for instance.
38
 Accordingly, 
macroscopic steady-state activation curves fitted with Boltzmann function were computed in 
order to determine whether IL-1β caused any shifts in voltage dependency. Data reported on 
Figure 4C shows that IL-1β induces a significant leftward shift in activation voltage that is 
consistent with the observed current reduction. Indeed, midpoint of activation voltage (V1/2) 
shifted from -88.4 to -93.2 mV (n=7-8, p<0.01) in IL-1β-treated cells indicating functionally 
that close to the MDP range, HCN channel availability is significantly reduced resulting in a 
slower DDR. 
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IL-1β reduces L-type Ca2+ current N-hiPSC-CMs 
ICaL was also subsequently evaluated considering it plays a crucial role in the DDR and 
contributes to the AP upstroke. Typical examples of ICaL recordings illustrated on Figure 5A 
show a reduction in current density in IL-1β-treated cells compared to CTL. Mean IV curve 
data shown on panel B indicates that chronic IL-1β results in a 40% reduction in peak ICaL 
density. Interestingly, analysis of macroscopic steady-state activation of ICaL shown of Figure 
4C, reveals that similarly to If, IL-1β induces a significant leftward shift in the activation curve 
of ICaL indicating opening of these channels at more hyperpolarized voltages and earlier 
activation during the DD phase, despite the lower current density. Overall, the 
electrophysiological results indicate that the slower AP frequency observed in IL-1β-treated 
N-hiPSC-CM is a result of a significant reduction in two main contributors to the DDR, If and 
ICaL. 
 
Effects of IL-1β on N-hiPSC-CM automaticity on ion channel transcription 
In order to determine the mechanism by which IL-1β caused a reduction in current density we 
used the single cell technique on treated and control N-hiPSC-CM. Data for the major genes 
underlying If and ICaL in the SAN are shown on Figure 6. Gene expression results indicate that 
expression of HCN4, CaV1.2 and CaV1.3 is not globally altered by IL-1β treatment. Although 
CaV1.2 seems to be augmented, CaV1.3 is equally reduced, indicating no overall change in the 
transcription level of these α subunit encoding for ICaL. Therefore, these results suggest that 
IL-1β does not reduce current density by transcriptionally regulating HCN and CaV1.2/1.3 
channels, but mediates its effects through post-transcriptional modifications. Indeed, these 
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findings are consistent with our previous results showing that IL-1β does not alter expression 
of ventricular CaV1.2, despite lowering its density by up to 40%.
31
 
 
DISCUSSION 
In this study, we hypothesized that inflammation and pro-inflammatory cytokines that are 
elevated in various pathologies, contribute to SND by affecting pacemaking. The rationale 
behind this notion comes from multiple clinical and experimental observations. Indeed, in 
individuals affected by inflammatory autoimmune or infectious diseases several cases of SND 
have been reported.
10,16,17
 Importantly, chronic low grade inflammation has also been linked to 
ageing, cardiovascular disease, diabetes and metabolic syndromes; conditions that  represent 
some of the most important risk factors for the development of SND.
4,12,19,39–45
 Although 
inflammation is a complex state where a myriad of cytokines and immunomodulating factors 
interact, the pro-inflammatory cytokine IL-1β is pivotal to the inflammatory cascades and was 
shown to be implicated in a wide range of pathologies ranging from arthritis to cardiovascular 
disease.
25–27,29
 Previously, we found IL-1β to be a potent modulator of ionic currents. 
Specifically, levels of circulating IL-1β were shown to be particularly elevated in an HIV 
mouse model that suffered from sinus pauses and bradycardia. Furthermore, treatment of 
ventricular myocytes with IL-1β was shown to have strong inhibitory effect on ICaL density, a 
key cardiac current that also plays a major role in SAN pacemaking.
18,31
 Accordingly, we 
tested in this study the potential of IL-1β in contributing to the pathogenesis of the SAN and 
development of SND.  
Our data shows that chronic IL-1β treatment induces several major changes to the spontaneous 
AP configuration. We highlight a lower DDR, a hallmark feature of bradycardia, but also 
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hyperpolarized MDP and AP threshold.  While a hyperpolarization associated with a more 
negative MDPs contributes to bradycardia by increasing time to reach threshold,
46,47
 we have 
found the threshold in IL-1β-treated cells to also be reduced thus, a complete negative shift in 
AP voltage range was observed. A possible explanation for the lower threshold is the negative 
shift in activation of ICaL that was highly significant from -50 to -35 mV. Even though current 
density was reduced by ~40%, the earlier activation of ICaL would result in sufficient 
depolarization to trigger AP upstroke at more hyperpolarized voltages. On the other hand, 
lower current densities of ICaL combined with that of a reduced If contribute to the slowing of 
the DD phase thereby, lowering AP frequency. Interestingly, activation of I f was also shifted 
negatively, explaining its significantly reduced density (up to 70%) at the MDP voltage range. 
Overall, the resulting slowing in AP rate of ~20% induced by IL-1β is even more pronounced 
than the effects of classic bradycardic agent ivabradine that was previously shown to reduce 
AP rate by ~16%,
46
 demonstrating that IL-1β produces very potent effects on pacemaking and 
may induce bradycardia in settings where its levels are elevated. Moreover, another 
contributing factor to bradycardia might be the longer AP repolarization revealed by higher 
APD observed in IL-1β-treated cells. Thus, the effects of IL-1β likely extend to repolarizing 
K
+
 channels in N-hiPSC-CMs in support of the strong bradycardic influence of this cytokine. 
While exploring the underlying mechanisms of IL-1β-induced bradycardia, no significant 
effects on channel mRNA expression were found, indicating that IL-1β likely exerts its effects 
through post-transcriptional mechanisms. Interestingly, it was previously demonstrated that 
IL-1β contributed to inducing an inotropic effect in ventricular myocytes by reducing 
intracellular cAMP and uncoupling β-adrenergic response through activation of inhibitory G 
protein  Gαi.
48,49
 Moreover, in ventricular myocytes treated with IL-1β we have found pertussis 
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toxin, an inhibitor of Gαi, rescues ICaL density reverting it to control values (unpublished data). 
These finding would be consistent with a negative shift in If activation induced by a decrease 
in intracellular cAMP concentration. It is also possible that IL-1β indirectly reduces cAMP 
levels by affecting ATP synthesis. For instance, in retinal neurones it was shown that IL-1β 
resulted in loss of mitochondrial membrane potential and depleted intracellular ATP.
50
 
Conceivably, the reduced ATP would not only reduce cAMP, indirectly affecting If and ICaL, 
but could also trigger activation of IKATP and hyperpolarize the MDP, as it was observed. In 
support of this notion, it was previously demonstrated that SAN cells expressed the ATP-
sensitive K
+
 current and that potent IKATP activators cromakalim and pinacidil hyperpolarized 
MDP and abolished or slowed the pacemaker activity.
51
 Nonetheless, in one study it was 
shown that in aged mice although increasing cAMP does somewhat rescue the slow AP firing 
rate; it does not completely reverse the ageing phenotype suggesting that there are other non-
identified factors at play that contribute to bradycardia.
52
 
Another important finding reported here is the use of N-hiPSC-CMs as a model of human 
SAN cells. While most of the efforts have been focused at maturing working myocardium in 
order to obtain adult-like myocytes suitable for experimental studies and regenerative 
medicine applications
53–55
, nodal-like, beating cells have been mostly overlooked. Using the 
novel single-cell qPCR technique we were able to analyze expression of key genes in N-
hiPSC-CM and compare them to working myocardium type cells as well as adult human SAN. 
Our results have revealed enrichment of SAN markers in N-hiPSC-CM specifically, HCN2, 
HCN4 and Cx45 while a lower expression of atrial and working myocardium genes ANP, 
Cx43 and NaV1.5 was observed. Thus, we conclude that N-hiPSC-CM represent a highly 
interesting in vitro model that shares a molecular a physiological signature with the human 
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SAN. Unquestionably, several of these markers are also shared with the atrioventricular node 
(AVN) owing to high resemblance in properties of the two nodes.
56
 Nevertheless, the AVN 
has been shown to have high Nkx2.5 expression compared to the ventricles, which is not the 
case in N-hiPSC-CM (data not shown).
56
 Furthermore, their rapid AP rate is consistent with 
the fast, dominant pacemaker role of the SAN and with intrinsic human heart rates.
36,37
 It is 
possible that a subpopulation with more AVN properties exist, however this will require 
substantial experimentation to be validated. Of note, several of the tested markers such as 
HCN4 and HCN2 also showed high expression levels in working-myocardium cells. While 
this does not invalidate the N-hiPSC-CMs it hints at the well-known immature phenotype of 
working hiPSC-CMs.
55
 Indeed, various lineage tracing and cardiac embryology studies have 
shown that the SAN develops early on and retains a pacemaker gene program through 
expression of several transcription factors that suppress differentiation. As such, mature SAN 
cells resemble immature and developing working myocardium cells,
57–59
 which is likely the 
case of hiPSC-CM where evidence of automaticity or spontaneous DDR has been observed in 
myocytes regardless of their individual types.
33,54
 
In conclusion, this study highlights a new role for N-hiPSC-CMs as a powerful model of adult 
SAN cells featuring the appealing advantage of human molecular machinery they hold. 
Automaticity of N-hiPSC-CMs was shown to be strongly affected by IL-1β, providing 
explanations on its potential role in inducing sinus bradycardia and promoting the 
development of SND in various pathologies where its levels are elevated. Naturally, owing to 
the complex inflammatory cascades, IL-1β cannot be solely accountable for inducing SND as 
several other pro-inflammatory cytokines have been shown to alter electrophysiological 
properties of cardiac cells while other have been shown to promote fibrosis.
20,22–24,31,60
 It will 
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therefore be important in the future to determine the role of IL-1β in inducing bradycardia in a 
complex disease setting where several other factors are at play.  
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Figure 1. Morphological characteristics of N-hiPSC-CMs. (A) Bright-field images of hiPSC-
CMs are shown. Examples of large, polygonal, typical WM-hiPSC-CMs are shown on the left 
panel. Two examples of N-hiPSC-CMs are shown on the right. Note the significantly smaller 
size, round shapes and distinct morphology. (B) Mean capacitance of WM-hiPSC-CMs and N-
hiPSC-CMs obtained from voltage-clamp experiments reveal significantly larger cell 
capacitance of WM-hiPSC-CMs compared to nodal-like cells. (N-hiPSC-CMs, n=20 and WM-
hiPSC-CMs n=18, *p<0.05). 
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Figure 2. Comparison of gene expression between N-hiPSC-CMs and WM-hiPSC-CMs. (A) 
Significant differences in expression of SAN-positive markers HCN2, HCN4, and Cx45 and 
working-myocardium-positive markers ANP, Cx43 and NaV1.5 were found using single-cell 
qPCR data that is represented in bar graphs for the two cell types. (B) Gene expression of 
pacemaker channels HCN2 and HCN4 in human SAN, atria and ventricles are compared, 
revealing high expression of HCN in the SAN compared to left atria (LA) and left ventricle 
(LV). Tissues were obtained from freshly explanted heart and expression analyzed by qPCR, 
n=1. 
  
 
 
Figure 3. AP parameters in CTL and IL-1β-treated N-hiPSC-CMs. (A) Recordings of 
spontaneous AP in perforated current-clamp mode obtained from CTL and IL-1β-treated cells 
are superimposed. Note slower rate, DDR and the hyperpolarized MDP, threshold and longer 
APD. (B) Mean data of the various AP parameters summarized in the table show significant 
changes in all parameters induced by IL-1β. (CTL n=10-15; IL-1β, n=9-12) (*p<0.05) 
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Figure 4. Effects of IL-1β on If in N-hiPSC-CMs. (A) Typical recordings of If obtained from 
CTL and IL-1β-treated N-hiPSC-CMs are shown while the mean IV relationship curves is 
shown on panel B (CTL, n=8; IL-1β, n=7, *p<0.05). (C) Mean data for the steady-state 
activation curves of If recorded under CTL and IL-1β conditions were fitted with Boltzmann 
equation. IL-1β results in a significant -4.8 mV shift. 
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Figure 5. Effects of IL-1β on ICaL in N-hiPSC-CMs. (A) Typical recordings of ICaL obtained 
from CTL and IL-1β-treated N-hiPSC-CMs are shown, where significant decrease in current 
density is noticeable. (B) Mean IV relationship curves for ICaL show ~40% reduction in peak 
current density in IL-1β-treated cells compared to CTL. (CTL, n=13; IL-1β, n=16, *p<0.05) 
(C) Mean macroscopic current activation curves for ICaL constructed and fitted with 
Boltzmann equation, reveal significant a negative shift in ICaL activation. 
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Figure 6. Regulation of gene expression by IL-1β. Single cell qPCR testing gene expression 
of major α-subunit of ion channels underlying If and ICaL were performed on CTL and IL-1β-
treated N-hiPSC-CMs. Data reveals that IL-1β induces no significant difference in global gene 
expression of HCN2, HCN4, while differentially modulating CaV1.2 and CaV1.3. 
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5 Discussion 
This thesis has been entirely dedicated to the advancement of knowledge of the SAN 
and its regulation. Although initially discovered more than 100 years ago, the SAN is a small, 
extremely complex and difficult structure to study and much remains to be known about its 
organization, function and role in physiological processes and disease. The SAN is the natural 
pacemaker of the heart that dictates rhythm while carrying the substantial responsibility of 
adjusting cardiac frequency to meet the physiological demands of the organism.
3
 Needless to 
say, failure to do so might result in devastating outcomes including shortness of breath, 
hypoperfusion, syncope, various arrhythmias, chronotropic incompetence and inability to 
perform the most simple physical activities, especially in the elderly population.
20,156
 
Considering the fact that the population is progressively ageing, it is estimated that the 
proportion of individuals suffering from SND will more than double in the next 50 years and 
currently, the only approved treatment for SND is the implantation of electronic 
pacemaker.
97,156
 Therefore, understanding how the SAN is regulated is becoming increasingly 
important and accordingly, we attempt to fill some of this knowledge gap with three studies 
presented in this work. Indeed, by using both physiological and pathophysiological models, 
we provide new evidence and mechanistic insight on the regulation of cardiac pacemaking 
during health and disease and lay a foundation with exciting new ideas that we will build on 
and extend in our future studies. 
5.1 Highlights, main findings and implications 
5.1.1 Pacemaking during pregnancy 
Starting with physiological mechanisms, the first two studies explored the influence of 
pregnancy on SAN function. It has been long known that during pregnancy there is an increase 
in resting heart rate and although several mechanisms explaining this adaptation have been 
proposed, none implicated SAN remodelling. To our knowledge, the findings reported here 
represent the first evidence in the literature clearly demonstrating that the SAN undergoes 
electrical remodelling to increase and sustain an elevated heart rate throughout pregnancy and 
that delivery results in a rapid and near complete reversal of this adaptation. In other words, 
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our findings support a new notion proposing that the SAN is a dynamic cardiac tissue capable 
of undergoing extensive remodelling in order to meet physiological demands and not, as 
historically thought, a static pacemaker which is simply regulated through autonomic tone 
balance and circulating catecholamines.  
Specifically, using a mouse model of pregnancy we first show that these mice exhibit 
an increase in heart rate similarly to pregnant women and when the hearts were perfused ex 
vivo, this increase persisted, indicating that that the faster heart rate was due to an intrinsic 
change to the heart and was not attributable to enhanced sympathetic tone, as previously 
suggested.
157
 Additional evidence supporting our observation came from hemodynamic 
measurements and blood work performed on pregnant mice revealing that neither arterial 
pressure nor circulating catecholamines differed compared to controls. Since the SAN is the 
intrinsic cardiac pacemaker, following these results, SANs of pregnant mice were dissected, 
enzymatically digested and individual SAN cells were isolated and subjected to several 
analyses in order to determine whether and how they contribute to an accelerated heart rate. Of 
note, obtaining individual cells represents a major challenge in exploring the SAN. Being no 
larger than 1.5 mm
2
 in mice, dissecting and digesting the SAN is a technique that requires 
dexterity, patience and years of optimization and yields only a little number of cells even when 
well executed (~10 on average) compared to ventricular or atrial cell preparations. 
Fortunately, we have managed to successfully record spontaneous APs from individual SAN 
cells and found that the ones isolated from pregnant mice had a significantly higher 
automaticity, with faster diastolic depolarization compared to controls. 
 Subsequently, we explored the role of membrane ion channels and intracellular Ca
2+ 
handling in this increased AP rate and reported that pregnancy induces a substantial increase 
in If and ICaL along with faster Ca
2+
 transient rates and SR Ca
2+ 
release. Molecularly, these 
changes were correlated with a significant increase in HCN2 protein expression and CaV1.3 
and RyR2 mRNA expression. Of note, no changes in mRNA expression of HCN2 were 
detected and the reason behind this remains unknown, however since this is not a major 
isoform in the SAN but has a key role in accelerating pacemaking during pregnancy it is 
possible that HCN2 channel turnover was reduced instead of initiating transcription. 
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The molecular work has been performed on whole SAN and due to its tiny size this 
required isolating and pooling several samples in order to extract enough material. Through 
technique optimization we were able to reduce the required number of animals for a single “n” 
number from 10-12 to 4-6 SANs, thereby cutting the amount of required animals and work by 
half and permitting the development of Western blot techniques optimized for SAN proteins 
including membrane-bound ion channels. 
 The coupled-clock, the current model of SAN pacemaking, is based on the principle 
that both membrane voltage and Ca
2+
 clocks are locked in together and mutually entrained to 
generate automaticity (introduced p.28 and summarized in Figure 7). Here, we report 
electrophysiological and molecular changes that highlight a specific circumstance where a 
complete modulation of the coupled-clock system occurs, providing additional support for a 
coupled-clock model of pacemaking. Specifically, it was demonstrated how several 
constituents of this system were regulated while working collectively through a pregnancy-
induced upregulation in order to accelerate and sustain rapid heart rates.  
Interestingly, the fast heart rates, being a known risk factor for arrhythmias also 
correlated with an increased arrhythmia risk in pregnant mice which was uncovered through in 
vivo electrophysiological testing. These findings are consistent with reports of arrhythmia 
susceptibility in pregnant women
84,85
 thus, our studies also provide a novel molecular 
determinant that explains, at least in part, why childbearing women may suffer from rhythm 
disturbances. We believe understanding the basic physiological mechanisms in health is 
crucial in order to identify how they are altered in pathology. Hence, a clear understanding of 
SAN function during pregnancy provides an important step towards the future of managing 
electrical disturbances in pregnant women, specifically and women‟s health generally. With 
the constantly increasing average age of first pregnancy
158
 and presence of progressively more 
comorbidities during this critical period, a clear understanding of the basic mechanisms 
underlying cardiac electrical function  is becoming ever more relevant.
157
 
Another important aspect that we also reported was that these changes were rapidly 
reversible upon delivery. Indeed, when we performed all of the experimentation and analysis 
on 24-48H postpartum mice, we found a normalization and return to baseline of the examined 
parameters including heart rate, AP frequency, If, ICaL as well as Ca
2+ 
transients frequency 
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indicating that pregnancy-related factors are contributing to this remodelling of the SAN. The 
brief postpartum period during which we performed our analysis was sufficient for ECG 
parameters, arrhythmia susceptibility, ionic currents and gene expression to return to control 
values, attesting to the rapidity of the events. Interestingly, a similar swift return to baseline is 
also observed in pregnant women, where heart rate has been reported to return to the pre-
pregnancy values within two weeks after delivery. Overall, these observations provide 
additional evidence in support of the pregnant mouse as a model with applicability and high 
relevance to human electrophysiology.
61,159
 
 
5.1.1.1 Role of hormones in regulating pacemaking 
Analysis of arrhythmia risk during various phases of pregnancy in women appears to 
coincide with moments of substantial fluctuation levels of hormones such as the ones observed 
during postpartum period. This observation suggests a major role for hormones as instigator of 
electrophysiological remodelling of the SAN. Hormones are the subject of current work in our 
laboratory in order to evaluate their role in regulating pacemaking and determine through 
which pathways they signal.  
Indeed, as mentioned in the previous sections and studies several hormones including, 
estrogen, progesterone, relaxin and thyroid hormones have been shown to affect ion channels 
in various ways. However, previously shown to have pleiotropic effects and regulate various 
ion channels and even excitability of neurones,
78,90–93
  oestrogen is likely to be a potent 
regulator of cardiac ion channels. Recently, we showed that oestrogen receptor α negatively 
regulate Kv4.3 subunit in the ventricles and prolongs repolarization.
160
 Furthermore, oestrogen 
was also shown to reduce Kv4.3 expression in ovariectomized mice and induce cardiac 
hypertrophy.
161
 Previously, we have used various mouse models including oestrogen 
administration, deficiency (ovariectomy) and oestrogen receptor knockout mice, to generate an 
extensive amount of results determining the role of oestrogen and oestrogen receptors in 
regulating ventricular K
+ 
channels, repolarization, and QT interval. Accordingly, using these 
models and approaches we have begun investigating the role of oestrogen in modulating the 
SAN. Preliminary data suggests that chronic treatment of mice with oestrogen significantly 
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increases heart rate (data not shown) and our subsequent step will be to evaluate the 
electrophysiological properties on the SAN and determine how they compare to pregnant 
mice. Moreover, it will be interesting to determine the effects of pregnancy on SAN 
automaticity in oestrogen receptor knock-out mice considering in these mice all the other 
hormones and associated regulatory pathways are present.
162
 Although female oestrogen 
receptor α knock-out mice are completely sterile, pregnant β receptor knock-outs can be 
studied. Alternatively, it will also be possible to administer chronic oestrogen treatment to 
both α and β knock-out mice in order to determine which receptor and underlying pathways 
are activated in the SAN, contributing to the increase in heart rate. 
Thyroid hormone is another major factor to be considered owing to its ability to 
regulate ion channels as well.
94,95
 We have started using propylthiouracil in pregnant mice in 
order to uncover the effects of thyroid hormones and the preliminary data thus far does not 
suggest a major role for this hormone in increasing heart rate during pregnancy (data not 
shown), despite its ability to induce several changes in electrophysiological parameters, 
similarly to what is observed in the general population.
163
 Lastly, relaxin, a key female 
hormone that has previously been shown to have various cardiac effects
164,165
 will be 
examined in more depth although we showed in our first study that it was not responsible for 
changes in If activation kinetics and did not increase cAMP significantly in the SAN. 
Nonetheless, there are reports showing that it can increase ICaL density making it a potential 
contributor to the faster heart rate during pregnancy.
157,165
 
 
5.1.1.2 Pregnancy affects other parts of the conduction system 
Interestingly, when closely analysing the ECGs it was noted that, compared to control 
mice, the rapid heart rate of the pregnant animals was also accompanied by a significantly 
shorter PR interval without any change in P wave duration. Since the duration of the PR 
interval comprises the P wave and impulse conduction through the atrio-ventricular junction, 
we concluded that the shorter PR interval in pregnant mice is likely to be a consequence of a 
faster AV node conduction with a preserved atrial conduction time as suggested by the similar 
values of the P wave durations between control and pregnant mice. This finding is not 
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completely surprising considering the atrio-ventricular node is regarded as an accessory 
pacemaker that shares numerous properties with the SAN including spontaneous pacemaking 
activity, expression of HCN channels, slow conducting connexins and several other ion 
channels.
4
 Thus, it is very likely that the changes that pregnancy brings about to the SAN also 
extend to the AV node and other parts of the conduction system in order to support 
propagation of the rapid heart rate throughout the entire heart. 
 
5.1.1.3 Role of autonomic nervous system in regulating heart rate 
The SAN is innervated by both sympathetic and parasympathetic branches of the 
autonomic nervous system allowing for precise heart rate control.
166
 Indeed, sympathetic 
stimulation causes the release of catecholamines that accelerate heart rate by augmenting 
conductance of key pacemaking ion channels in the SAN including HCN and CaV1.2/1.3. 
Conversely, parasympathetic stimulation by means of the vagal nerves induces an opposite 
effect resulting in a slowing of heart rate.
37
 After the first trimester of pregnancy, several 
studies have previously shown that women exhibit lower heart rate variability and a blunted 
response to Valsalva manoeuvres.
167–169
 This indicates that there is an enhancement of 
sympathetic and reduction in vagal parasympathetic tones. The overactive sympathetic branch 
overrides vagal input, hence reducing the heart rate variability while also blunting the response 
to a vagal stimulation that normally rapidly decreases heart rate. Therefore, it has been 
suggested that the increase in heart rate during pregnancy could be explained by the increase 
in sympathetic tone. However, our study performed in mice, where sympathetic drive is 
already dominant, shows that an intrinsic change to the heart is responsible for the increase in 
heart rate during pregnancy.
157
 As such, when hearts were perfused ex vivo the rate dropped by 
~30% highlighting the strong sympathetic tone in mice, yet a difference in heart rate between 
control and pregnant mice remained. In fact, the difference between the two groups was 
somewhat even larger ex vivo most likely due to the loss of the vagal influence that was 
slightly dampening the heart rate increase in pregnant animals.
157
 Indeed, we have shown 
presence of vagal tone in pregnant mice through atropine administration (unpublished data). 
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We thus, conclude that although sympathetic tone in pregnant women might be contributing to 
some extent to the increased heart rate, it is acting over an electrically remodelled SAN. 
 In additional support of an intrinsic regulating of heart rate in women, it was shown 
that women have a higher heart rate and that the intrinsic heart rate i.e. after autonomic 
blockade, is higher than in men, suggesting an inherent difference in the hearts of men and 
women.
170,171
 This observation would also be consistent with the previously discussed role of 
female hormones, notably oestrogen, in regulating cardiac electrical properties. 
 
5.1.1.4 Comparison of pregnancy to other physiological adaptations 
In many ways similar to pregnancy, an interesting physiological adaptation to be 
considered is exercise. Indeed, chronic exercise activates pathways that lead to physiological 
eccentric hypertrophy. Eccentric hypertrophy develops as a result of increased venous return 
and preload resulting in parallel replication of sarcomeres in the ventricles, thus, expanding 
the cardiac chamber for enhanced blood capacity.
172
  This hypertrophy can be paralleled to the 
one observed during pregnancy where a similar hemodynamic changes to exercise occur. For 
instance, stroke volume, cardiac output, myocardial contractility and total vascular compliance 
are all increased in order to provide adequate blood supply to the organs and muscles.
173,174
 
Conversely to pregnancy however, resting heart rate is reduced by exercise and in high 
performing endurance athletes bradycardic rates lower than 30 bpm having been reported.
175
 
Historically, this profound bradycardia has been attributed to enhanced vagal tone in athletes. 
However, evidence now shows that bradycardia persists after complete autonomic blockade, 
indicating that an intrinsic remodelling of the SAN is responsible for slow heart rates.
22
 
Interestingly, denervating either rats or dogs and subjecting them to physical training 
completely prevents the exercise-induced bradycardia, underlining the essential role for the 
autonomic system in inducing remodelling of the SAN. Furthermore, it was also shown that in 
athletes, AV node recovery time was significantly prolonged suggesting AV node dysfunction 
and indicating that the electrophysiological remodelling also extended to other parts of the 
conduction system.
176
 Thus, even though both pregnancy and exercise training appear to be 
physiological states that share several similarities, there is a sharp contrast when it comes to 
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the regulation of the SAN and the conduction system whereby intense aerobic exercise, 
ironically, promotes deep bradycardia and other pathological remodelling of atria often 
requiring implantation of pacemaker later in life.
20
  
 
Indeed, molecular analysis and vis-à-vis comparison of athlete and pregnant hearts 
reveal that in pregnancy, high levels of oestrogen induce a physiological eccentric hypertrophy 
that is negative for changes in pathological markers of hypertrophy such as α- and β-myosin 
heavy chain, atrial natriuretic factor, phospholamban, and SERCA2a that are normally 
affected in heart disease. The increase in cardiac hypertrophy was previously attributed to 
lower Kv4.3 and c-Src tyrosine kinase activation, a kinase that can be activated by stretch.
161
 
On the other hand, during exercise hypertrophy, a significant increase in insulin growth factor 
activates downstream PI3K(p110α) and Akt1, leading to increase in cardiac mass, output and 
improved overall function.
177
 This implies that the molecular signature underlying the 
hypertrophy in exercise and pregnancy are different. Thus, although the outcome in both of 
these physiological states is a beneficial hypertrophy,  the evidence points to a major role for 
hormones in regulating mechanical and electrophysiological properties of the heart and the 
SAN. This also highlights a main difference in the instigating factors and underlying 
signalling pathways between these two physiological states where a strong dependence on 
autonomic control for exercise-induced remodelling is required. Overall, these findings could 
explain why the SAN function is enhanced by pregnancy and diminished during chronic 
intense exercise. 
 Recently, the molecular mechanisms underlying pathological remodelling during 
exercise were the subject of several studies that triggered worldwide discussion.
178–180
 
However, it is essential to note that the benefits of physical exercise are in no case being 
questioned nor is exercise being portrayed as a pathological condition. Importantly, a 
distinction must be made between moderate physical activity and intense endurance exercise 
seen at the professional level such as in Olympians or Tour de France athletes. In a group of 
retired cyclists, higher rates of SND were observed and generally, in extremely athletic 
individuals, irreversible bradycardia and SND associated with atrial fibrillation is often 
observed, requiring the implantation of cardiac pacemaker.
22,181
 In order to determine the 
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underlying mechanisms of this pathological electrical remodelling, rodents were subjected to 
intense and long training times of treadmill running or swimming. Examination of these 
animals revealed that endurance exercise training in rodents results in slower automaticity of 
the SAN attributable to a lower expression of HCN4 correlating with a downregulation of 
Tbx3.
182
 Furthermore, the significant lowering in resting heart rate was associated with higher 
susceptibility to atrial fibrillation that was explained by electrical remodelling, increased 
fibrosis and atrial enlargement.
183,184
 Interestingly, it was shown that the pathological 
remodelling of the atria associated with exercise was dependent on the pro-inflammatory 
cytokine tumour necrosis factor α.183 Thus, it appears that intense physical activity can also 
induce remodelling of supraventricular tissues and contributes to SND through inflammatory 
pathways, thereby supporting our hypothesis that inflammation might be a common 
denominator between seemingly unrelated diseases that result in SND. 
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5.1.2 Pacemaking and inflammation 
The second theme of this thesis focused on understanding the cellular and molecular 
mechanisms that result in SND.  Bradycardia and SND are affecting more and more people as 
the population is getting older and the current treatment options are limited to the implantation 
of electronic pacemaker. In fact, the estimate that over the next 50 years the rate of SND will 
more than double might even be an understatement of the prevalence of the condition. 
Considering there are many challenges in examining, diagnosing and reporting SND in large 
epidemiological studies, this means projections are based on current numbers that are 
currently underestimated.
97,156
 The consequences of SND can vary from mild discomforting 
symptoms such as shortness of breath to atrial fibrillation, syncope, and chronotropic 
incompetence, rendering affected individuals incapable of completing any task that requires 
the slightest effort and increase in heart rate.
20
 Several years ago, while analysing telemetry 
and ECG data in an HIV mouse model in our laboratory, data revealed several types of 
electrical disturbances. Although we were particularly interested in the ventricle, we noted 
sinus pauses and arrhythmias consistent with SND in these mice.
132,133
 Following these 
observations, we showed that circulating pro-inflammatory cytokines that were elevated in 
HIV mice were able to cause electrical remodelling and alter properties of several major 
ventricular ion channels including K
+
,
 
Na
+
 and Ca
2+
 channels.
69,133,134
 Interestingly, by 
examining the literature later on, several reports showing clear SAN dysfunction in infectious 
conditions were noted. Furthermore, SND was also present in autoimmune inflammatory 
conditions, diabetic conditions and even ageing.
122,185,156,186
 With our previous data showing 
that pro-inflammatory cytokines can alter ionic currents in the heart, we were able to propose 
the hypothesis that inflammation is a key process that is shared by multiple pathologies and 
even ageing that can lead to SND. As pointed out earlier, even intense exercise associated with 
deleterious electrical remodelling and bradycardia involved a pro-inflammatory cytokine.
183
 
Although a plethora of cytokines are upregulated in various disease states, we began 
evaluating the effects of IL-1β on pacemaking in our first study. There are several reasons 
behind this. IL-1β is a major cytokine that is activated early on in the inflammatory cascades. 
We initially detected it in HIV mice and at high concentrations it was shown to induce 
cardiomyopathy. Conversely, its blocking was shown to be protective in myocardial 
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infarction, heart failure and several other conditions.
133,187–191
 Analysis of blood samples of 
patients suffering from inflammatory conditions such as rheumatoid arthritis, heart failure and 
relapsing pericarditis, also revealed that the levels of IL-1β are particularly elevated and 
importantly, we previously showed that IL-1β was a potent suppressor of ventricular ICaL, a 
current that also plays a critical role in pacemaking.
69,192
 In addition, the presence of anti-IL-
1β treatments approved for human administration increases potential usefulness and 
translational potential of the study should IL-1β be validated as a SND target. 
Accordingly, we began our investigation with IL-1β in hiPSC-CM nodal myocytes 
using previously tested conditions where a prolonged treatment was to be administered 
considering no acute effects on ionic currents could be observed (data not shown). Following a 
72H-treatment with IL-1β recordings of spontaneous action potentials revealed a significant 
slowing in their rate. Analysis of the various parameters revealed that the DDR (or slope of 
phase 4) of the APs was dramatically reduced. Since the DDR is a key regulator of rate, this 
was the first evidence that IL-1β adversely affects automaticity. 
The voltage-dependent molecular determinants of the DDR being If, T and L-type Ca
2+
 
currents we subsequently examined these individual currents in order to determine whether 
they were affected. T-type Ca
2+ 
channels are known to be expressed and contribute to 
automaticity of mouse and rabbit SAN. They were also shown to be expressed in humans 
SAN.
9,193
 However, no current was detected in  nodal hiPSC-CM although it was shown to be 
expressed at the mRNA level (CaV3.1).
194
 This could either mean that these cells lack a 
functional current or that human SAN expresses non-functional T-type channels. Although the 
T-type channel blocker mibefradil was shown to lower heart rate in humans,
195
 to our 
knowledge the very little data from adult human SAN that exists is limited to If and a few 
other currents with no direct evidence or recordings attesting to the existence of ICaT current in 
the SAN. Thus, no conclusion can be made about this subject at present and it would be 
tempting to resolve this issue in the future. Historically, expression of T-type Ca
2+ 
channels 
have been widely known to be repressed in the adult cardiac tissue and only reactivated during 
pathology and in N-hiPSC-CM we found that IL-1β induces re-expression of CaV3.1 
(preliminary data not shown).
193
 Since most human SAN data is derived from elderly patients 
it is possible that ion channel expression was noted to be more elevated than normal due to 
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presence of some form of pathological reactivation of gene expression. Arguably, T-type Ca
2+ 
channels may not be necessary for human pacemaking owing to the low depolarization 
frequency compared to smaller animals and rodents where fast Ca
2+ 
kinetics, supported by 
CaV3.1, are absolutely necessary to sustain rapid rates. Thus, a transition in depolarizing 
current from If to ICaL may be possible and in support of this view smaller If and NCX current 
with weaker Ca
2+
 transients have been noted in the human SAN compared to the rabbit, 
potentially indicating that the slower rates found in human might not require large 
conductance and very rapid channel kinetics.
196–198
 Of course, this aspect remains purely 
speculative and remains to be validated in the future. 
Nonetheless, a robust ICaL could be recorded and data showed that IL-1β causes a near 
40% reduction in its density, consistent with our observed effect in ventricular cells.
69
 The 
smaller ICaL is consistent with a lower DDR and reduced AP rate. Lastly, the pacemaker 
current If was recorded in both groups and mean data showed that IL-1β caused a near 70% 
reduction in its density at voltage range close to the maximal diastolic potential, i.e. the 
functionally relevant range. Analysis of If activation revealed that IL-1β causes a significant 
negative shift in activation, consistent with the slower automaticity and lower conductance 
that were observed compared to the controls. Overall, our findings indicates that IL-1β 
through its effects on ionic currents involved in pacemaking adversely affects automaticity and 
may well be a factor in the development of bradycardia and SND. With the data reported in 
human cardiac cells, this provides an increased relevance and human applicability aspect to 
the results. 
 
5.1.2.1 hiPSC-CMs as an in vitro SAN cell model  
Early stages of any project ideally require a robust, fast and cost-effective way of 
determining whether there is any merit to extensively testing a particular hypothesis. Since we 
needed to determine if a chronic exposure to IL-1β had any effect on SAN and pacemaking, 
not many options were available. Considering isolation of SAN cells and their subsequent 
culture was not a feasible choice (extremely low cell number, culture conditions undefined, 
etc.), a pre-established in vitro model or in vivo experimentation was necessary. Since defined 
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in vitro models of SAN cells do not really exist per se, this made the situation rather difficult. 
In vivo models are interesting and a viable option but they present many limitations for early 
studies, especially in our case where long term IL-1β treatments are required. Large quantities 
of recombinant cytokines, animals, housing during entire treatment duration and subsequent 
reagents and experimentation proves globally to be extremely costly for initial and pilot 
studies. 
Incidentally, we had in the laboratory a relatively new source of human cardiac cells 
derived from induced pluripotent stem cells that were being used for other projects. Through 
characterization work, a subpopulation of spontaneously beating cells was identified. These 
cells were already labelled as nodal-like myocytes in previous studies due to their action 
potential morphology
200
 however, very little information other than that was known. This 
finding presented itself as an opportunity to advance the characterization of these cells as they 
might carry the potential to become a novel and unique in vitro model of human SAN cells. 
Indeed, the extremely limited availability of human SAN tissues with the technically 
challenging isolation of individual SAN cells from animals make these cells a highly 
interesting and appreciated model to individuals interesting in studying regulation of 
pacemaking properties. 
 Accordingly, a new strategy was devised in order to determine the 
electrophysiological and molecular signature of nodal-like hiPSC-CMs. First, using current-
clamp technique, spontaneous action potentials were recorded and their various parameters 
were analysed. Our data is consistent with the values recorded from adult human SAN. 
Overall, cycle length, action potential duration, maximal diastolic potential and diastolic 
depolarization rate all seemed to be, although not identical, within an acceptable range and 
comparable to AP data recorded from isolated individual human SAN cells.
196
 These 
parameters are compared between the two cell types in Figure 10. 
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 Comparison between AP recordings obtained from human SAN Figure 10.
cells to APs we recorded in N-hiPSC-CM. Top- Examples of adult human AP 
recordings (from (Verkerk et al. 2007) are shown on the left while N-hiPSC-
CM are on the right. Fresh human SAN cells were isolated from arrhythmic 
patient. Note extremely long DD in human SAN not necessarily representative 
of mean data. Red traces indicate AP with 2mM Cs
2+
 to block If. Bottom- 
Mean data shows that several parameters between the two groups are 
comparable. Even more so following IL-1β treatment for rate and MDP. 
Highly comparable parameters are represented in red. *Highly variable 
parameter which might also be consistent with IL-1β-treated N-hiPSC-CM 
DDR values. Modified from Verkerk et al. 2007.
197
 
 
 
 
 
 
 
 
7 
 
 
 
 
 
 
 
It is important to evaluate human data with caution. For instance, a major limitation is 
that the cells in this previously mentioned study were isolated from a patient suffering from 
supraventricular arrhythmias requiring SAN ablation, indicating potentially severe SAN 
electrical remodelling and SND. This factor alone would account for many of the observed 
differences between AP parameters. Furthermore, APs were recordings under different 
experimental conditions. A remarkable observation however, is that several AP parameters 
from IL-1β treated cells are more consistent and much closer to the values reported for adult 
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human SAN APs. Heart failure and SND might also account for the slower AP rate in human 
SAN cells. Although the AP frequency in N-hiPSC-CM appears to be faster than previously 
reported in adult human cells, it is consistent with intrinsic heart rates of otherwise healthy 
adults 20–40 years of age (Figure 7) obtained either by pharmacological autonomic blockade 
or denervation.
201,202
 Lastly, with the existence of other human SAN AP reports, it will be 
noteworthy eventually to compare all of this data while ensuring that similar recording 
conditions were maintained. Overall, we conclude that AP parameters of hiPSC-CM show a 
highly interesting resemblance and are consistent with adult human data of SAN AP, this 
observation was further supported by the presence of robust If and ICaL currents.  
 
A novel aspect of this characterization was the ability to determine the molecular 
signature of these nodal cells and establish whether they express known markers of human 
SAN and if indeed they differed from the working myocardium cells. In order to complete this 
objective, developing a method to separate the two cell populations and analysing their gene 
expression was necessary. Using the patch-clamp setup, individual myocytes could be picked 
up using a modified electrode fitted on an electronic micromanipulator that would allow rapid 
removal of adherent cells. Cells were promptly deposited in tubes filled with required reagents 
for single-cell qPCR technique. Although qPCR reactions are possible with the content of one 
cell, in order to reduce variability and chance of no detection resulting in experimental error, 
several cells were pooled per “n” number up to maximum of 5 cells. qPCR data showed that 
nodal hiPSC-CM had a high expression of the SAN hallmark genes, pacemaker channel 
HCN4 and slow conducting Cx45, compared to their working myocardium counterpart. 
Furthermore, negative markers of SAN were also tested. We report lower expression of atrial 
marker ANP, fast conducting Cx43 and cardiac NaV1.5 Na
+
 channel. Some of these results 
were also compared to explanted human heart tissues obtained from patients undergoing 
surgery. As an example, the data shows expectedly high expression of HCN isoforms in the 
SAN and dramatically lower expression in atrial and ventricular tissues validating the single 
cell technique and conditions. 
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The HCN expression in different human cardiac tissues is nonetheless not consistent 
with the results obtained in working myocardium hiPSC-CMs that show relatively high 
expression of HCN4. Indeed, this result does not invalidate the nodal phenotype but rather 
points out to an already widely known phenomenon, the immaturity of hiPSC-CM.
154,155,203
  
It is likely that nodal-like myocytes are not necessarily immature like their working 
myocardium counterparts. During embryogenesis, at the tube heart stage, the myocardium 
contracts poorly, has very low T-tubule density, poorly developed sarcomeres and SR, slow 
conduction and automaticity, essentially resembling nodal cells. As early as E10.5-12.5, 
contractions within the tube trigger initial chamber formation and the sinus venous region 
progressively becomes more and more isolated as working myocytes mature.
13
 The sinus 
venous region retains expression of repressive transcription factor that prevent its 
differentiation into working myocardium cells, eventually getting encircled and developing 
into a mature SAN. In other words, the nodal fate is established early on in embryogenesis and 
through complex transcriptional networks that progressively lead to loss of pacemaker 
channels and slow conducting gap junctions, working myocardium cells form.
204
  
Thus, in hiPSC-CM working myocardium cells might be in the early stages of 
development where they still share properties of both working and nodal-like cells.  In support 
of this view, we analysed expression of Nkx2.5 in hiPSC-CM. Nkx2.5 is a key transcription 
factor involved in septation, chamber development and expression of contractile proteins (see 
p.28).
3
 Our preliminary data shows lower expression of Nkx2.5 in nodal cells compared to the 
working type (data not shown) indicating a maintained repression of Nkx2.5 that prevents the 
development of various proteins required for contractility. Interestingly, it has been reported 
that culturing hiPSC-CM for long periods of time matures the working myocardium 
phenotype.
205
 It is possible that this is the result of long-term expression of Nkx2.5. 
Overall, the electrophysiological data combined with gene expression supports the 
notion that nodal hiPSC-CM might be a novel and useful in vitro model to study mechanisms 
of human cardiac automaticity. Currently, a comprehensive approach to fully characterize 
these cells is undergoing development. Functionally, Ca
2+ 
homeostasis will be examined and 
compared to current available data in animal models and molecularly, additional expression 
profiling of other key genes will be performed. For instance, expression of key cardiac 
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proteins that are differentially expressed between the SAN and working myocardium tissues 
including Cx40, Cav1.3, Shox2, Tbx3, MLC2v, MLC2a as well as RyR2, SERCA2a and 
various K
+ 
channels will all be assessed and we hope that an enrichment of nodal factors with 
a reduced expression of working myocardium genes will be observed. Eventually, this 
expression profile will also be compared to that of adult human SAN thereby completing a 
major milestone in the characterization of nodal hiPSC-CM. 
 
5.1.2.2 In vivo effects of IL-1β  
While human cellular models are highly interesting, akin to every model, they have 
limitations. Considering they are in vitro models of disease, they are missing major circulating 
factors and the complex physiological milieu of a whole organ system. Thus, in vivo and 
animal validation is also required in order to generate a complete functional approach that 
encompasses multiple models thereby increasing the translational potential and substantiating 
the data. Accordingly, with the in vitro data serving as a starting point we have begun testing 
chronic administration of IL-1β into adult mice. Mouse recombinant IL-1β solution or saline 
were filled into miniosmotic pumps. The pumps were primed and implanted subcutaneously 
between the scapulae, release rate was calibrated for 3 μg/kg daily.191 Pumps were implanted 
for either 7 or 14 days in order to determine appropriate timeline required to obtain an effect. 
At the end of the treatment, ECG measurements for every animal were taken and were 
compared to baseline values obtained prior to pump implantation. In the future, live telemetry 
devices will be implanted in order to monitor heart rates continuously. Using telemetry data 
we can determine whether the effects of IL-1β are variable within a day or with activity level. 
Heart variability analysis correlated with day-night cycles and activity levels will allow 
determining how the heart rate fluctuates with IL-1β and uncover influence of sympathetic and 
vagal tones. Since there is evidence that IL-1β uncouples the β-adrenergic response, these 
results might prove to be noteworthy.
199
 Interestingly, our preliminary data on 14 days and not 
7-day treated animals reveals that the delta-decrease in heart rate was significantly larger in 
mice treated with IL-1β compared to saline, suggesting that chronic infusion of IL-1β into 
mice might progressively induce bradycardia. Once these results are validated with a larger 
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number of animals, a full ex vivo and cellular analysis of the SAN similar to the studies 
present will be performed. In addition, optical mapping through use of voltage sensitive dyes 
on intact isolated SAN will be performed. This will allow determining whether conduction 
velocity, lead pacemaker and arrhythmogenic potential are affected by chronic IL-1β. 
Eventually, Ca
2+ 
homeostasis will also be examined in both N-hiPSC-CM and mouse SAN 
cells. We anticipate that the use of an approach combining animal data and human cellular 
model of the SAN will prove to be additional benefit and advantage in drawing a complete 
picture on the role of IL-1β in SND. 
 
5.2 Future directions 
It is certain that the studies presented here constitute merely the beginning of large 
projects filled with new and exciting work to come in the near future. Eventually, we hope that 
the outcomes to be valuable across multiple disciplines ranging from pregnancy, hormonal 
regulation of SAN and women‟s health to the elderly and patients suffering from SND. In 
regards to the SND-related studies, much work remains to be done in terms of characterizing 
nodal hiPSC-CM, in vivo testing and gaining mechanistic insight. Adopting a 
multidisciplinary approach in order to build an integrative and comprehensive model of 
disease will be an essential requirement for the development of new therapies. As an example, 
diseases where inflammatory cascades are activated induce the production of a plethora of 
cytokines that can have redundant, synergistically or antagonistic functions to each other. 
Indeed, there are more than 40 different cytokines in the interleukin family alone and while 
cytokines like IL-1β, TNFα or interleukin-6 are pro-inflammatory others such as interleukin-
10 have anti-inflammatory effects.
206
 Integrating their individual effect into an equation that 
yields a net outcome will therefore be an extremely challenging aspect. In heart disease, 
tumour necrosis factor α, TGF-β and platelet-derived growth factor, to name a few, have been 
shown to induce ionic current remodelling, fibrosis and activate hypertrophic pathways 
134,140,207,208,183,209,210
 and teasing out their role in influencing pacemaking or SAN remodelling 
will be essential.  
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As a strategy for the future, once we have clarified the role of IL-1β in inducing SND, 
we will refer to various animal models such as mouse models of HIV, arthritis or other 
inflammatory conditions where pacemaking is affected and attempt to rescue the phenotype 
through IL-1β blockade. Alternatively, this approach could also be complemented using new 
technologies that permit profiling of hundreds of cytokines at once in order to identify the 
ones that are particularly highly expressed. I trust this will prove to be particularly useful in 
determining the role of inflammation in ageing-induced SND. Recently, it was shown frailty 
and not chronological age correlated with decline in SAN function. Indeed, the frailest 
animals, identified by means of a reproducible frailty index, had the most extensive electrical 
and structural remodelling with the worse SAN function.
126
 Consequently, use of large scale 
profiling on these animals might reveal particular cytokines that are highly active and are 
contributing to the rapid decline in SAN function. Previously, we have shown that TNFα and 
IL-1β induce oxidative stress in the ventricular myocytes, it would therefore be unsurprising if 
they were found to be elevated in frail animals and contributing to SAN senescence.
69
 In short, 
there might be a strong link between frailty, inflammation and SND that is certainly worth 
investigating.  
In regards to physiological mechanisms and adaptation to pregnancy, several 
undergoing experiments in our laboratory are attempting to determine the role of hormones in 
regulating electrophysiological properties of the heart and the SAN in particular. New models 
of oestrogen administration are being tested while the use of oestrogen receptor knockout mice 
will also be very useful in determining the downstream signalling pathways that lead to 
electrical remodelling. These in vivo and cellular approaches will also be combined with nodal 
hiPSC-CM data generated from cells treated under various conditions. The in vitro analysis of 
nodal myocytes will facilitate the elucidation of molecular changes and signalling pathways in 
response to various hormones within a human myocyte context in order to eventually generate 
a comprehensive view of the physiological changes that occur during pregnancy. This will 
allow us to establish how the adaptations extend to changes seen in women‟s lifespan and 
whether any of these changes can be used to our advantage during disease states. 
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6 Conclusions 
In conclusion, this thesis has been entirely dedicated to the understanding of the SAN. 
Despite its modest size, the SAN proves to be a fascinatingly complex pacemaking structure. 
Overall, we have shown compelling evidence that, far from being a static pacemaker 
controlled by autonomic balance, the SAN is an adaptive tissue that has evolved to respond to 
varying external stimuli. Our work identified novel physiological mechanisms that allow the 
SAN to adapt to the increasing physiological demands during pregnancy. We believe that 
understanding the regulatory pathways during health is a necessity in order to grasp the 
changes brought by disease. To that end, we have also begun a new chapter in understanding 
the mechanisms underlying the pathology of the SAN with the help of cutting edge 
technologies and development of novel cellular models to study human pacemaking 
mechanisms. Eventually, we hope that this work will contribute to advancing new therapeutic 
options, improving women health and the wellbeing of the ageing population.  
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